Zurueck zur Suche

Reporte zur Charge booster 1855191

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

388Reporte angezeigt
8Todesfaelle
44Hospitalisiert
7Lebensbedrohlich
12Bleibende Schaeden
CA 98 FL 29 PA 20 MI 20 NY 19 OH 19 VA 14 WA 11 CO 10 AZ 10 MA 9 GA 8

VAERS 2684643

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
-
Alter
21,0
Geschlecht
M
Eingang
21.09.2023
Impfdatum
29.12.2021
Beginn
22.08.2023
Tage bis Beginn
601,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure Alcohol use Angiogram pulmonary abnormal Blood gases normal Blood lactic acid normal COVID-19 COVID-19 pneumonia Chest X-ray abnormal Dyspnoea Hepatic enzyme increased Hyponatraemia Hypophagia Infection Liver function test increased Lymphadenopathy Mononucleosis heterophile test positive Pharyngitis streptococcal SARS-CoV-2 test positive

Symptomtext

Patient is a 23 y.o. male with no past medical history who presented to hospital 8/22/2023 with shortness of breath found to AHRF due to COVID, positive Mono and Strep A pharyngitis, discharged on decadron and amoxicillin to complete full 10 days. 1. Acute Hypoxemic Respiratory Failure: 2/2 to confirmed positive COVID and Strep A. No PE. No prior oxygen requirement, requiring 2L since admit. Significant cervical adenopathy. No stridor on exam. VBG and lactate normal. WBC 15. CT PA and CXR consistent with covid. Home O2 eval without qualification. 2. COVID pneumonia: Confirmed positive 8/22. Symptomatic x 4 days. S/p solmedrol 60 mg 8/22. No remdesivir due to LFT elevation. Tesslon pearls for supportive care. Decadron x 10 days. 3. Strep A: Appears to have been prescribed amoxicillin outpatient and started on Unasyn in ED. Transitioned to oral Amoxicillin 8/24 to complete full 10 days. 4. Positive Mono spot: supportive care, oral hydration / nutrition. 5. Sepsis POA- related to #2,#3, #4, supportive care, antibiotics, steroids with improvement. 6. Hyponatremia: Unclear etiology. In the setting of poor oral intake and acute infection. S/p 1 L NS bolus in ED w/ 24 hrs of maintenance fluid, normalized 7. Elevated Liver Enzymes: Unclear etiology. Likely 2/2 to recent increased alcohol intake. Last reported drink 8/18. No abdominal pain. Repeat CMP as outpatient to ensure resolution.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2639240

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
-
Alter
19,0
Geschlecht
M
Eingang
31.05.2023
Impfdatum
14.12.2021
Beginn
08.10.2022
Tage bis Beginn
298,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure Hypoxia

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE RESPIRATORY FAILURE HYPOXIA

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2594657

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
MI
Alter
69,0
Geschlecht
F
Eingang
10.03.2023
Impfdatum
05.12.2021
Beginn
04.03.2023
Tage bis Beginn
454,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute kidney injury Acute respiratory failure Blood culture negative COVID-19 COVID-19 pneumonia Dehydration Dyspnoea Electrolyte imbalance Fall Hyperkalaemia Hyperphosphataemia Hyponatraemia Hypophagia Hypotension Hypoxia Imaging procedure abnormal Infection Laboratory test abnormal

Symptomtext

Discharge Provider: MD Primary Care Provider : DO Admission Date: 3/4/2023 Discharge Date: 3/7/2023 Discharge Diagnoses: Superimposed bacterial pneumonia COVID-19 pneumonia Electrolyte derangements - resolved Fall History of seizure Compression deformity of the T12 Adrenal insufficiency Immuno deficiency secondary to chronic steroid use Crohn's disease High output ileostomy Anemia of chronic disease Anxiety Hypertension Hyperlipidemia Coronary artery disease status post stenting Chronic diastolic heart failure Chronic pain syndrome Chronic nausea History of CVA MGUS Neuropathic toe ulcer Hospital Course: Patient is a 71 y.o. female with obesity (BMI 35) and Crohn's disease on chronic prednisone, s/p ileostomy, short bowel syndrome on TPN who presented on 3/4/2023 with acute respiratory failure and acute renal failure secondary to infection and dehydration. For the past 2 weeks, patient had shortness of breath, low po intake with continued high volume ileostomy output. In the emergency department, patient was dehydrated, hypotensive and hypoxic requiring 2 L nasal cannula, and altered beyond baseline. Labs showed metabolic derangements including metabolic acidosis, hyponatremia, hyperkalemia, hyperphosphatemia along with an AKI. She was found to be COVID positive. Imaging showed superimposed pneumonia. Patient was given IV vancomycin and Levaquin along with fluid replacement. She was admitted for acute renal failure, pneumonia and electrolyte derangements. Acute hypoxemic respiratory failure Superimposed bacterial pneumonia COVID-19 pneumonia Patient was treated with 5 days of IV Rocephin and 3 days of a mix of IV and oral azithromycin. Her respiratory failure resolved and blood cultures remain negative. Patient's symptom medically improved before discharge.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Seizure (HCC) Vitamin B12 deficiency Essential hypertension Kidney stone Hx of H. pylori infection TIA (transient ischemic attack) Chronic venous insufficiency Iron deficiency anemia Schatzki's ring Crohn's disease of both small and large intestine Mixed hyperlipidemia Immunodeficiency secondary to steroids Long term (current) use of systemic steroids Vitamin D deficiency MGUS (monoclonal gammopathy of unknown significance) Adenoma Secondary adrenal insufficiency Neuropathic foot ulcer, right, limited to breakdown of skin (HCC) Coronary artery disease without angina pectoris High output ileostomy (HCC) Status post insertion of drug-eluting stents from proximal to distal RCA, 08/03/2021 Chronic pain syndrome Medication management contract agreement Postmenopausal osteoporosis Ischemic cardiomyopathy Mild left ventricular systolic dysfunction (EF 0.50) Anemia of chronic disease Chronic diastolic heart failure (HCC) History of ST elevation myocardial infarction (STEMI) On total parenteral nutrition (TPN) History of ventilator dependency (HCC) Thrombus of Distal Aortic Arch (HCC) Nausea Lung nodule Cracked skin Intertrigo Other viral warts Hypokalemia Community acquired pneumonia of left lower lobe of lung COVID-19
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet aspirin 81 MG enteric coated tablet carvedilol (COREG) 3.125 MG tablet cefdinir (OMNICEF) 250 MG/5ML suspension (Expired) cholecalciferol (VITAMIN D3) 125 MCG (5000 UT) capsule clopidogrel (PLAVIX) 75 M
Allergien
Benadryl [Diphenhydramine] KeflexHives, Nausea and Vomiting Contrast Dye [Ivp Dye, Iodine Containing]Hives Azathioprine SodiumNausea and Vomiting Bumex [Bumetanide] CodeineNausea and Vomiting Darvon [Propoxyphene Hcl] Entyvio [Vedolizumab]Itching Flagyl [Metronidazole]Nausea and Vomiting Imuran [Azathioprine Sodium]Nausea and Vomiting MethotrexateNausea and Vomiting Sulfa DrugsRash Venofer [Iron Oxide, Saccharated] Zocor [Hmg-coa-r Inhibitors]Dizziness
Vorherige Impfungen
-

VAERS 2568680

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
MI
Alter
86,0
Geschlecht
F
Eingang
26.01.2023
Impfdatum
14.12.2021
Beginn
07.01.2023
Tage bis Beginn
389,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Acute respiratory failure Angiogram pulmonary abnormal Atelectasis C-reactive protein normal COVID-19 Confusional state Cough Full blood count normal Headache Heart rate increased Hiatus hernia Hyponatraemia Nausea Positive airway pressure therapy Procalcitonin normal SARS-CoV-2 test positive Tachycardia Urine analysis normal

Symptomtext

COVID+ 1/7/2023. Vaccination Status - J&J x2 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: PA-C Admission Date: 1/7/2023 Discharge Date: 1/19/2023 HOSPITAL PROBLEMS 1. Covid-19 Infection 2. Atelectasis 3. Afib 4. Hypothyroidism 5. Depression 6. Hyperglycemia secondary to steroid use 7. Prediabetes 8. Hyponatremia DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 87 y.o. female with history of AFib RVR on Eliquis. Presented to emergency department with 5 days of headache and nausea and cough. She was COVID positive, tachycardic in the 130s and afebrile. Initial labs including complete blood count, procalcitonin, UA and CRP were normal. She did have mild hyponatremia. She required 2 L of nasal cannula in the emergency department. CTA thorax negative for pulmonary embolus but showed bibasilar atelectasis with chronic left-sided hiatal hernia. She was admitted for acute hypoxic respiratory failure in the setting of COVID-19. While admitted she received remdesivir for 5 days. She was also on Decadron 6 mg for 8 days. She was intermittently confused however respiratory status improved overall. She was weaned to room air during on day 2 of admission. She did require 2 L nasal cannula at night, baseline is CPAP. She would often refuse her CPAP when offered. Course was complicated by persistently elevated heart rate above 100 reaching 130 at times. She was initially on home dose of metoprolol 75 mg twice a day. There was no improvement with increase to 100 mg twice a day. Eventually Cardizem 120 mg daily was added on 01/10. Heart rate significantly improved and was persistently in the 80s. She was evaluated by PT/OT who recommended subacute rehab. She was medically stable for discharge to SAR on 01/19/2023.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
12,0
Labordaten
-
Aktuelle Erkrankungen
11/28/21 ? ED at Hospital Dizziness CHIEF COMPLAINT: DIZZINESS (no bowel movement for a week, lightheadedness, dizzy) Medications ? magnesium citrate solution 296 mL Diagnosis: 1. Constipation, unspecified constipation type 2. COVID-19 virus not detected OV with Colon & Rectal Surgery:12/2/2021 Assessment: Internal hemorrhoids (primary encounter diagnosis) Chronic constipation Plan: A high fiber diet with plenty of fluids (up to 8 glasses of water daily) is suggested to relieve these symptoms. Metamucil, 1 tablespoon once or twice daily can be used to keep bowels regular if needed. Advised to take miralax daily as well. We did discuss doing a colonoscopy as well. She does not want to have one done. Advised to titrate the miralax for her bowel function.
Vorgeschichte
Atypical atrial flutter Environmental allergies Rotator cuff arthropathy, left Tachy-brady syndrome Long term current use of antiarrhythmic drug Poorly fitting dentures Hiatal hernia Complex sleep apnea syndrome Hypothyroidism Moderate episode of recurrent major depressive disorder Cardiomyopathy, nonischemic Persistent atrial fibrillation Physical deconditioning
Andere Medikamente
Amiodarone HCl 200 mg Oral Daily Apixaban 5 MG take 1 tablet by mouth twice a day Calcium Carbonate-Simethicone,Alum & Mag... Oral DULoxetine HCl 30 mg Oral Every morning Fluticasone Propionate 50 MCG/ACT 1 spray Each Nare Daily PRN Levothy
Allergien
CodeineConfusion CornItching Wheat Bran EnvironmentalOther Tuberculin TestsRash
Vorherige Impfungen
-

VAERS 2512482

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
IN
Alter
59,0
Geschlecht
F
Eingang
20.11.2022
Impfdatum
15.12.2021
Beginn
17.11.2022
Tage bis Beginn
337,0
Dosis
2
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute respiratory failure Cardiac disorder Chest X-ray abnormal Chest pain Chronic obstructive pulmonary disease Condition aggravated Coronary artery disease Cough Dyslipidaemia Dyspnoea Dyspnoea exertional Electrocardiogram abnormal Fatigue Hypercapnia Respiratory failure Sinus tachycardia Tachycardia Tachypnoea

Symptomtext

Document Type: ED Physician Progress Note Document Subject: ED Progress Note Performed By: on November 17, 2022 08:41 EST Verified By: MD on November 17, 2022 13:53 EST Encounter Info: Hospital, Inpatient, 11/17/22 - * Final Report * Basic Information Time Seen: MD / 11/17/2022 08:38 Chief Complaint Shortness of breath (Complaint of) History of Present Illness 60 year old female with hx of COPD presents to the emergency department via private vehicle with shortness of breath onset four days ago. The patient states that she is unable to ambulate more than a few steps at home without feeling dyspneic and fatigued. She reports associated cough and chest pain. Denies n/v/d. She was recently admitted to this facility for similar symptoms. Discharged on 10/21 with doxycycline, prednisone, and oxygen 2L NC as needed. The patient states that she has used her oxygen constantly since her current symptoms began. She completed her discharge course of abx and an additional course prescribed by her PCP. She adds that she has been using her nebulizer at home frequently to minimal relief of symptoms. Patient has an appointment with pulmonology on 12/7. Review of Systems Respiratory: +sob, +cough, +fatigue Cardiovascular: +chest pain Gastrointestinal: -nausea, -vomiting, -diarrhea Additional review of systems information: Except as noted above in the HPI and the ROS, all other systems reviewed and otherwise negative. Physical Exam/Objective Vitals & Measurements last 24 hours VITAL SIGNS No qualifying data available. General: Alert, no acute distress Head: Normocephalic, atraumatic Eye: PERRL, EOMI Cardiovascular: Tachycardic, regular rhythm, no murmur Respiratory: Tachypneic, wheezing GI: Soft, nontender, nondistended Musculoskeletal: Normal ROM Neuro: A/Ox4, No focal neuro deficits Psychiatric: Cooperative, appropriate mood & affect Medical Decision Making Vital signs, nursing charting and past history reviewed as pertinent to the case. I have reviewed all studies ordered by myself and any relevant comparisons. Differential diagnosis includes but not limited to: COPD exacerbations vs less likely cardiogenic cause vs less likely PE Will get labs, EKG, CXR and give steroids, breathing tx, and azithromycin. Likely disposition: admission 11/17/22 10:21:22 Discussed case with Dr., hospitalist. He accepts the patient for admission. Requests BiPAP. Re-Assessment 11/17/22 09:40:34 Reassessed patient who feels slightly better after breathing tx. Overall, feels worse than her prior COPD exacerbation when she was admitted. Patient is still slightly tachypneic and is requiring 3.5L NC to stay above 90%. Discussed plan for admission for further evaluation and treatment. Patient agreeable to plan. All questions answered. Condition Stable Disposition: 11/17/22 10:32:24 Admitted, accepted by Dr. Attestations: Scribe, 11/17/22 08:44:55 MD, have reviewed this note and attest to its contents. It was prepared under my direction and at the time of my signature I will have reviewed it in its entirety and edited where appropriate. Assessment/Plan Acute respiratory failure with hypoxia and hypercarbia J96.01 CAD (coronary artery disease) I25.10 COPD exacerbation J44.1 Dyslipidemia E78.5 Tobacco use Z72.0 Follow Up No qualifying data available Chronic Problem List CAD (coronary artery disease) COPD (chronic obstructive pulmonary disease) Current chronic use of inhaled steroid Current use of steroid medication Dyslipidemia Dyspnea H/O: pneumonia Long term use of drug Obesity Preventive measure Tobacco use Procedure/Surgical History ?Mammogram (08/2008) ?Cardiac catheterization ?Carpal tunnel ?Cervicectomy ?Cholecystectomy ?Colonoscopy ?Partial hysterectomy ?Tonsillectomy Medications Home Medications (16) Active albuterol-ipratropium inh soln 2.5 mg-0.5 mg/3 mL 3 mL, Neb Inhal, 4 Times Daily cefDINIR 300 mg oral capsule 300 mg = 1 Capsule, Orally, Q12H cetirizine 10 mg oral tablet 10 mg = 1 Tablet, Orally, Daily DME (Vendor) Oxygen See DME Order Details or printed requisition for more information., This is a print requisition order, cannot be ePrescribed. fluticasone 50 mCg/inh nasal spray 1 Spray, intraNASAL, BID hydroCODONE-acetaminophen 7.5 mg-325 mg oral tablet 1 Tablet, Orally, TID losartan 50 mg oral tablet 50 mg = 1 Tablet, Orally, Daily Misc Supplies See Instructions, Home nebulizerDX: COPDlength of need 99 months nicotine 14 mg/24 hr transdermal film, extended release 1 Patch, Topical, Daily nitroGLYCerin 0.4 mg sublingual tablet 0.4 mg = 1 Tablet, PRN, Sublingually, Q5min pravastatin 40 mg oral tablet 40 mg = 1 Tablet, Orally, At Bedtime predniSONE 20 mg oral tablet See Instructions, 3 tablets daily x4 days, 2 tabs x4 days, 1 tab x4 days, 1/2 tab until gone ProAir HFA 90 mCg/inh inhalation aerosol 2 Puff, PRN, Inhalation, Q4H Symbicort 160 mCg-4.5 mCg/inh inhalation aerosol 2 Puff, Inhalation, BID traZODONE 50 mg oral tablet 25 mg = 0.5 Tablet, Orally, At Bedtime Trelegy Ellipta 200 mCg-62.5 mCg-25 mCg inhalation powder 1 Puff, Inhalation, Daily Medication Administration Given albuterol 2.5 mg/0.5mL (0.5%) inhalation solution, 5 mg, Neb Inhal albuterol 2.5 mg/0.5mL (0.5%) inhalation solution, 2.5 mg, Neb Inhal albuterol-ipratropium inh soln 2.5 mg-0.5 mg/3 mL, 3 mL, Neb Inhal Ativan, 1 mg, IV Push Ativan, 1 mg, IV Push azithromycin, IVPB losartan, 50 mg, Orally methylPREDNISolone sodium succinate, 125 mg, IV Push Allergies NKA Social History Alcohol Current, Liquor, 1-2 times per month Electronic Cigarette/Vaping E-Cigarette Use Never. Employment/School Employed, Work/School description: GM. Home/Environment Married, 3 Children, Lives with Spouse. Nutrition/Health Diet: Regular. Substance Abuse Denies Tobacco Tobacco Use: Former smoker, quit more than 30 days ago. 1.5 packs per day. Started age 16.0 Years. Stopped age 60 Years. Family History CHF (congestive heart failure)...: Father. Diabetes...: Mother and Father. Throat cancer...: Father. Lab Results CO2 retention that is mostly compensated Diagnostic Results XR Chest PA or AP Portable 11/17/22 10:05:09 IMPRESSION: Coarse lung markings suggesting a component of mild and possibly chronic pulmonary vascular congestion similar to recent studies. No consolidating infiltrates or other acute findings. Electronically Signed by: Signed By: MD EKG EKG done at 0845 shows sinus tachycardia rate of 103 bpm, normal intervals, no acute ischemic findings. Signature Line Electronically Signed on 11/17/22 13:24 EST ________________________________________________________ Electronically Signed on 11/17/22 13:53 EST ________________________________________________________ MD Reviewed by

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2478561

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
IN
Alter
44,0
Geschlecht
M
Eingang
14.10.2022
Impfdatum
09.01.2022
Beginn
09.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Abdominal pain Cerebrovascular accident Death Fatigue Gait inability Headache Life support Mobility decreased Pain

Symptomtext

For the next month, he experienced severe headaches worse than a migraine, overall body ache, and pain, abdominal pain, severe exhaustion unable to get up and walk due to fatigue. He had 3 doctor visits prior to having a stroke about 1 month after the vaccine. He was taken to the ER, and put on life support for 4 days. When life-support was stopped, he died.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Metformin 500mg, Losartan 50mg, HCTZ 25mg, Cetirizine 10mg, Atorvastatin 20, Multivitamin,
Allergien
none
Vorherige Impfungen
EXTREME FATIGUE FOR 1 WEEK, 43 YR OLD, COVID19 JANSSEN, JOHNSON AND JOHNSON

VAERS 2456487

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
OH
Alter
93,0
Geschlecht
F
Eingang
23.09.2022
Impfdatum
03.08.2021
Beginn
07.09.2022
Tage bis Beginn
400,0
Dosis
1
Route/Site
UN / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Tested COVID positive after death.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
Nasal swab collected 08/19/2022 tested positive for SARS-CoV-2 Antigen on 8/19/2022.
Aktuelle Erkrankungen
-
Vorgeschichte
None
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2444886

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
-
Alter
91,0
Geschlecht
F
Eingang
14.09.2022
Impfdatum
23.11.2021
Beginn
24.01.2022
Tage bis Beginn
62,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 COVID-19 pneumonia Death SARS-CoV-2 test positive

Symptomtext

Pt in a SNF; pt had a positive COVID test in the facility on 1/24/22; treated with 10 days of ABX for COVID pneumonia; pt passed away in the facility

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
CKD IV, dementia, HTN, GERD
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2425340

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
-
Alter
49,0
Geschlecht
F
Eingang
31.08.2022
Impfdatum
21.11.2021
Beginn
14.07.2022
Tage bis Beginn
235,0
Dosis
1
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute kidney injury Acute respiratory failure Anticoagulant therapy Asthenia Blood creatinine increased Blood sodium increased COVID-19 COVID-19 pneumonia Death Endotracheal intubation Hyperlipidaemia Hypernatraemia Hypotension Hypothyroidism Intensive care Pulse absent Renal failure Respiratory distress

Symptomtext

Physician Discharge Summary Patient ID: Age: 50 y.o. Admit Date: 7/14/2022 2:57 AM Discharge Date: 7/17/2022 Unit: 4A109/4A109A Discharge Diagnosis: Principal Problem: Pneumonia due to COVID-19 virus Active Problems: Hypernatremia Elevated troponin Hyperlipidemia AKI (acute kidney injury) Hypothyroidism Chronic respiratory failure with hypoxia Hospital Course: 50yo female presented to ED from home with respiratory distress r/t COVID 19. Has significant past medical history, including L sided paralysis due to previous CVA. She has PEG tube and is on 4L NC PTA. Was also hypotensive and in renal failure w/hypernatremia Continue to decompensate, was intubated and admitted to COVID ICU. Nephrology and Pulm/CCM consulted. Despite full care, she continue to have hemodynamic instability and decompensation. Also developed R UE and LLE loss of pulses and was started on Heparin gtt. Multiple discussions regarding goals of care initiated. Given her overall poor health/debility, family chose to purse comfort/withdrawal of care. This was initiated per protocol and patient expired at 06:42 today. Consults: IP CONSULT TO PULMONOLOGY IP CONSULT TO NEPHROLOGY IP CONSULT TO SOCIAL WORK IP CONSULT TO SEPSIS NURSE NAVIGATOR IP CONSULT TO DIETARY IP CONSULT TO DIETARY IP CONSULT TO SOCIAL WORK IP CONSULT TO WOUND CARE IP CONSULT TO SOCIAL WORK IP CONSULT TO VASCULAR SURGERY Significant Diagnostic Studies: COVID +, Na 156, Cr 2.1 at admission Disposition: Funeral home of family's choice Discharge Condition: deceased

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2414738

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
-
Alter
56,0
Geschlecht
F
Eingang
18.08.2022
Impfdatum
11.12.2021
Beginn
01.02.2022
Tage bis Beginn
52,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
COVID-19 Death Dyspnoea Endotracheal intubation Gastrostomy General physical health deterioration Intensive care Mechanical ventilation Positive airway pressure therapy Pulmonary oedema SARS-CoV-2 test positive Tracheostomy

Symptomtext

2/1/22 pt tested positive for COVID and was hospitalized; prolonged mechanical ventilation; tracheostomy; PEG tube; dc'd to LTCF; 5/17/22 back to hospital Rehabilitation Unit; past 2 days with increasing SOB; admitted to hospital 6/5/22; BiPAP; ICU; Pulmonary Edema and possible pneumonia; Bumex started; required intubation; condition worsened; failed ventilation weaning; finally passed weaning and extubated; plans to place tracheostomy; pt labored on BiPAP; family transitioned pt to comfort care/hospice and she died in the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
15,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
ESRD, RENAL TRANSPLANT
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2357739

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
MI
Alter
67,0
Geschlecht
M
Eingang
09.08.2022
Impfdatum
06.04.2021
Beginn
30.06.2022
Tage bis Beginn
450,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute myocardial infarction COVID-19 Dyspnoea SARS-CoV-2 test positive SARS-CoV-2 test

Symptomtext

ACUTE MYOCARDIAL INFARCTION; COVID-19; DYSPNOEA; SARS-COV-2 TEST POSITIVE; This spontaneous report received from a health care professional by a Regulatory Authority VAERS (Vaccine Adverse Event Reporting System) concerned a 67 year old male of unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: hypertension, diabetes, coronary artery disease, and congestive heart failure. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 043A21A expiry: UNKNOWN) dose was not reported, 1 total, administered on 06-APR-2021 for an unspecified indication. Age at time of vaccination 67 years old. Concomitant medication included oxygen for drug used for unknown indication (wears oxygen 4 liters at night.). The drug was associated with Batch and lot tested and found within specifications. On 30-JUN-2022, patient experienced dyspnoea (patient stated that patient started having trouble breathing), acute myocardial infarction (patient was admitted for an non-ST-elevation myocardial infarction (NSTEMI) and found to be COVID positive), covid-19 and SARS-COV-2 (severe acute respiratory syndrome coronavirus-2) test positive. Laboratory data included: SARS-CoV-2 test Positive (Dose number in series 1). On an unspecified date, the patient was hospitalized. Number of days of hospitalization was not reported. Latency was 450 days. The patient received second dose of covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191, expiry: UNKNOWN) dose was not reported, 1 total, administered on an unspecified date for an unspecified indication. It was unknown whether patient had any adverse events following vaccination with second dose of covid-19 vaccine ad26. cov2.s (Dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the dyspnoea, acute myocardial infarction, covid-19 and SARS-COV-2 test positive was not reported. This report was serious (Hospitalization Caused / Prolonged). This report was associated with product quality complaint 90000242636 (for batch number 043A21A) and 90000242637 (for batch number 1855191). The suspected product quality complaint has been confirmed to be for PQC-90000242636 (batch number 043A21A) the reported allegation was not confirmed and the root cause was determined to be not manufacturing related. Batch and lot tested and found within specifications based on the PQC evaluation/investigation performed. The suspected product quality complaint has been confirmed to be voided (PQC-90000242637, batch number 1855191) (did not meet PQC criteria as this reporter received a Janssen vaccine both as primary and a booster dose series vaccination. This case indicates that infection occurred at a timing interval of less than 14 days post the booster dose. Therefore the reported symptomatic covid infection will be processed against the primary dose only. PQC 90000242636 captures the report for the primary dose, based on the PQC evaluation/investigation performed. Additional information was received from department on 04-AUG-2022. The following information was updated and incorporated into the case narrative: Added product quality complaint result for PQC no: 90000242636.; Sender's Comments: V4: The additional information in this version is product quality complaint result for PQC no: 90000242636.This doesnot alter causality of previously reported events. 20220732603-covid-19 vaccine ad26.cov2.s-Covid-19,Sars-cov-2 test positive . The event(s) shows an incompatible temporal relationship. Therefore, this event(s) is considered not related. 20220732603-covid-19 vaccine ad26.cov2.s- Acute myocardial infarction, Dyspnoea. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY ( hypertension, diabetes, coronary artery disease, and congestive heart failure.) . Therefore, this event(s) is considered not related.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
Test Date: 20220630; Test Name: SARS-COV-2 TEST; Test Result: Positive
Aktuelle Erkrankungen
Congestive heart failure; Coronary artery disease; Diabetes; Hypertension
Vorgeschichte
-
Andere Medikamente
OXYGEN
Allergien
-
Vorherige Impfungen
-

VAERS 2357739

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
MI
Alter
67,0
Geschlecht
M
Eingang
09.08.2022
Impfdatum
06.04.2021
Beginn
30.06.2022
Tage bis Beginn
450,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute myocardial infarction COVID-19 Dyspnoea SARS-CoV-2 test positive SARS-CoV-2 test

Symptomtext

ACUTE MYOCARDIAL INFARCTION; COVID-19; DYSPNOEA; SARS-COV-2 TEST POSITIVE; This spontaneous report received from a health care professional by a Regulatory Authority VAERS (Vaccine Adverse Event Reporting System) concerned a 67 year old male of unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: hypertension, diabetes, coronary artery disease, and congestive heart failure. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 043A21A expiry: UNKNOWN) dose was not reported, 1 total, administered on 06-APR-2021 for an unspecified indication. Age at time of vaccination 67 years old. Concomitant medication included oxygen for drug used for unknown indication (wears oxygen 4 liters at night.). The drug was associated with Batch and lot tested and found within specifications. On 30-JUN-2022, patient experienced dyspnoea (patient stated that patient started having trouble breathing), acute myocardial infarction (patient was admitted for an non-ST-elevation myocardial infarction (NSTEMI) and found to be COVID positive), covid-19 and SARS-COV-2 (severe acute respiratory syndrome coronavirus-2) test positive. Laboratory data included: SARS-CoV-2 test Positive (Dose number in series 1). On an unspecified date, the patient was hospitalized. Number of days of hospitalization was not reported. Latency was 450 days. The patient received second dose of covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191, expiry: UNKNOWN) dose was not reported, 1 total, administered on an unspecified date for an unspecified indication. It was unknown whether patient had any adverse events following vaccination with second dose of covid-19 vaccine ad26. cov2.s (Dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the dyspnoea, acute myocardial infarction, covid-19 and SARS-COV-2 test positive was not reported. This report was serious (Hospitalization Caused / Prolonged). This report was associated with product quality complaint 90000242636 (for batch number 043A21A) and 90000242637 (for batch number 1855191). The suspected product quality complaint has been confirmed to be for PQC-90000242636 (batch number 043A21A) the reported allegation was not confirmed and the root cause was determined to be not manufacturing related. Batch and lot tested and found within specifications based on the PQC evaluation/investigation performed. The suspected product quality complaint has been confirmed to be voided (PQC-90000242637, batch number 1855191) (did not meet PQC criteria as this reporter received a Janssen vaccine both as primary and a booster dose series vaccination. This case indicates that infection occurred at a timing interval of less than 14 days post the booster dose. Therefore the reported symptomatic covid infection will be processed against the primary dose only. PQC 90000242636 captures the report for the primary dose, based on the PQC evaluation/investigation performed. Additional information was received from department on 04-AUG-2022. The following information was updated and incorporated into the case narrative: Added product quality complaint result for PQC no: 90000242636.; Sender's Comments: V4: The additional information in this version is product quality complaint result for PQC no: 90000242636.This doesnot alter causality of previously reported events. 20220732603-covid-19 vaccine ad26.cov2.s-Covid-19,Sars-cov-2 test positive . The event(s) shows an incompatible temporal relationship. Therefore, this event(s) is considered not related. 20220732603-covid-19 vaccine ad26.cov2.s- Acute myocardial infarction, Dyspnoea. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY ( hypertension, diabetes, coronary artery disease, and congestive heart failure.) . Therefore, this event(s) is considered not related.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
Test Date: 20220630; Test Name: SARS-COV-2 TEST; Test Result: Positive
Aktuelle Erkrankungen
Congestive heart failure; Coronary artery disease; Diabetes; Hypertension
Vorgeschichte
-
Andere Medikamente
OXYGEN
Allergien
-
Vorherige Impfungen
-

VAERS 2273230

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
-
Alter
76,0
Geschlecht
M
Eingang
09.05.2022
Impfdatum
20.01.2022
Beginn
15.02.2022
Tage bis Beginn
26,0
Dosis
2
Route/Site
UN / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure COVID-19 SARS-CoV-2 test positive

Symptomtext

Narrative: Patient COVID positive despite 2 doses of COVID vaccine. Patient admitted for acute hypoxic respiratory failure.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
Patient tested COVID positive 2/15/2022
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2184374

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
MA
Alter
45,0
Geschlecht
F
Eingang
17.03.2022
Impfdatum
31.01.2022
Beginn
10.03.2022
Tage bis Beginn
38,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Anticoagulant therapy Coagulation test Computerised tomogram thorax abnormal Dyspnoea Embolism arterial Pain in extremity Pulmonary embolism Ultrasound Doppler normal

Symptomtext

Pt developed left calf pain on 3/10/2022 and her family noted she had increased shortness of breath. She came into the office for evaluation for possible Deep vein thrombosis on 3/15/22. She was noticeably short of breath in office. She had an ultrasound of the left leg and then a chest CT on 3/16/2022. The chest CT showed Peripheral pulmonary arterial thromboembolism right lower lobe. She was sent to the lab for coagulation studies and then started on Eliquis 3/16/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
Ultrasound of Left Lower Extremity (negative) 3/16/2022 Chest CT 3/16/2022 Peripheral pulmonary arterial thromboembolism right lower lobe.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Naproxen 250mg PRN EPINEPHrine (EPIPEN) 0.3 mg/0.3 mL injection PRN
Allergien
Bee Stings Codeine Sulfate Erythromycin Base Morphine Sulfate Azithromycin
Vorherige Impfungen
-

VAERS 2005464

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
NH
Alter
58,0
Geschlecht
M
Eingang
12.02.2022
Impfdatum
-
Beginn
13.12.2021
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Anticoagulant therapy Bradycardia Cerebrovascular accident Computerised tomogram Magnetic resonance imaging Confusional state Heart rate Memory impairment Transient ischaemic attack

Symptomtext

STROKE; BRADYCARDIA; FELT SOME CONFUSION; FORGETFULNESS; This spontaneous report received from a patient concerned a 58 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: occasional alcohol use, non-smoker, and hypertension. The patient did not have history of drug abuse or illicit drug use and had no known drug allergies. The patient previously received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported and batch number: 202A21A and expiry date: unknown) dose was not reported, 1 total, administered on 10-APR-2021 to right arm for prophylactic vaccination. On 11-APR-2021, the patient stated that he experienced sore arm from the initial Johnson and Johnson Covid-19 vaccine and stated which was resolved on 12-APR-2021 (Dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191 and expiry date: unknown) dose was not reported, 1 total, administered on 12-DEC-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 13-DEC-2021, the patient felt some confusion and forgetfulness after the booster dose (Dose number in series 2). It was resolved on 14-DEC-2021. On 22-DEC-2021, the patient experienced stroke and his wife called emergency and he went to the medical facility. When stroke happened, he also experienced Vertigo, vomiting, and tiredness/fatigue, which the tiredness he attributed to the bradycardia he experienced (Dose number in series 2). The patient's heart rate went down to 20 bpm (beats per minute) and it was treated with atropine by the caregivers. The patient went to the hospital on 22-DEC-2021, and was treated with TPA (Tissue plasminogen activator) and was discharged from hospital on 24-DEC-2021 (Dose number in series 2). Upon discharge, he could not walk for two weeks due to dizziness/vertigo. The patient was still doing physical therapy for the vertigo symptoms as on report time. The patient would see the physician again on 02-FEB-2022. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bradycardia on 29-DEC-2021, and felt some confusion, and forgetfulness on 14-DEC-2021, and was recovering from stroke. This report was serious (Hospitalization Caused / Prolonged). This case, involving the same patient is linked to 20220200341 (Dose number in series 1).; Sender's Comments: V0: 20220210630-covid-19 vaccine ad26.cov2.s- bradycardia, stroke. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
3,0
Labordaten
Test Date: 20211222; Test Name: Heart rate; Result Unstructured Data: 20 beats per minute
Aktuelle Erkrankungen
Alcohol use; Hypertension; Non-smoker
Vorgeschichte
Comments: The patient did not have history of drug abuse or illicit drug use and had no known drug allergies.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2005464

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
NH
Alter
58,0
Geschlecht
M
Eingang
12.02.2022
Impfdatum
-
Beginn
13.12.2021
Tage bis Beginn
-
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Anticoagulant therapy Bradycardia Cerebrovascular accident Computerised tomogram Magnetic resonance imaging Confusional state Heart rate Memory impairment Transient ischaemic attack

Symptomtext

STROKE; BRADYCARDIA; FELT SOME CONFUSION; FORGETFULNESS; This spontaneous report received from a patient concerned a 58 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: occasional alcohol use, non-smoker, and hypertension. The patient did not have history of drug abuse or illicit drug use and had no known drug allergies. The patient previously received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported and batch number: 202A21A and expiry date: unknown) dose was not reported, 1 total, administered on 10-APR-2021 to right arm for prophylactic vaccination. On 11-APR-2021, the patient stated that he experienced sore arm from the initial Johnson and Johnson Covid-19 vaccine and stated which was resolved on 12-APR-2021 (Dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191 and expiry date: unknown) dose was not reported, 1 total, administered on 12-DEC-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 13-DEC-2021, the patient felt some confusion and forgetfulness after the booster dose (Dose number in series 2). It was resolved on 14-DEC-2021. On 22-DEC-2021, the patient experienced stroke and his wife called emergency and he went to the medical facility. When stroke happened, he also experienced Vertigo, vomiting, and tiredness/fatigue, which the tiredness he attributed to the bradycardia he experienced (Dose number in series 2). The patient's heart rate went down to 20 bpm (beats per minute) and it was treated with atropine by the caregivers. The patient went to the hospital on 22-DEC-2021, and was treated with TPA (Tissue plasminogen activator) and was discharged from hospital on 24-DEC-2021 (Dose number in series 2). Upon discharge, he could not walk for two weeks due to dizziness/vertigo. The patient was still doing physical therapy for the vertigo symptoms as on report time. The patient would see the physician again on 02-FEB-2022. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bradycardia on 29-DEC-2021, and felt some confusion, and forgetfulness on 14-DEC-2021, and was recovering from stroke. This report was serious (Hospitalization Caused / Prolonged). This case, involving the same patient is linked to 20220200341 (Dose number in series 1).; Sender's Comments: V0: 20220210630-covid-19 vaccine ad26.cov2.s- bradycardia, stroke. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
3,0
Labordaten
Test Date: 20211222; Test Name: Heart rate; Result Unstructured Data: 20 beats per minute
Aktuelle Erkrankungen
Alcohol use; Hypertension; Non-smoker
Vorgeschichte
Comments: The patient did not have history of drug abuse or illicit drug use and had no known drug allergies.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2085978

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
SD
Alter
87,0
Geschlecht
M
Eingang
03.02.2022
Impfdatum
13.12.2021
Beginn
20.01.2022
Tage bis Beginn
38,0
Dosis
1
Route/Site
SYR / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 disease after which death occurred. The invidudual was vaccinated with the Janssen product on 12/13/2021. They did not have a specific symptom onset date available, but tested positive via antigen test on 01/20/2022 as part of on-going testing at the HCF at which they were a resident. They died on 01/22/2022. It does not seem this individual had COVID-19 symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
Positive COVID-19 antigen test despite being vaccinated on 01/20/2022.
Aktuelle Erkrankungen
-
Vorgeschichte
Late-onset Alzheimer's Type Dementia, Parkinson's Disease, Paroxysmal Atrial Fibrillation, Hypertension, the individual was a resident of a HCF at the time of the adverse event
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2051338

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
VA
Alter
18,0
Geschlecht
M
Eingang
20.01.2022
Impfdatum
15.01.2022
Beginn
18.01.2022
Tage bis Beginn
3,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute myocardial infarction Blood creatine phosphokinase Chest pain Dyspnoea Electrocardiogram abnormal Magnetic resonance imaging abnormal Myocarditis Pericardial effusion

Symptomtext

Chest pain. Per progress notes: 1/18/22: 18-year-old male brought back from the vertical process to T1 for concerning EKG suggestive of STEMI in the setting of recent receiving the January vaccine. Patient describes chest pain with shortness of breath starting today - the chest pain is ongoing but the shortness of breath has significantly resolved. STEMI code was called prior to my assessment of the patient and the interventions arrives shortly after I I did. Further history and exam was truncated by STEMI protocol to not delay catheterization Patient denies known cardiac history, lower extremity swelling or pain, past PE or DVT. Denies history of uncontrolled hypertension or pain radiating through to the back 1/19/22: This morning's CPK shows that the patient has myocarditis in addition to pericarditis so he has myopericarditis presumably post a vaccination. Have us discussed the case with Medical College this morning. They recommend that is nonsteroidal be stopped in that he have a cardiac MRI to assess the burden of inflammation that he be started on high doses of steroid that is Solu-Medrol 500 mg IV 3 times a day his colchicine be continued. We need to be mindful of LV function checking an echo in a couple of days. We need to limit activity he is going to need to take it easy we have to keep a close eye on him to make sure he does not developed LV dysfunction. I would think that at the earlier sign of LV dysfunction we would need to discuss transfer. 1/19/22: Acute myopericarditis presumably secondary to the coronavirus vaccine. EF is preserved. MRI confirms that the patient is myocarditis confirms that his EF is preserved shows relatively small amount of ventricular inflammation and does show a very small hemodynamically insignificant pericardial effusion. I discussed the case as noted earlier with the heart advanced heart failure team. We both agreed that nonsteroidals are not say for a good idea with myocarditis the colchicine makes sense for the pericarditis and they recommended very high dose steroid and that we keep an eye on his EF checking an echo in a couple of days. Post discharge she will have to modulate his activity. We will have to decide long-term how we will use steroids. I will reach out to our new associate to lay out a long-term plan

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
None documented
Vorgeschichte
None documented
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 1932122

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

kritisch
Staat
CA
Alter
63,0
Geschlecht
F
Eingang
08.12.2021
Impfdatum
02.12.2021
Beginn
02.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death Impaired work ability Urticaria

Symptomtext

12/2/21: Vaccine given at 10:00am at employee vaccine clinic. Notified by patient at 2:28pm that she was "breaking out with hives" and she had taken Benadryl. Patient contacted me again at 3:58pm that she was going to urgent care because the "hives are getting worse". At 6:48pm she reported "got the shot and medication for the next 5 days." 12/3/21 at 7:50am I contacted Patient to check on her status. She replied "still got 1 hive just took medication didn't go in hives on lips haven't cleared yet but it will....Dr said I will be ok....I good thankfully oh laying down drinking lots of water". 12/6/21 I went to her work site to check on her status and was told "she called out". I called her and left a voicemail to get more details for this report. On 12/7/21 I learned that Patient's daughter reported to the facility that Patient had died the night before. Her family provided no other details. We do not know the official cause of death or any more information at this point. We do not know which doctor or urgent care she visited on 12/2/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
unknown
Aktuelle Erkrankungen
none
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
denied all allergies
Vorherige Impfungen
-

VAERS 2695002

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
-
Alter
69,0
Geschlecht
M
Eingang
12.10.2023
Impfdatum
19.11.2021
Beginn
20.09.2023
Tage bis Beginn
670,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Abdominal pain upper Acute kidney injury Agonal respiration Alanine aminotransferase increased Angiogram pulmonary abnormal Aspartate aminotransferase increased Blood creatinine increased Blood glucose abnormal Blood lactic acid Blood potassium decreased Blood pressure systolic decreased Blood sodium decreased Blood thyroid stimulating hormone decreased Bundle branch block right COVID-19 Chest pain Computerised tomogram head abnormal Computerised tomogram thorax abnormal

Symptomtext

Patient is a 71 y.o. male patient of, MD with history of panhypopituitarism, secondary to craniopharyngioma that was surgically removed 1997, CAD s/p stenting, T2DM, CKD3, and hypothyroidism who presented to facility on 9/20/23 following episode of unresponsiveness,Pt found minimal responsive on toilet by spouse. Pt agonal breathing and required NRB per EMS. Progressive improvement following supportive measures upon ED arrival. No trauma reported. No falls. Reportedly patient not feeling well for few weeks. Tested positive for COVID this admission. Admitted to ICU for lactic acidosis and hypotension, both of which have resolved with fluid administration. ID had seen patient and signed off. Patient was also seen by nephrology and endocrinology for panhypopituitarism. Patient had labile blood sugars that are much lower this day. Discussed with Dr. prior to discharge with endocrinology, he is recommended to hold long-acting insulin and short-acting insulin at discharge. Prednisone home dose 5 mg was advised to be increased to 15 mg for 5 days, this was due to some concerns of mild adrenal insufficiency,patient was instructed that if his blood sugars are greater than 180 to call his primary care physician as well as his endocrinologist for further guidance on resuming his insulin. Patient's oral intake was poor while in the hospital, most likely contributed to his hypoglycemia. He will need close monitoring and follow-up to resume his insulin patient verbalized understanding.Endocrinology team okay with discharge. Nephrologist is recommended to continue DDAVP at discharged. Patient medically stable and discharged home with HHC. DM 2, now with hypoglycemia Home: Metformin, Trulicity and basalgar 40 u, lispro 20 u q ac, A1c 7.6 Metformin and trulicity stopped, was on lantus and SSI Long-acting insulin was decreased to 20 units, and pre-meal 7u- both discontinued as pt has required dextrose gel his AM, qill request endocrinology consultation due to labile blood sugars. Hold off long-acting insulin dose monitor sugars for now due to significant lows, await endocrine input Acute metabolic encephalopathy Panhypopituitarism secondary to craniopharyngioma Presumably orthostatic syncope in the setting of poor intake, dehydration Afebrile, HR 55, SBP low Pt was not able to take medications due to COVID infection Echo 9/20 normal LV fn, EF~60%, CTPA neg PE, chronic interstitial lung disease IVF resuscitation continued, restarted DDAVP, prednisone Encephalopathy has resolved, MS back to baseline PT / OT: 5-7 d w hopeful progression Keep until further PT / OT, CM consulted for discharge needs,has not been ambulating here Atypical chest/epigastric pain, appears to be related to gastritis, on prednisone vs musculoskeletal Ekg repeated today shows RBBB without new ST changes Start pantoprazole and add maalox 4x daily, may be contributing to poor oral intake Metabolic acidosis Lactic acidosis Lactic acid 10.1>1.3, secondary to dehydration,improved after IVF Sepsis due to COVID infection Transaminitis Reports URI symptoms and diarrhea for 1 day, no fevers or shortness of breath Met sepsis crieria, Sepsis was present on admission and continues to be treated Consulted infectious disease, continued recommendations appreciated Continue home dose steroids, started on Remdesivir ID consulted, AST 110->633, ALT 43->176, ? Related to remdesivir Due to improvement in COVID and hemodynamics ID has cleared pt for discharge AKI on CKD 3 Hyponatremia Hypokalemia Hypomagnesemia Scr on admission 2.62 (baseline ~ 1.3), Na 128, on DDAVP AKI due to dehydration, IV contrast, hypotension Nephrology consulted to assist w both K low again 3.2-replace 60meq , replace mag Abnormal CT head History of panhypopituitarism secondary to craniopharyngioma Follows with neuro-ophthalmology and endocrinology Per chart review, he had surgery for craniopharyngioma via right frontal craniotomy in 1997 at facility with Dr., Home regimen: prednisone 5 mg daily, levothyroxine 175 mcg desmopressin 0.1 twice daily, not on testosterone replacement CT head 9/20 shows mass centered in the suprasellar region perched, could relate to residual neoplasia or postoperative change related to prior tumor resection, possible ecchordosis physaliphora. Clinically neurological function intact, continue outpatient follow-up with facility MRI brain pending Abnormal CT Lung nodule Per chart review, quit smoking about 27 years ago, started smoking 52 years ago, approximately 30-pack-year smoking history surveillance for 3x5 noncalcified nodule of the right lower lobe, outpatient follow-up History of hypothyroidism Secondary to above, TSH <0.01 T4 1.4, continue home synthroid History of CAD No chest pain or shortness of breath LHC 9/2022: extensive CAD with stable collaterals. No intervention. Continue home aspirin, atorvastatin, Plavix Elevated troponin Troponin 77>85 (10%) no reported chest pain or dyspnea Likely 2/2 demand ischemia Echo 9/20 normal LV fn, EF~60%, no further w/u needed

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
6,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2659939

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
OH
Alter
27,0
Geschlecht
M
Eingang
24.07.2023
Impfdatum
17.11.2021
Beginn
18.11.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Abnormal behaviour Amnesia Brain fog Epilepsy Impaired driving ability Intensive care Laboratory test Loss of personal independence in daily activities Magnetic resonance imaging Mechanical ventilation Pneumonia Pulmonary oedema Seizure

Symptomtext

I have no memory of what happened. I am repeating what I have been told. I was in the car with my Dad at a job(work) we left for lunch and I started calling for God and attempted to exit the vehicle. He pulled over were I could get out of the car. I had a seizure and they got me home where I continued to have seizures and got fluid in my lungs. I ended up getting pneumonia. I was on a ventilator for 6 days. I was in the ICU for at least 10 days. Long story short, I have been diagnosed with epilepsy. I have brain fog and It has affected me in massive ways. I can't even drive my child anywhere.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
10,0
Labordaten
Mri's and EMU test. Extensive testing. Diagnosed with Epilepsy.
Aktuelle Erkrankungen
No
Vorgeschichte
Fusion Fracture in neck. other than that, no. Spine pain.
Andere Medikamente
No
Allergien
No
Vorherige Impfungen
-

VAERS 2635556

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
-
Alter
43,0
Geschlecht
F
Eingang
23.05.2023
Impfdatum
26.11.2021
Beginn
16.04.2022
Tage bis Beginn
141,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Anaphylactic reaction Lacunar stroke

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY ANAPHYLAXIS, SEQUELA

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2419388

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
-
Alter
33,0
Geschlecht
F
Eingang
24.08.2022
Impfdatum
15.12.2021
Beginn
01.12.2021
Tage bis Beginn
-
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Anaphylactic reaction

Symptomtext

Pt self reported anaphylactic reaction. Unknown time course and severity. Pt did not seek any known treatment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
PMH: ? Abnormal Pap smear 2004 hx HPV 2004 ? Anemia 2011 anemia with ParaGard IUD ? GERD (gastroesophageal reflux disease) ? H/O colposcopy with cervical biopsy at age 16 ? HPV in female ? Insomnia ? Lump in armpit ? Obesity
Andere Medikamente
Medications: acetaminophen (TYLENOL) 500 MG tablet Take 2 tablets by mouth every 6 (six) hours as needed for Pain or Fever. albuterol sulfate (PROVENTIL HFA;VENTOLIN HFA) 90 mcg/actuation HFA inhaler Inhale 1 Inhalation by mouth every 6 (si
Allergien
Allergies: Bee Sting (anaphylaxis)
Vorherige Impfungen
-

VAERS 2399444

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CO
Alter
48,0
Geschlecht
M
Eingang
02.08.2022
Impfdatum
02.08.2022
Beginn
02.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Dizziness Fall Head injury Hyperhidrosis Seizure Skin abrasion Syncope Tooth fracture Unresponsive to stimuli

Symptomtext

Patient received Vaccination at 1645 on bus and proceeded outside to wait under pavilion for observation. Patient was seated in chair next to spouse when patient had syncopal episode and and fell out of chair, hitting back of his head. Patient was observed unresponsive for approximately a minute and then had seizure for approximately fifteen seconds before entering postictal stage. Within two minutes patient was a and o times four. An abrasion was noted to the back right side of patient?s head and his front left tooth was chipped during the event though patient did not fall forward onto face. EMS was contacted at 1650 and patient was kept alert and talking while vitals were taken waiting for EMS. Manual blood pressure observed at 122/72 with a palpated pulse of 64. Patient was observed to be diaphoretic and reported feeling dizzy with a headache. C spine was established as a precaution due to nature of event and fall though patient denied nausea, had full PMS, and PERL was present. Patient denies allergies and any medical history. EMS arrived and patient care and report was handed off to Fire Department with no other changes observed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2364503

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
OH
Alter
64,0
Geschlecht
M
Eingang
11.07.2022
Impfdatum
03.12.2021
Beginn
25.06.2022
Tage bis Beginn
204,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Angioplasty Anticoagulant therapy Chest X-ray abnormal Chest pain Computerised tomogram thorax abnormal Pulmonary thrombosis

Symptomtext

Pt reports he had Janssen booster on 12/3/21 at the pharmacy. Patient reports he was out of town fishing and started to notice he was having severe chest pain. Pt called emergency number and was taken to hospital then transferred to medical center. Pt reports they did CT scans and x-ray. Then was determined several blood clots in both lungs. Pt reports they did angioplasty. Pt was sent home on Eliquis 5mg PO daily and atorvastatin 400mg PO daily. Pt reports he is scheduled to see a hematologist and cardiologist. Pt unknown of appointment schedule.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary thrombosis
Hospital-Tage
5,0
Labordaten
See notes for details. Pt reports angioplasty done on the 6/26/2022. Pt reports was on F/U chest x-ray was on 6/29/22.
Aktuelle Erkrankungen
n/a
Vorgeschichte
Myasthenia Gravis COPD CHF
Andere Medikamente
one day vitamin (multivitamin) once daily Vitamin D3 4000Iues once a day Magnesium Oxide 50mg daily Prednisone 10mg PO and 5mg every other day alternating schedule
Allergien
-
Vorherige Impfungen
-

VAERS 2292276

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
IN
Alter
45,0
Geschlecht
M
Eingang
24.05.2022
Impfdatum
-
Beginn
01.02.2022
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Deep vein thrombosis

Symptomtext

DEEP VEIN THROMBOSIS IN LEFT LEG; This spontaneous report received from a patient concerned a 45 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: multiple sclerosis, alcohol user (occasional average one drink per month), non-smoker, mobic allergy, latex-mild allergy, and drug allergy (Interferon Beta A-1). The patient had no drug abuse or illicit drug usage. On an unspecified date, the patient was previously received Pfizer biontech covid-19 vaccine (tozinameran) (Dose number in series 1) (form of admin, route of admin, and batch number were not reported, expiry: unknown) dose was not reported, administered for prophylactic vaccination. On an unspecified date, following vaccination with Pfizer biontech covid-19 vaccine (tozinameran), the patient experienced severe anaphylactic reaction (Dose number in series 1). The patient additionally received booster dose of covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191 expiry: 11-APR-2022) dose was not reported, 1 total administered in arm on 19-JAN-2022 for prophylactic vaccination. Age at time of vaccination 45 years old. No concomitant medications were reported. Patient reported that he first noticed something with his leg in mid FEB-2022, and then it became worse in late MAR-2022 to early APR-2022 (Dose number in series 2). The patient was transported to emergency room. The patient experienced deep vein thrombosis in left leg (Dose number in series 2). On 27-APR-2022, the patient was admitted to the hospital. On 29-APR-2022, patient was discharged after having the blood clot removed (Dose number in series 2). The patient was hospitalized for 3 days. On around 02-MAY-2022 or 03-MAY-2022, the patient followed up with his PCP (Primary care physician). The patient visited physician office and emergency room. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from deep vein thrombosis in left leg. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20220534919-Covid-19 vaccine ad26.cov2.s-deep vein thrombosis in left leg. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
Alcohol use (occasional average one drink per month); Allergy to NSAIDs; Drug allergy (Interferon Beta A-1); Latex allergy; Multiple sclerosis; Non-smoker
Vorgeschichte
Comments: The patient had no drug abuse or illicit drug usage.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2249967

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
AZ
Alter
21,0
Geschlecht
F
Eingang
25.04.2022
Impfdatum
22.04.2022
Beginn
22.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Hypotension Loss of consciousness Muscle twitching Mydriasis

Symptomtext

Patient passed out within a minute of receiving Janssen Vaccine. She was hypotensive (BP 99/48), pupils dilated, and began twitching. EMS was called and evaluated patient. EMS determined the patient did not need to be transported to the ER via ambulance and the patient's roommate was called to pick her up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
-

VAERS 2216435

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
MN
Alter
19,0
Geschlecht
M
Eingang
05.04.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Cough Dizziness Fatigue Flushing Hyperhidrosis Hypertension Nausea Pain Pruritus Skin discolouration Syncope

Symptomtext

The vaccine was administered at approx. 14:15 on 4/5/22. Towards the end of the 15min monitoring period, I experienced flushing of the skin, coughing, sweating, and itchiness across my body. My neck was particularly pink and itchy. At this time RPN gave me a glass of water since I became nauseous. After being suggested to take my blood pressure, the automatic blood pressure machine reported my blood pressure to be high (128/82) at 14:43 (I donate blood and do not have any phobia of needles nor did I experience anxiousness when receiving the vaccine). Soon after the test, I began to perspire and experience chills despite being flushed. It was at this time that I began to feel extremely tired and lightheaded. After being requested to stay at the facility RPN gave me "20mL (50mg) of Benadryl in case of allergic reaction". During this time she suggested that I consider going to my primary clinic, the ER, or an urgent care sight. 15min later she offered to call an ambulance, which I declined, and cautiously allowed me to go home at 15:21. Once home (approx. 15min later) I collapsed onto the couch to take a nap before my 16:00 class. At this time I do not have a fever but all symptoms remain with the addition of bodily aches. Soon after the test, I began to perspire and experience chills despite being flushed. It was at this time that I began to feel extremely tired and lightheaded.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
No
Allergien
No
Vorherige Impfungen
-

VAERS 2201376

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
PA
Alter
25,0
Geschlecht
M
Eingang
28.03.2022
Impfdatum
01.03.2022
Beginn
15.03.2022
Tage bis Beginn
14,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Eye movement disorder Hyperhidrosis Hypotonia Syncope Unresponsive to stimuli

Symptomtext

A COUPLE MINUTES AFTER ADMINISTERING VACCINE, PATIENT WAS SITTING IN PHARMACY WAITING AREA FOR THE REQUIRED 15 MINUTE PERIOD. CUSTOMER ALERTED ME THAT HE WAS SLUMPED OVER. WENT OUT AND SAW PATIENT SLUMPED OVER WITH EYES CLOSED. PATIENT UNRESPONSIVE TO TOUCH AND SOUND. HE HAD A PULSE AND COULD VISIBLY SEE STOMACH MOVING SO HE WAS BREATHING. PATIENT SWEATING PROFUSELY AND FAINTED A COUPLE TIMES- EYES WERE ROLLING AROUND IN HEAD. CALLED 911 AND LAID PATIENT ON BACK ON THE FLOOR- STAYED WITH PATIENT UNTIL EMTS ARRIVED. GOT PATIENT A SODA TO DRINK BEFORE LEAVING. PATIENT DID STATE HE ONLY HAD A GRANOLA BAR BEFORE COMING FOR VACCINE AND IS NOT GOOD WITH SHOTS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2189148

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
MA
Alter
41,0
Geschlecht
M
Eingang
19.03.2022
Impfdatum
19.03.2022
Beginn
19.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Deafness Hyperhidrosis Loss of consciousness Memory impairment

Symptomtext

Pt was nervous about vaccine. Does not like needles. After the vaccine, during the 15 min waiting time, pt became very sweaty, could not hear and passed out for about 10 seconds. He did not fall, he was seated but was unaware what had happened to him. Emergency number was then called and by the time they came the pt was fine. His vitals were normal.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Diabetic, Anxiety
Andere Medikamente
unknown
Allergien
Hydrocodone and Novocaine
Vorherige Impfungen
-

VAERS 2182532

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
FL
Alter
62,0
Geschlecht
M
Eingang
16.03.2022
Impfdatum
20.12.2021
Beginn
21.12.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Anticoagulant therapy Cardiac assistance device user Cardiac dysfunction Cardiac failure Catheterisation cardiac normal Chest pain Cough Dyspnoea Haemoptysis Hypoaesthesia Impaired work ability Intensive care Intracardiac thrombus Laboratory test Magnetic resonance imaging normal Paraesthesia Pneumonia SARS-CoV-2 test negative

Symptomtext

pt states the day after his vaccine he developed a dry cough. He had covid in 2020 and thought he had the virus again but tested negative. He developed SOB. On Jan 4th, 2022 he went to the facility. He was coughing up blood upon arrival and he was sent to emergency room. He sat all day waiting to be seen. He was taken to intensive care after being diagnosed with 3 blood clots, pneumonia, and was in heart failure. Due to the blood clot on the left side of this heart it was only pumping 15%. He had MRI and a heart catheter however, they could not find anything wrong. He was admitted and was in intensive care for 3 days and regular room for 2 weeks. He was discharged and went back to work on light duty. He started having chest pains on 3/1/22 and went back to the ER. They ran more test and a double cardio catheter but did not find anything wrong. He is on blood pressure and blood thinner medication. He is currently wearing a life vest but he may need a pacemaker. He will FU w/ his cardio doctor on May 10th. His little finger on his right hand has been numb with a tingling sensation since this started. He called his PCP but she is out on vacation so he is waiting on her to discharge him to go back to work.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
17,0
Labordaten
MRI labs cardio cath covid test
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
nka
Vorherige Impfungen
-

VAERS 2162735

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CA
Alter
52,0
Geschlecht
M
Eingang
07.03.2022
Impfdatum
15.12.2021
Beginn
24.12.2021
Tage bis Beginn
9,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein
Bell's palsy Blood test Computerised tomogram normal Electrocardiogram Electroencephalogram Eyelid function disorder Facial paralysis Hemiparesis Hypoaesthesia SARS-CoV-2 test negative

Symptomtext

Bell's Palsy Face drooping, eye not blinking, numb face left side Treated with Steroids for 10 days and antiviral medications Started improving at 2.5 weeks and 4 weeks with minimal symptoms left. Slight weakness still on that side of face.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
Neurological testing, Checked for any previous infection with covid (negative), Covid Test, , EKG, blood tests, CT Scan (nothing found) 12/24/2021 EEG 12/29
Aktuelle Erkrankungen
none
Vorgeschichte
High Blood Pressure
Andere Medikamente
Lisinopril Norco Trazadone
Allergien
none
Vorherige Impfungen
Covid Vaccine Pfizer swollen hands

VAERS 2158178

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
AZ
Alter
25,0
Geschlecht
M
Eingang
04.03.2022
Impfdatum
31.01.2022
Beginn
14.02.2022
Tage bis Beginn
14,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Bell's palsy Facial paralysis Headache Neck pain Paralysis

Symptomtext

Face Drooping and paralysis. Extreme neck pain and headaches on the left side.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
Deferential Diagnosis of Bell?s Palsy 3/03/22
Aktuelle Erkrankungen
COVID 19 positive case Positive test 1/15/22 Force to receive vaccination due to agency requirement.
Vorgeschichte
N/a
Andere Medikamente
N/A. No medications. Perfectly healthy
Allergien
No allergies.
Vorherige Impfungen
-

VAERS 2144378

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
SC
Alter
34,0
Geschlecht
F
Eingang
26.02.2022
Impfdatum
25.02.2022
Beginn
25.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Blood glucose normal Fall Head injury Hypotension Loss of consciousness Skin laceration Syncope

Symptomtext

Patient was given first COVID-19 vaccine, Janssen J&J. Approximately 1-2 minutes after administration patient fainted. Patient denies fainting episode previously with any vaccine. Patient fell and hit her head as she passed out. Emergency services were called in and the patient was evaluated for appropriate treatment of cut in head as well as low blood pressure.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
Blood press checked, low at 80/60; Blood sugar checked, normal at 85
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2119426

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
FL
Alter
52,0
Geschlecht
M
Eingang
17.02.2022
Impfdatum
03.12.2021
Beginn
10.12.2021
Tage bis Beginn
7,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Balance disorder Dysarthria Dyspnoea Impaired self-care Intervertebral disc injury Magnetic resonance imaging head normal Paralysis Peripheral swelling Walking aid user

Symptomtext

He got his vaccine, started to feel a little bit weak and gradually as the week went by he could hardly walk. Within 2 weeks he was paralyzed. He was hospitalized at Hospital and they found some damaged disc. They did an MRI of the brain, and saw a neurologist who told him there was nothing wrong with him and didn't check his MRI of the brain. He has slurred speech a lot, extreme loss of balance and using a walker now, which he never had problems with balance or anything before. He has to get a CNA, nurse, PT to come to the house to assist him with daily care. He said that they call somebody else, and tell him to call another doctor and they don't seem to know what to do. He had no neurological issues before the vaccine, said it's extreme. His legs and feet are swollen, and has gone from being normal to this state over night. He will FU with a neurologist, but does not have any appointments scheduled at this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paralysis
Hospital-Tage
6,0
Labordaten
MRI of the brain, did not give him any results, just said it was OK.
Aktuelle Erkrankungen
None.
Vorgeschichte
Parkinson's disease.
Andere Medikamente
Carbidopa/levodopa, Pramipexol.
Allergien
None.
Vorherige Impfungen
-

VAERS 2112969

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CO
Alter
45,0
Geschlecht
M
Eingang
15.02.2022
Impfdatum
15.12.2021
Beginn
18.12.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Angiogram normal Dysarthria Muscular weakness Neurological symptom Pneumonia aspiration Respiratory failure SARS-CoV-2 test negative Sinusitis Syncope

Symptomtext

Janssen COVID-19 Vaccine EUA: patient hospitalized with acute neurologic symptoms (slurred speech, syncope, and lower left leg weakness), aspiration pneumonia, pan-sinusitis, and hypoxemic respiratory failure after running out of home oxygen. Administered supplemental oxygen and antimicrobials. Discharged to home medically stable.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
18,0
Labordaten
CTA head and neck: negative for hemorrhage, occlusion, and stroke; SARS-CoV-2 PCR: negative
Aktuelle Erkrankungen
COVID-19, chest pain
Vorgeschichte
hyperlipidemia, benign prostatic hyperplasia, hypertension, depression/anxiety, macrocytic anemia, obesity, deep vein thrombosis, hypothyroidism, pulmonary nodules
Andere Medikamente
apixaban, aspirin, bupropion, carvedilol, citalopram, diclofenac, levothyroxine, lisinopril, pantoprazole, potassium chloride
Allergien
None
Vorherige Impfungen
-

VAERS 2105484

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
VA
Alter
31,0
Geschlecht
M
Eingang
11.02.2022
Impfdatum
11.02.2022
Beginn
11.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Loss of consciousness Syncope

Symptomtext

Patient fainted for few seconds Breathing and pulse was okay and was conscious right after I elevated his head, gave him water and monitored him for 20 minutes

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2096724

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
NY
Alter
18,0
Geschlecht
F
Eingang
08.02.2022
Impfdatum
07.02.2022
Beginn
07.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Fall Syncope

Symptomtext

Patient experienced syncope and fell from chair to floor 5-7 minutes after receiving vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2091497

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
OH
Alter
19,0
Geschlecht
M
Eingang
05.02.2022
Impfdatum
05.02.2022
Beginn
05.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Loss of consciousness Pallor Tremor

Symptomtext

pt was ghostly white when sitting in chair prior to vaccine, pt stated he was very afraid of needles and shots. Sat and talked to patient until he said he was comfortable getting vaccine. pt took several deep breaths and was vaccinated. Had pt sit in chair for a minute or so and talked to him. instructed pt he could go over and sit in more comfortable chair or walk around for 15 minutes. Approximately 1-2 minutes after leaving vaccination chair, pt's GF yelled she needed help that pt had passed out. I immediately walked to pt and he was lying face down on carpet in the aisle. I touched pt and attempted to stir him while calling his name. His eyes flung open and he attempte to sit up. I had pt remain still any lying on floor until I was comfortable that he was breathing ok and he knew his name and where he was. I instructed my techinician to call 911 and have EMS come to store. Pt then sat up on floor and my technician brought him a bottle of water. Pt was still ghostly white and his hands were very mildly shaking, like he was nervous. Stayed with pt, sitting on floor until EMS arrived. Pt was then walked to ambulance with EMS and evaluated there.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
asthma
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2075485

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
VA
Alter
27,0
Geschlecht
M
Eingang
31.01.2022
Impfdatum
28.01.2022
Beginn
28.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Feeling abnormal Heart rate decreased Hypotonia Loss of consciousness Syncope

Symptomtext

Patient fainted approximately 10 minutes after immunization was given. Before syncope, he asked for water as he was feeling strangely. He was seated when he fainted and he simply slumped in the chair. He was unconscious for about 2 minutes before regaining consciousness. He declined calling 911 but a employee who is EMT certified evaluated the gentleman. Pulse was found to be low. 911 was called and the patient was further evaluated by city EMT personnel. They did not transport the patient for further care . He left the premises within 30 minutes of the syncopal episode under his own power.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
EMT evaluation at the time of the incident.
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
-

VAERS 2065821

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
MA
Alter
40,0
Geschlecht
F
Eingang
26.01.2022
Impfdatum
24.01.2022
Beginn
24.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Syncope

Symptomtext

Near Syncopal episode, treated on site by Ems and transported to Emergency Dept for further assessment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
unknown
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
No known Allergies per patient
Vorherige Impfungen
-

VAERS 2053250

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CA
Alter
32,0
Geschlecht
M
Eingang
21.01.2022
Impfdatum
01.12.2021
Beginn
01.01.2022
Tage bis Beginn
31,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Skin discolouration Thrombosis

Symptomtext

Nothing serious but I noticed black patches on my right arm. It was probably a subcutaneous clot which went away in about 4 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2040472

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
MI
Alter
33,0
Geschlecht
M
Eingang
17.01.2022
Impfdatum
17.01.2022
Beginn
17.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Fall Loss of consciousness Pallor

Symptomtext

Patient passed out,felt down , unconscious ,he was pale, had pulse. We called emergency I kept talking to patient and wake him up till the ambulance arrived. I called him after few hours to check on him

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
no allergy
Vorherige Impfungen
-

VAERS 2039504

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
AZ
Alter
51,0
Geschlecht
M
Eingang
17.01.2022
Impfdatum
11.01.2022
Beginn
11.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Seizure

Symptomtext

Seizure 9 hours after booster

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
5 day hospitalization
Aktuelle Erkrankungen
None
Vorgeschichte
Cancer survivor. Seizures, 5 years prior, dry mouth, thyroid
Andere Medikamente
Keppra
Allergien
None
Vorherige Impfungen
-

VAERS 2039381

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge 1855191

schwer
Staat
NY
Alter
23,0
Geschlecht
F
Eingang
17.01.2022
Impfdatum
14.01.2022
Beginn
14.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Asthenia Breast pain Dizziness Fatigue Feeling abnormal Headache Hypertension Hypoaesthesia Loss of consciousness Nausea Pain Pyrexia Tachycardia

Symptomtext

Passed out, brain fog , headache, fever, body aches, pains all over body, numbness, soreness, tachycardia, high blood pressure, lightheaded, dizzy, nauseous, weakness, and fatigue.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Lyme disease, Vasovagal Syncope, Hypoglycemia, Gastritis
Vorgeschichte
-
Andere Medikamente
Vitamins
Allergien
Cymbalta
Vorherige Impfungen
moderna vaccine -heart issues and passed out

VAERS 2032314

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CA
Alter
37,0
Geschlecht
F
Eingang
13.01.2022
Impfdatum
13.01.2022
Beginn
13.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Dizziness Presyncope

Symptomtext

NEAR SYNCOPE, LIGHTHEADED, DIZZINESS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2032279

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
OH
Alter
23,0
Geschlecht
M
Eingang
13.01.2022
Impfdatum
13.01.2022
Beginn
13.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Loss of consciousness Paraesthesia Tinnitus

Symptomtext

Pt. reports 2 minutes after getting his vaccine feeling lightheaded and dizzy. Pt. passed out. Woken up with ammonia inhalant. VS: 1558 No BP, OxSat: 90%, HR: 59x min. 4PM BP 120/82, OxSat 98%, hr: 73X min. 4:19PM BP 126/80, hands "tingling, ears still ringing". 4:35PM pt states he is "back to normal" Pt exit the facility with his wife. He was advised to report this to his PC and get medical advise before getting his booster.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2029253

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CA
Alter
40,0
Geschlecht
F
Eingang
12.01.2022
Impfdatum
12.01.2022
Beginn
12.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Dizziness Loss of consciousness Nausea

Symptomtext

Patient passed-out for about 1 minute after about 5 minutes after vaccine was given. When she recovered, her blood pressure and pulse were normal. Customer dizzy and nauseous. Paramedics picked-up the patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Not available
Vorgeschichte
Metabolic disease
Andere Medikamente
Not available
Allergien
Latex, eggs
Vorherige Impfungen
-

VAERS 2021339

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CT
Alter
23,0
Geschlecht
M
Eingang
10.01.2022
Impfdatum
10.01.2022
Beginn
10.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

Patient was nervous about injection but received it without compliant. Waited 15 minutes. Got up to go shopping and fainted at checkout about 25 minutes after injection.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
Ambulance came to take his blood pressure and pulse and he was reported to be fine and left on this own.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2019454

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
WA
Alter
48,0
Geschlecht
M
Eingang
08.01.2022
Impfdatum
08.01.2022
Beginn
08.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cold sweat Dizziness Hyperhidrosis Hypotension Loss of consciousness Nervousness

Symptomtext

Patient received Janssen, he had brief loss of consciousness when being monitored for possible adverse reaction. He was sweaty, clammy and complained of dizziness when regained consciousness. Hypotension noted with BP less than 90 for diastolic. He was shaky and confirmed not having a meal for the whole and has a big fear on needle. Snack was offered and pushed fluid, VS normal when rechecked, left the clinic Alert and oriented.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
DENIED
Vorgeschichte
DENIED
Andere Medikamente
DENIED
Allergien
DENIED
Vorherige Impfungen
-

VAERS 2014015

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
NY
Alter
21,0
Geschlecht
M
Eingang
07.01.2022
Impfdatum
04.01.2022
Beginn
04.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

Patient fainted after vaccine. Patient quickly arose after fainting and was and monitored for 30 minutes with no other adverse reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Lung disease/asthma
Andere Medikamente
-
Allergien
None
Vorherige Impfungen
-

VAERS 2011241

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CA
Alter
20,0
Geschlecht
M
Eingang
06.01.2022
Impfdatum
06.01.2022
Beginn
06.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood glucose normal Dizziness Hyperhidrosis Syncope

Symptomtext

Patient received 1st vaccine, patients became diaphoretic and dizzy, then fainted while sitting in the chair. Patient was transferred to gurney. MD stat called. Vitals taken and MD assessment completed. BP initially in 79/39, HR: 56, Temp: 96.3, O2 Sat: 98% on room air, RR: 16, Blood glucose: 106. Vitals stabilized upon departure- BP:105/59, HR: 72.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
unknown
Vorgeschichte
Panic attack, Migraine, Major Depressive Disorder, Syncope, Hypokalemia, Anxiety
Andere Medikamente
Contrast dye
Allergien
n/a
Vorherige Impfungen
-

VAERS 2006630

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CA
Alter
24,0
Geschlecht
F
Eingang
05.01.2022
Impfdatum
05.01.2022
Beginn
05.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fatigue Loss of consciousness Pain Seizure

Symptomtext

Patient had seizure after a few minutes of administering Janssen covid immunization - 1st dose - patient passed out and was in and out of it while lying on the floor for a couple of minutes. We immediately called 911 and patient was already awake when 911 got on the scene. Patient reported that she was very tired and achy all over. Patient stayed in the store for few more minutes and went home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2001284

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CA
Alter
60,0
Geschlecht
F
Eingang
04.01.2022
Impfdatum
31.12.2021
Beginn
31.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Computerised tomogram Laboratory test Syncope

Symptomtext

Syncopal event 30 minutes after shot given. Transported to ER for possible seizure activity.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
CT scan, ED work up, Labs
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Losartan, Levothyroxone
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1996147

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CA
Alter
18,0
Geschlecht
F
Eingang
31.12.2021
Impfdatum
31.12.2021
Beginn
31.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Head injury Syncope

Symptomtext

Patient fainted after receiving her COVID booster and hit her head on the ground

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 1982437

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
FL
Alter
27,0
Geschlecht
F
Eingang
27.12.2021
Impfdatum
27.12.2021
Beginn
27.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Fall Loss of consciousness Nasal injury Nervousness Palpitations

Symptomtext

Pt received the shot and proceeded to sit in the chair for the 15 minutes so she can be watched. She then passed out and hit her nose on the ground. we ran out to assess the situation and she came to as soon as we went to her. Pt refused to let us call 911 to have paramedics come check her out. no allergic reaction was seen. pt said she felt better enough to sit back up on chair. once she sat in the chair she then passed out again but came to immediately after falling to the ground. manager on duty, pharmacy manager and immunizing tech were there to support. pt was asked when the last time she ate which was over 12 hours prior so we gave her a glucose tablet and some water. pt said her heart was racing but she said it was because she was nervous about getting the shot. pt called her roommate to get drive her back home and said she would call us back if anything else happened. pt was able to walk to the car herself (immunizing tech made sure she made it inside the car) and said she felt way better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
penicillin
Vorherige Impfungen
-

VAERS 1982150

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
IN
Alter
26,0
Geschlecht
M
Eingang
27.12.2021
Impfdatum
27.12.2021
Beginn
27.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hyperhidrosis Loss of consciousness Nausea Pallor Presyncope

Symptomtext

The patient had a vasovagal response about 10 minutes into the 15 minute holding protocol. Passed out in the chair, got pale, and very sweaty. The patient came to after about 1 minute. Stayed conscious enough to sip water and say he was ok.. He then passed out again. We called 911, an ambulance came, but the patient didn't want to be taken to the hospital. The patient then sat for another 15 to 20 minutes. He had regained his color, and was no longer nauseous. He went home after this additional waiting period.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1982042

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CO
Alter
35,0
Geschlecht
M
Eingang
27.12.2021
Impfdatum
27.12.2021
Beginn
27.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Dizziness Fall Seizure

Symptomtext

Patient was given his first dose of J&J covid vaccine. Patient was asked to wait by pharmacy for at least 15 minutes before leaving. Almost immediately he came back in and stated he felt dizzy. I instructed him to take a seat as I grabbed juice and water. As I walked back into the room he fell onto his stomach and head. The lady with him stated he was having a seizure and I called 911 right away. EMS showed up about 5 minutes after words and assessed the patient. The patient appeared to have another siezure while EMTs were here so they took the patient to the ER to be further assesed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
siezure
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
felt faint/dizzy

VAERS 1981838

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
NY
Alter
33,0
Geschlecht
M
Eingang
27.12.2021
Impfdatum
04.12.2021
Beginn
05.12.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Presyncope Supraventricular tachycardia

Symptomtext

Symptomatic SVT resulting in near syncope requiring treatment with valsalva and vagal maneuvers for treatment

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
I am a hospitalist physician assistant and diagnosed the SVT
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
NA
Allergien
NA
Vorherige Impfungen
-

VAERS 1981180

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
NY
Alter
61,0
Geschlecht
M
Eingang
26.12.2021
Impfdatum
26.12.2021
Beginn
26.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Loss of consciousness Muscle rigidity Urinary incontinence

Symptomtext

Patient started making growling noises. Other customers observed him become rigid, then loose consciousness and slide from chair to knees on floor. I was called. The patient seemed to be unconscious. I lowered him to the floor, and called 911. I started talking to him. He regained consciousness and was able to speak with me after 1 minute. Patient was also incontinent of bladder. 911 arrived after approximately 5 minutes. They came and took patient to the hospital for evaluation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
Unknown.
Aktuelle Erkrankungen
None noted
Vorgeschichte
None noted
Andere Medikamente
Sildenafil, Atorvastatin, Atenolol
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1975515

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
FL
Alter
35,0
Geschlecht
M
Eingang
23.12.2021
Impfdatum
21.12.2021
Beginn
21.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Hyperhidrosis Loss of consciousness

Symptomtext

Patient was in a seated position approximately 5 minutes after receiving the Janssen COVID vaccine. He briefly lost consciousness for about 30 seconds. His head was back and feet were outstretched. He never stopped breathing. His change in condition was noticed by one of the pharmacy employees who is a Registered Nurse. He had regained consciousness by the time I responded. He stated that he felt lightheaded and was sweating. He was given some water and crackers and observed for approximately 20 more minutes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none known
Vorgeschichte
none known
Andere Medikamente
none known
Allergien
penicillin
Vorherige Impfungen
-

VAERS 1975389

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
FL
Alter
27,0
Geschlecht
M
Eingang
23.12.2021
Impfdatum
22.12.2021
Beginn
22.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hyperhidrosis Loss of consciousness Syncope Tremor

Symptomtext

PATIENT STARTED TO EXPERIENCE TREMORS ,SYNCOPE AND PROFUSE SWEATING ABOUT 10 MINUTES AFTER RECEIVING VACCINE. HE LOST CONSCIOUSNESS FOR ABOUT 1 MINUTE. HE WAS ATTENDED TO BY PARAMEDICS FOR ABOUT 15 MINUTES THEN LEFT ON HIS OWN.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
VERTIGO
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 1968026

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
MD
Alter
26,0
Geschlecht
M
Eingang
21.12.2021
Impfdatum
21.12.2021
Beginn
21.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Fall Head injury Loss of consciousness Seizure

Symptomtext

Patient passed out and had seizure-like reaction before falling out the the chair he was waiting in and hitting his head on the the floor. Fire/Paramedics were called to the scene and took over. Pt left with emergency services

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
unknown
Allergien
n/a
Vorherige Impfungen
flu shot (unknown brandnname)

VAERS 1964085

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CA
Alter
35,0
Geschlecht
M
Eingang
20.12.2021
Impfdatum
20.12.2021
Beginn
20.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Hyperhidrosis Presyncope

Symptomtext

Patient is a 35 year old male who has completed a 30-minute observation period with the following signs and symptoms of an adverse reaction: other - dizziness, near sycope, diaphoresis. Janssen/J&J COVID-19 vaccine #1 in series administered. o Action(s) taken: Other - monitored BP, normal vital signs, rest, cold compress o Vitals: o o 12/20/21 1500 o 12/20/21 1505 o 12/20/21 1510 o BP: o 128/81 o 131/78 o 122/78 o BP Patient Position: o LYING o LYING o LYING o BP Location: o LA-LEFT ARM o LA-LEFT ARM o LA-LEFT ARM o Pulse: o 95 o 85 o 85 o Resp: o 15 o o o SpO2: o 99% o 99% o 99% o o o No SOB, no hives no rash noted. Speaks in full sentences. o Allergy to COVID-19 vaccine documented in Allergies activity: No, not allergic reaction o Patient advised to discuss reaction to clinician, and see doctor if condition worsens o D/c home at 1530. Stable. Ambulatory. Wife is driver

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
ADHD
Vorgeschichte
ADHD
Andere Medikamente
Aderall
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1962473

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
-
Alter
25,0
Geschlecht
M
Eingang
19.12.2021
Impfdatum
18.12.2021
Beginn
18.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Seizure Vomiting

Symptomtext

After giving the vaccine, pt was asked to wait in the waiting area for 15 minutes. Seizure occurred during that time. Witness said it happened twice and he threw up as well. Ambulance was called and he was taken to the ER.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1961997

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
IN
Alter
27,0
Geschlecht
M
Eingang
18.12.2021
Impfdatum
18.12.2021
Beginn
18.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dizziness Loss of consciousness Musculoskeletal stiffness Neck pain Seizure

Symptomtext

Pt experienced a seizure event; became stiff and passed out for about 30 seconds. When he came to he expressed that he was dizzy and his neck hurts.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
-

VAERS 1959696

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CA
Alter
58,0
Geschlecht
F
Eingang
17.12.2021
Impfdatum
16.11.2021
Beginn
17.11.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Deep vein thrombosis Fibrin D dimer Joint swelling Pain Pain in extremity Tenderness Ultrasound Doppler abnormal

Symptomtext

Day after booster on 11/16/21 my right leg was aching. 7 days later on 11/23/21 my sole of my right foot was very painful upon walking. This resolved 2 days later by 11/25/21. On day 11 (11/26/21) my ankle was slightly swollen and painful to touch. These symptoms continued to migrate up my leg to my inner thigh. On 12/13/21 I was seen by my primary care Doctor and was sent for a d-dimer blood test which was 1.77. I was seen in vascular dept and ultrasound indicated multiple DVT from my groin to my ankle.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
-
Labordaten
12/13/21 D-dimer blood test and Ultrasound.
Aktuelle Erkrankungen
Diverticulitis 10/21
Vorgeschichte
-
Andere Medikamente
40 mg Lisinopril
Allergien
-
Vorherige Impfungen
-

VAERS 1955401

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CA
Alter
20,0
Geschlecht
F
Eingang
16.12.2021
Impfdatum
16.12.2021
Beginn
16.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Chills Hyperhidrosis Pallor Presyncope

Symptomtext

Client experienced near-syncopal event approximately 5-10 minutes post vaccination. Client has history of syncope with blood donation. Client diaphoretic, exhibiting pallor, weak, shivering. Vitals taken q15 minutes x 3. Client signs/symptoms resolved over next 30 minutes. Client able to walk with steady gait out of vaccination site, accompanied and driven home by spouse.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
Iron supplement, oral birth control
Allergien
n/a
Vorherige Impfungen
-

VAERS 1954336

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
WA
Alter
27,0
Geschlecht
M
Eingang
15.12.2021
Impfdatum
15.12.2021
Beginn
15.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Hyperhidrosis Pallor Syncope Wheelchair user

Symptomtext

Syncopal event post admin approximately 2-3 mins after moving from vaccine tent to observation area. Was in seated position during episode. Witnessed by friend sitting next to them. A&O x 3 upon evaluation, diaphoretic, pale, VSS. Provided water and snacks, wheelchair to cot for further observation. Patient informed that had similar episode before with a blood draw and was very nervous prior to admin of vaccine. VS checked before leaving, vss, no longer diaphoretic. Advised on safety prior to future vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1952414

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
MS
Alter
64,0
Geschlecht
M
Eingang
15.12.2021
Impfdatum
15.12.2021
Beginn
15.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Loss of consciousness Malaise Pallor

Symptomtext

Patient came in to get a Covid Janssen booster. Patient stated being afraid of needles. Patient was given vaccine said he didn't feel a thing. Patient was told to have a seat and wait 15 minutes. After about 5 minutes patient got up to tell an associate of not feeling well and passed out. Patient was pale in the face but came to. Patient was sat up and given water and ice until patient felt better. Patient waited around and even walked around the store and felt better before leaving. Patient declined for us to call someone to bring him home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1947828

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CA
Alter
40,0
Geschlecht
F
Eingang
14.12.2021
Impfdatum
29.11.2021
Beginn
05.12.2021
Tage bis Beginn
6,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood test abnormal Dizziness Dyspnoea Fibrin D dimer Hyperhidrosis Inflammation Migraine Nausea Thrombosis

Symptomtext

Migraines, Sweating, Shortness of Breath, Dizziness, Nausea - caused by Blood clotting

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
December 13, 2021 - Blood testing showing blood clotting by levels of D-Dimer and high inflammation
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
zyrtec
Allergien
Penicillin, Coco Betaine, Nickel
Vorherige Impfungen
-

VAERS 1943639

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
AL
Alter
50,0
Geschlecht
M
Eingang
13.12.2021
Impfdatum
13.12.2021
Beginn
13.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Loss of consciousness Seizure

Symptomtext

PT PASSED OUT AND HAD A SMALL SEIZURE WITHIN 1 MINUTE OF VACCINE ADMINISTRATION. THE SEIZURE LASTED ABOUT 7 SECONDS. WE LAID HIM DOWN ON THE FLOOR AND MONITOR HIM. HE REGAINED CONSCIOUSNESS AND NORMAL VITAL SIGNS WITHIN 10 SECONDS. WE CALLED 911 AND THE PATIENT WAS TAKEN TO THE HOSPITAL FOR FURTHER MONITORING.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
VITAL SIGNS WERE MONITORED ON-SITE AND WERE WITHIN NORMAL LEVELS
Aktuelle Erkrankungen
NO
Vorgeschichte
HISTORY OF VAGUS NERVE REACTION TO VACCINES
Andere Medikamente
NO
Allergien
NO
Vorherige Impfungen
-

VAERS 1936119

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
NY
Alter
23,0
Geschlecht
M
Eingang
09.12.2021
Impfdatum
09.12.2021
Beginn
09.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Heart rate decreased Loss of consciousness Seizure

Symptomtext

After the vaccination, the patient was sitting in the waiting area. A few moments later, he slumped over in his chair and was visibly seizing. It lasted less than 30 seconds. When he came to, he knew where he was and could answer our questions but did not know what was going on. I called 911 and EMS came after a few minutes. They checked him out, said his pulse was very low (in the 30s) and transported him out of the store on a stretcher to evaluate further in the ambulance.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
asthma, seasonal allergies
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1935230

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
MS
Alter
40,0
Geschlecht
F
Eingang
09.12.2021
Impfdatum
23.11.2021
Beginn
25.11.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Deep vein thrombosis Muscle spasms Pain Pain in extremity Thrombosis Ultrasound scan abnormal

Symptomtext

Went to ER on 11/26/21, ultrasound done on left leg and found blood clot from groin to knee long. Leg pain, aches, cramps Partial DVT identified within the left common, superficial, and popliteal veins. Went back to ER on 12/4/21 due to additional symptoms Ultrasound done on right arm, right and left leg and blood clots were found in all 3. Pain, aches, cramps Right arm: Nonocclusive DVT in the right basilic vein. Right leg: There is nonocclusive acute DVT in the right common femoral vein and superficial femoral vein and popliteal vein. Left leg: There is nonocclusive acute DVT in the left common femoral vein and superficial femoral vein and popliteal vein

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
-
Labordaten
Ultrasound
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Lexapro Estradiol
Allergien
None
Vorherige Impfungen
-

VAERS 1933293

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
FL
Alter
39,0
Geschlecht
M
Eingang
08.12.2021
Impfdatum
08.12.2021
Beginn
08.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

Vasovagal syncope. This was a known issue as the patient notified us prior that he usually has this problem with injections. Patient was seated in waiting area after being vaccinated and went unconscious, slid down the chair onto the floor in a sitting position where he was caught by an employee before any secondary injury occurred. He was conscious within seconds and was given water. Patient's emergency contact (spouse) was notified immediately and she came to pick him up. He had recovered sufficiently to ambulate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
none
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
none listed
Vorherige Impfungen
-

VAERS 1931273

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CO
Alter
29,0
Geschlecht
F
Eingang
08.12.2021
Impfdatum
-
Beginn
03.12.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Loss of consciousness

Symptomtext

BLACKING OUT; LIGHT HEADEDNESS; This spontaneous report received from a patient concerned a 29 year old female. The patient's height, and weight were not reported. The patient's past medical history included: covid-19 in APR-2021, and concurrent conditions included: celiac disease, and gluten allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: Unknown) dose was not reported, 1 total, administered on left arm on 03-DEC-2021 for prophylactic vaccination (dose number series is 1). No concomitant medications were reported. On 03-DEC-2021, after the injection, the patient experienced light headedness. On 04-DEC-2021, in the morning while in kitchen, the patient started to black out. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from blacking out, and light headedness. This report was serious (Other Medically Important Condition).; Sender's Comments: V0- 20211212231-covid-19 vaccine ad26.cov2.s- Blacking out. This event(s) is considered unassessable. The event(s) has a compatible/ suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Allergy to grains; Celiac disease
Vorgeschichte
Medical History/Concurrent Conditions: COVID-19
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1928610

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
GA
Alter
56,0
Geschlecht
F
Eingang
07.12.2021
Impfdatum
03.12.2021
Beginn
05.12.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Fall Head injury Syncope Tenderness

Symptomtext

The night prior to syncopal event, was told by spouse that I was "burning up" I did not feel warm. The next day, prodromal lightheadedness while standing during singing resulted in a fall to floor. In retrospect, I hit head as now experiencing point tenderness posteriorly. After regaining awareness was able to resume usual activity.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
hypertension, diabetes
Andere Medikamente
Metformin, Januvia, hydrochlorothiazide-lisinopril, ziac, cetirizine
Allergien
none
Vorherige Impfungen
PPSV23, HEP A-HEP B, purpura, 08/28/2020

VAERS 1926191

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
MN
Alter
22,0
Geschlecht
M
Eingang
06.12.2021
Impfdatum
02.12.2021
Beginn
02.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cold sweat Feeling hot Hypotension Pallor Paraesthesia Presyncope Syncope Tinnitus

Symptomtext

Near fainting (syncope). NO redness, NO itching. Pale, clammy skin. Hypotension: BP 90/71 mmHg and pulse 54. Pt had ringing in ears, tingling in arm and felt hot. BP taken at 5:40PM. Given ice pack, Gatorade to drink. Note: patient was very thin and disclosed that he had not eaten anything all day. Both parents were with him. Vaccine administrator theorized stress due to shot added to lack of food and water that day lead to syncope, Arm at site of injection did not appear affected. Pt became more alert and was able to walk out with assistance. Advised to go to urgent care if he faints again or if redness appears at injection site.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
Two blood pressure readings, approx.20 minutes apart. Both 90/71 mmHg with pulse remaining in the 50s.
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
None disclosed by patient
Allergien
None
Vorherige Impfungen
-

VAERS 1925095

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CA
Alter
30,0
Geschlecht
M
Eingang
06.12.2021
Impfdatum
03.12.2021
Beginn
03.12.2021
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

patient was waiting the appropriate time outside of the pharmacy while seated and fainted

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 1923534

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CA
Alter
44,0
Geschlecht
F
Eingang
04.12.2021
Impfdatum
04.12.2021
Beginn
04.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Loss of consciousness Malaise Syncope

Symptomtext

Patient fainted after receiving 1st dose of Janssen 0.5ml at 1537. Patient was given 15 minutes of observation. While waiting for her husband to receive his shot. Patient stated, "I don't feel good". LVN called RN to assess patient. Upon assessment, patient appears perspiring, clinched both hands (fist) to her chest. Right away, RN asked Husband assist patient to the floor. Patient was unconscious for about 30 seconds. 911 was called and paramedics arrived on seen at 1548. During 911 phone call, patient began responding to verbal command to name, time, place. Vitals was taken O2 98 RA, 79HR, R .20, B/P 128/92. Patient then stated she has history of epilepsy, and allergic reaction to tetanus shot. Did not want to go to the ambulance. We had patient wait in observation for 30mins. Vitals before she left were 02 99% and Pulse 76.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NA
Vorgeschichte
Patient has a history of epilepsy, and reaction to tetanus shot. This was mentioned after the vaccination was administered.
Andere Medikamente
N/A
Allergien
NO
Vorherige Impfungen
Patient did not provide us with any known reaction during screening. After adverse reaction, she stated she had a allergic react

VAERS 1914567

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
MD
Alter
61,0
Geschlecht
F
Eingang
01.12.2021
Impfdatum
24.11.2021
Beginn
26.11.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Electric shock sensation Headache Hypoaesthesia Limb discomfort Pain Pain in extremity Paraesthesia Sleep disorder

Symptomtext

headaches, body aches, painful sharp pulsing ticklish feeling on right side of right foot; numbness on left foot with occasional sharp electrical light pain shooting up the leg. This kept me up for 2 nights. Currently, I am still feeling mild tingling under the left foot which has spread to the entire left foot. Both feet are numb.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electric shock sensation
Hospital-Tage
-
Labordaten
I contacted my doctor who told me this does not sound related to vaccine and told me to come in if it gets worse. I figured it would be useless to go. It is improving but in the event of getting worse, I will go to emergent care as my doctor does not seem to be concerned. I am on the other hand extremely worried as this was by booster shot and worry about having to take another shot in the future. I will probably be a lot more reluctant to take the next jab.
Aktuelle Erkrankungen
-
Vorgeschichte
supraventricular tachycardia; high cholesterol; heart pain syndrome for which electrical stimulator implant is used as needed
Andere Medikamente
metropolol; azetimibe; calcium chewable tables;
Allergien
penicillin; acetaminophen; iodine
Vorherige Impfungen
Covid 19 Jessen - original shot; 05/17/21; fever, soreness

VAERS 1904016

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CA
Alter
25,0
Geschlecht
M
Eingang
27.11.2021
Impfdatum
26.11.2021
Beginn
26.11.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Disorientation Dizziness Hypotension Pallor Syncope

Symptomtext

Patient came for a J&J Covid 19 vaccine as a walk in. Patient experienced a fainting spell (? LOC 1 to 2 seconds) in pharmacy almost immediately following administration. Symptoms dizziness, pale, slightly disorientated. 911 was called. They assessed patient H/R slow but normal, BP low but normal. Advised patient to go hospital for further review but patient declined. Patient sat in pharmacy sipping water till he felt better to leave.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
None
Andere Medikamente
n/a
Allergien
None
Vorherige Impfungen
-

VAERS 1893780

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
MA
Alter
34,0
Geschlecht
F
Eingang
23.11.2021
Impfdatum
21.11.2021
Beginn
21.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Syncope

Symptomtext

Patient fainted a few minutes after receiving vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
BP check by emergency services
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
-

VAERS 1867814

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

schwer
Staat
CA
Alter
45,0
Geschlecht
M
Eingang
13.11.2021
Impfdatum
13.11.2021
Beginn
13.11.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Presyncope

Symptomtext

Shortly after receiving his booster dose of Johnson & Johnson COVID-19 vaccine, the client became dizzy upon walking approximately 15 feet. Patient was quickly helped to a chair, and Dr. , our on-site doctor was notified. Dr. interviewed the patient and determined that he had a bradycardic vasovagal reaction and became lightheaded. Patient was given Gatorade and allowed to sit. Dr. determined that further assistance from our stand-by EMS was not required. At 10:08am, Blood pressure was taken and found to be 140/90, his heart rate was 66bpm, oxygen saturation was 98%. Patient was able to stand and walk on his own. He stated that he felt fine and left the premises at 10:30am under his own power.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
Client denies any illnesses.
Vorgeschichte
Client denies any long-standing health conditions.
Andere Medikamente
None.
Allergien
No Known Allergies.
Vorherige Impfungen
-

VAERS 2646060

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
NY
Alter
21,0
Geschlecht
M
Eingang
15.06.2023
Impfdatum
12.03.2022
Beginn
12.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Aortic valve thickening Arrhythmia Carditis Chest pain Echocardiogram Electrocardiogram Electrocardiogram ambulatory Mitral valve thickening Palpitations Tricuspid valve incompetence

Symptomtext

Mitral Valve Thickening, Aortic Valve thickening, Tricuspid Regurgitation, Chest pains, heart inflammation, Heart Palpitations, Heart Arrythmia. All ongoing, 18 months later.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arrhythmia
Hospital-Tage
-
Labordaten
EKG-12 (March 30th, 2022), Echocardiogram (April 1st 2022), Holter Monitor (April 4th, 2022)
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2636843

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
-
Alter
61,0
Geschlecht
M
Eingang
25.05.2023
Impfdatum
06.01.2022
Beginn
07.06.2022
Tage bis Beginn
152,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Hypotension

Symptomtext

HYPOTENSION

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypotension
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2586923

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
FL
Alter
89,0
Geschlecht
M
Eingang
24.02.2023
Impfdatum
12.12.2021
Beginn
12.02.2023
Tage bis Beginn
427,0
Dosis
2
Route/Site
SYR / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 pneumonia Chronic obstructive pulmonary disease Condition aggravated

Symptomtext

Hospitalization for COPD with acute exacerbation and pneumonia from COVID-19 on dates 2/12/2023- 2/14/2023. Treated with dexamethasone.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19 pneumonia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
oxycodone
Vorherige Impfungen
-

VAERS 2570188

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
ID
Alter
53,0
Geschlecht
M
Eingang
29.01.2023
Impfdatum
02.06.2022
Beginn
02.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood test abnormal Computerised tomogram abdomen abnormal Echocardiogram normal Fatigue Hepatic cirrhosis Hepatic mass Impaired work ability Neuralgia Paraesthesia Peripheral swelling Platelet count decreased Skin discolouration Splenomegaly Ultrasound Doppler normal Varices oesophageal

Symptomtext

Within a few weeks Severe leg and feet swelling in one leg, then it spread to both legs every day Severe fatigue Tingling in fingers/hands Tingling in feet and calves Nerve pain in legs and feet Discolorization in calves and feet Blood work shows extremely low platelets - 63,000 then down to 59,000 one week later Forced to go part time at job due to physical impairment

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
Dec 12, 2022 - CT Scan - enlarged spleen measuring 20 cm in length Gastroesophageal varices Hepatic Cirrhosis without focal parenchymal lesion Liver: cirrhotic morphology of the liver with associated capsular nodularity. July 12, 2022 - Ultrasound of lower extremity veins using 2D imaging No evidence of superficial venous obstruction Several blood tests - low blood platelets Jan 2023 - Ultrasound of heart -good
Aktuelle Erkrankungen
Fatty Liver
Vorgeschichte
Nearly 2 years post-knee replacement surgery
Andere Medikamente
Vitamin D
Allergien
-
Vorherige Impfungen
-

VAERS 2557485

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
MI
Alter
75,0
Geschlecht
F
Eingang
11.01.2023
Impfdatum
07.01.2022
Beginn
14.12.2022
Tage bis Beginn
341,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Cough Dyspnoea Pyrexia SARS-CoV-2 test positive

Symptomtext

12/14/22 presents to EC ED for "fever, cough, SOB". PMHx of "severe non-CF bronchiectasis with secondary severe COPD s/p bilateral lobectomy."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
12/14/22 SARS-CoV-2 (COVID-19) detected.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2490061

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
MI
Alter
71,0
Geschlecht
M
Eingang
26.10.2022
Impfdatum
22.11.2021
Beginn
12.10.2022
Tage bis Beginn
324,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acidosis Benign prostatic hyperplasia Brain natriuretic peptide increased COVID-19 Cardiac failure congestive Chest X-ray normal Chronic left ventricular failure Chronic obstructive pulmonary disease Condition aggravated Dyspnoea Fibrin D dimer normal Glycosylated haemoglobin increased Hypercapnia Hyperglycaemia Insulin therapy Leukocytosis Liver function test Renal function test

Symptomtext

Admission Date: 10/12/2022 Discharge Date:10/21/2022 HOSPITAL COURSE Patient is a 72 y.o. male with a history of persistent atrial fibrillation, diastolic heart failure, and oxygen-dependent chronic obstructive pulmonary disease who presented to the hospital 10/12 with dyspnea. Few hours prior to arrival he suddenly became very dyspneic. He usually uses 3 L of supplemental oxygen at baseline but turned up to 5 at home and then called EMS. Patient received 125 mg of Solu-Medrol and a DuoNeb treatment on the way to the hospital in the ambulance. On arrival, he had mild leukocytosis. He tested positive for COVID-19. He was initially hypercapnic and slightly acidotic. This resolved after continuous nebulizer. D-dimer was negative. CXR was clear. Patient was admitted for COPD with acute exacerbation 2/2 Covid 19 infection. Remdesivir was started on 10/12 and was completed on 10/16 daily renal and liver function monitoring for kidney and liver toxicity was done. For COPD exacerbation he was started on solumedrol 40 mg IV every 12 hours and then was transitioned to prednisone 40 mg PO. Patient completed a 5 days course of azithromycin IV (10/13-10/17). Patient received duo-nebs every 4 hours while awake. He was continued on his home Budesonide/Fometorol and Spiriva INH. Patient is being discharge on prednisone 10 mg with a taper. Patients was treated for fasting hyperglycemia. Hyperglycemia was most likely steroid induced and improved from the switch from solumedrol to prednisone. Patient was placed on a moderate sliding scale insulin but d/c at discharge. Hemoglobin A1c obtained was 6.4%. Patient showed symptoms of a mild acute exacerbation for his chronic diastolic congestive heart failure. CXR showed no acute cardiopulmonary abnormalities but BNP was 2,420. Patient was given 40 mg of IV lasix (10/17-10/18) and then transitioned to lasix 20 mg PO BID which he tolerated well. Patient had symptoms correlating to BPH he was started on flomax 0.4 mg patient stated this helped with emptying bladder.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
9,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Chronic obstructive pulmonary disease Nocturnal hypoxia Chronic respiratory failure with hypoxia COPD with acute exacerbation 2/2 COVID 19 infection Coronary artery disease involving native coronary artery of native heart with unstable angina pectoris Atrial fibrillation and flutter Hypertension Mitral valve stenosis LBBB (left bundle branch block) Persistent atrial fibrillation Combined systolic and diastolic congestive heart failure Atrial flutter Acute on chronic combined systolic and diastolic heart failure Decompensated heart failure Severe mitral valve stenosis Postoperative anemia due to acute blood loss Penile edema Hyperlipidemia Stress hyperglycemia Prediabetes Tobacco use with probable chronic obstructive pulmonary disease Alcohol abuse History of cardioversion Current every day smoker S/P mitral valve replacement Abdominal distention
Andere Medikamente
albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler aspirin 81 MG chewable tablet atorvastatin (LIPITOR) 10 MG tablet Budeson-Glycopyrrol-Formoterol (BREZTRI AEROSPHERE) 160-9-4.8 MCG/ACT AERO Cholecalcif
Allergien
NKA
Vorherige Impfungen
-

VAERS 2449626

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
52,0
Geschlecht
U
Eingang
17.09.2022
Impfdatum
03.01.2022
Beginn
01.01.2022
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Arthralgia Blood glucose Blood test Burning sensation COVID-19 Hypoaesthesia Insomnia Neuralgia Paraesthesia SARS-CoV-2 test Vaccination failure

Symptomtext

BURNING SENSATION IN THE THUMBS; PAIN IN KNEES; NUMB/ KNEES FEEL NUMB; COULD NOT SLEEP; CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; TINGLINGS ON THE OUTSIDE OF HEAD/FEET/HANDS; SEVERE PAINS ALSO INVOLVING NERVE PAINS/NERVE PAIN IN THE FEET TO LOWER LEGS; This spontaneous report received from a patient via a company representative concerned a 52 year old of unspecified sex, race and ethnicity. The patient's weight was 91 kilograms, and height was not reported. The patient's concurrent conditions included: diabetes. The patient previously received covid-19 vaccine ad26.cov2.s (Dose number in series 1), (suspension for injection, route of admin not reported, batch number: 203A21A expiry: UNKNOWN) dose was not reported, 1 total administered on 09-JUL-2021 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination (Dose number in series 1). The patient received booster dose of covid-19 vaccine ad26.cov2.s (Dose number in series 2), (suspension for injection, route of admin not reported, batch number: 1855191 expiry: UNKNOWN) dose was not reported, 1 total administered on 03-JAN-2022 for covid-19 prophylaxis. Age at time of vaccination 52 years old. No concomitant medications were reported. Since JAN-2022 patient suffered from tingling on the outside of his head, since February patient also experienced tingling in his feet which was getting more and more present and more spread over toes, legs, and arms and patient at the time of reporting had severe pains which involved nerve pains (Dose number in series 2). Patient had covid symptoms at the end of FEB-2022 (17-FEB-2022) and tested positive (confirmed covid-19 infection) on 18-FEB-2022 which resulted to confirmed clinical vaccination failure (Dose number in series 2). On APR-2022, Laboratory data included: Blood glucose was higher than it should be. On MAY-2022, Laboratory data included: Blood glucose something like 170. while it must had to be between 80 and 120. Something like above 200 is really much too high, according to the physician. Got some pills, and started measuring, and left sugars behind (Dose number in series 2) From the beginning of JUN-2022 it started to seed further in the feet. At the end of June it was so bad that patient often couldnot sleep and at mid JUL-2022 spread to whole feet, and first tingling in the hands, but almost negligible and patient took Gabapentin for nerve pain, 100 mg 2 times a day (Dose number in series 2). On JUL-2022, Laboratory data included: Blood test all looks fine. On AUG-2022, the patient experienced pain in knees, and numb/ knees feel numb (Dose number in series 2). On 16-AUG-2022, the patient experienced burning sensation in the thumbs (Dose number in series 2). On 20-AUG-2022, patient had extension of nerve pain in the feet to lower legs, the following week also pain in knees (severe pains also involving nerve pains/nerve pain in the feet to lower legs) and It was not totally numb, on the contrary, the feet were very sensitive. Patient knees felt numb, but they were not (patient don't know how to describe this)(Dose number in series 2). On SEP-2022, Laboratory data included: Blood glucose At the moment most values are between 80 and 120, only when stressed it goes towards 150. Blood got drawn at the beginning of July, and that all looked fine. But at the time of reporting patient had pain in the feet which increased enormously since July and the last 2-3 weeks also pulled further into patient legs, and hands were started to hurt. The pain starts to get so bad that it almost starts to define your day. Things like oxycodone and tramadol still work, but that's not the solution either. As patient mentioned, this all was started in January or February. Treatment medications (dates unspecified) included: gabapentin (600 mg, 3 times a day), tramadol (50 mg 2 times a day), and oxycodone. If patient do not take it,it can barely got through the day and event patient suffered from lower legs and feet, hands, and the occasional nerve shoots randomly in patient body. The patient also visited emergency room and physician office for the adverse events. Patient scheduled visit to neurologist on 07-SEP-2022 (Dose number in series 2) The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from severe pains also involving nerve pains/nerve pain in the feet to lower legs, and pain in knees, and the outcome of tinglings on the outside of head/feet/hands, could not sleep, burning sensation in the thumbs, numb/ knees feel numb, confirmed covid-19 infection and confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0- 20220909740-COVID-19 VACCINE AD26.COV2.S-Confirmed clinical vaccination failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
Test Date: 20220218; Test Name: COVID-19 VIRUS TEST; Test Result: Positive ; Test Date: 202204; Test Name: SUGAR TEST; Result Unstructured Data: was higher than it should be; Test Date: 202205; Test Name: SUGAR TEST; Result Unstructured Data: something like 170; Test Date: 202207; Test Name: BLOOD TEST; Result Unstructured Data: all looks fine; Test Date: 202209; Test Name: SUGAR TEST; Result Unstructured Data: At the moment most values are between 80 and 120, only when stressed it goes towards 150
Aktuelle Erkrankungen
Diabetes
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2428821

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
FL
Alter
67,0
Geschlecht
M
Eingang
04.09.2022
Impfdatum
23.07.2022
Beginn
24.07.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal discomfort Chills Condition aggravated Cyst Dizziness Fatigue Gout Injection site discolouration Injection site induration Injection site pain Pain Staphylococcal infection

Symptomtext

Huge Gout Flare up not yet recovered Hip Infection MRSA cyst and pain better but not gone Injection site pain, hardness, discoloration still not recovered Body Pain, chills, dizzy, fatigue, GI distress

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
CHF, Hip Infection,COPD, RADS, GERD, Gout
Vorgeschichte
CHF, Hip Infection,COPD, RADS, GERD, Gout
Andere Medikamente
Cardivol, HTZS, linsopril, Amolpine, Oxycodone, Eliquiz,
Allergien
None
Vorherige Impfungen
Shingles vacine caused two month unable to walk

VAERS 2416781

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
OH
Alter
76,0
Geschlecht
M
Eingang
20.08.2022
Impfdatum
05.01.2022
Beginn
25.06.2022
Tage bis Beginn
171,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Alanine aminotransferase increased Albumin globulin ratio Anion gap Aspartate aminotransferase increased Blood albumin normal Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium decreased Blood chloride normal Blood creatine phosphokinase MB Blood creatine phosphokinase normal Blood creatinine normal Blood glucose normal Blood magnesium decreased Blood osmolarity decreased Blood potassium normal Blood sodium decreased Blood urea normal

Symptomtext

Chief Complaint: SOB History Of Present Illness: Patient is a 76 y.o. male with pulmonary fibrosis and h/o right upper lobectomy who came to the ER with SOB, cough and fever which started yesterday. He had 100.1 degree fever on arrival here. He tested (+) for Covid-19. He only had single dose of J&J vaccine. He is being admitted. Past Medical History: Patient has a past medical history of Bladder cancer, Bladder tumor, CAD (coronary artery disease), Chronic kidney disease, stage 3, COPD (chronic obstructive pulmonary disease), Diabetes, DOE (dyspnea on exertion), Former cigarette smoker, Hypertension, Lung nodule, Malignant neoplasm of upper lobe of right lung, Mediastinal lymphadenopathy, Obesity (BMI 30-39.9), Phimosis, Prostate cancer, Pulmonary nodules (10/2021), S/P angioplasty with stent (12/11/2020), and Sleep apnea. Past Surgical History: Patient's has a past surgical history that includes Hx Cardiac Catheterization; Hx Broken/Fx Bones; Hx Prostate Biopsy; Hx Knee Arthroscopy (Right); Hx Cystoscopy (Bilateral, 5/9/2019); Hx Cystoscopy (N/A, 5/9/2019); Hx Cystoscopy (Bilateral, 4/19/2018); Hx Cystoscopy (4/19/2018); Hx Cystoscopy (N/A, 8/10/2017); Left heart cath (N/A, 8/15/2012); IVUS (N/A, 8/15/2012); Drug-eluting stent placement (N/A, 8/15/2012); Left heart cath (N/A, 10/8/2011); Drug-eluting stent placement (N/A, 10/8/2011); Left heart cath (N/A, 12/17/2020); Drug-eluting stent placement (N/A, 12/17/2020); CT Guided Lung Biopsy (Right, 10/27/2021); Hx Thoracoscopy (Right, 12/9/2021); Hx Bronchoscopy (N/A, 12/9/2021); Hx Arterial Line Insertion (12/9/2021); Hx Intercostal Nerve Block (Right, 12/9/2021); Hx Thoracotomy (Right, 12/9/2021); and Hx Biopsy (Right, 12/9/2021). Family History: Patient's family history includes Alzheimer's Disease in his father; Cancer in his sister; Diabetes in his brother and mother; Heart Disease in his brother; Renal Disease in his mother. Social History: He reports no history of alcohol use. He reports no history of drug use. He reports that he quit smoking about 17 years ago. His smoking use included cigarettes. He has a 17.50 pack-year smoking history. He has never used smokeless tobacco. Allergies: Lisinopril, Sulfa (sulfonamide antibiotics), and Tuberculin ppd PTA Medications: Prior to Admission Medications Prescriptions Last Dose Informant Patient Reported? Taking? Budesonide-Formoterol (SYMBICORT) 160-4.5 mcg/Actuation inhaler No No Sig: Take 1 Puff by inhalation Twice a day. Insulin Syringe-Needle U-100 (BD INSULIN SYRINGE ULTRA-FINE) 1 mL 31 gauge x 5/16 Syrg No No Sig: 1 Syringe As directed. albuterol (VENTOLIN HFA) 90 mcg/Actuation inhaler No No Sig: Take 1 Puff by inhalation Every 4 hours as needed (WHEEZING). amLODIPine (NORVASC) 10 mg tablet No No Sig: Take 1 Tablet by mouth Once Daily. ascorbic acid, vitamin C, 500 mg tablet Yes No Sig: Take 500 mg by mouth Daily. aspirin (ASPIRIN) 81 mg DR tablet Yes No Sig: Take 325 mg by mouth Once Daily. atorvastatin (LIPITOR) 20 mg tablet No No Sig: Take 1 Tablet by mouth At bedtime. blood sugar diagnostic test strips No No Sig: by Other route Three times a day. One Touch Ultra. Diagnosis E11.65 carvediloL (COREG) 25 mg No No Sig: Take 1 Tablet by mouth Twice a day. cloNIDine (CATAPRES) 0.1 mg/24 hr patch No No Sig: 1 Patch by Transdermal route Every 7 days. clopidogreL (PLAVIX) 75 mg tablet No No Sig: Take 1 Tab by mouth Daily. docusate sodium (COLACE) 100 mg capsule No No Sig: Take 1 Capsule by mouth Twice a day as needed for Constipation. losartan (COZAAR) 50 mg tablet No No Sig: Take 1 Tablet by mouth Once Daily. metFORMIN (GLUCOPHAGE) 1,000 mg tablet No No Sig: Take 1 Tablet by mouth Twice a day. Facility-Administered Medications: None Review of Systems: Review of Systems Unable to perform ROS: Acuity of condition Physical Exam: Blood pressure 132/75, pulse 88, temperature 100.1 ?F (37.8 ?C), temperature source Oral, resp. rate (!) 29, SpO2 96 %. Physical Exam Vitals reviewed. Constitutional: General: He is not in acute distress. Appearance: He is well-developed. He is ill-appearing. HENT: Head: Normocephalic. Eyes: General: No scleral icterus. Pupils: Pupils are equal, round, and reactive to light. Cardiovascular: Rate and Rhythm: Regular rhythm. Heart sounds: No murmur heard. Pulmonary: Effort: No respiratory distress. Breath sounds: Rhonchi present. Abdominal: General: Bowel sounds are normal. There is no distension. Palpations: Abdomen is soft. Tenderness: There is no abdominal tenderness. Musculoskeletal: General: No tenderness. Cervical back: Neck supple. Skin: General: Skin is warm and dry. Findings: No rash. Neurological: Mental Status: He is alert and oriented to person, place, and time. Cranial Nerves: No cranial nerve deficit. Labs: CBC: Lab Results Component Value Date/Time WBC 8.6 06/25/2022 2125 RBC 4.16 06/25/2022 2125 HGB 11.6 06/25/2022 2125 HCT 34.1 06/25/2022 2125 MCV 81.9 06/25/2022 2125 MCH 27.9 06/25/2022 2125 MCHC 34.0 06/25/2022 2125 RDW 14.8 06/25/2022 2125 MPV 8.3 06/25/2022 2125 PLATELETCNT 307 06/25/2022 2125 Cardiac Enzymes: Lab Results Component Value Date/Time CK 98 10/08/2011 1630 CKMB 1.8 10/08/2011 1630 TROPONINI <0.03 06/25/2022 2126 CMP: Results for orders placed or performed during the hospital encounter of 06/25/22 (from the past 72 hour(s)) Comprehensive Metabolic Panel Collection Time: 06/25/22 9:26 PM Result Value Ref Range SODIUM 135 135 - 145 mmol/L POTASSIUM 3.7 3.6 - 5.0 mmol/L CHLORIDE 99 (L) 101 - 111 mmol/L CO2 21 21 - 31 mmol/L ANION GAP 15 GLUCOSE 125 (H) 70 - 110 mg/dL CREATININE 1.0 0.6 - 1.2 mg/dL BUN 15 2 - 32 mg/dL CALCIUM 8.5 8.5 - 10.5 mg/dL PROTEIN TOTAL 6.7 6.1 - 7.8 g/dL Albumin 3.7 3.2 - 5.0 g/dL T BILIRUBIN 0.4 0.2 - 1.0 mg/dL ALP 66 42 - 121 [iU]/L AST 65 (H) 10 - 42 [iU]/L ALT (SGPT) 38 10 - 60 [iU]/L OSMOLALITY 272 266 - 309 A/G Ratio 1.2 B/C 15 10 - 20 ESTIMATED GFR 73 mL/min Magnesium Lab Results Component Value Date/Time MAGNESIUM 1.2 06/25/2022 2126 SARS-CoV-2 RNA Detected Imaging: Reviewed ASSESSMENT/PLAN: Problems and Relevant Co-morbid conditions:: Principal Problem: Pneumonia due to COVID-19 virus Active Problems: Type 2 diabetes mellitus with diabetic nephropathy, without long-term current use of insulin Essential hypertension * Pneumonia due to COVID-19 virus Remdesivir, steroid, and ancillary medications started. Self proning encouraged. Incentive spirometer ordered. CHO diet. SS. Will continue appropriate regular medications.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19 pneumonia
Hospital-Tage
2,0
Labordaten
see above
Aktuelle Erkrankungen
Type 2 diabetes mellitus with diabetic nephropathy, without long-term current use of insulin Essential hypertension
Vorgeschichte
Type 2 diabetes mellitus with diabetic nephropathy, without long-term current use of insulin Essential hypertension
Andere Medikamente
albuterol 90 mcg/Actuation inhaler Commonly known as: VENTOLIN HFA Take 1 Puff by inhalation Every 4 hours as needed (WHEEZING). amLODIPine 10 mg tablet Commonly known as: NORVASC Take 1 Tablet by mouth Once Daily. ascorbic acid (vitami
Allergien
Lisinopril, Sulfa, Tuberculin Ppd
Vorherige Impfungen
-

VAERS 2397605

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
PA
Alter
49,0
Geschlecht
F
Eingang
30.07.2022
Impfdatum
29.06.2022
Beginn
07.07.2022
Tage bis Beginn
8,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Joint stiffness Musculoskeletal stiffness Pain Pain in extremity Paraesthesia

Symptomtext

I started to experience diffuse joint pain and stiffness approximately a week to 10 days after vaccination. I am experiencing pain with walking after being at rest for even short periods of time. These symptoms get a little better the more active I am throughout the day but worsen during the night while I am in bed. I also have intermittent tingling in my hands along with pain and stiffness in my fingers and hands and knees especially throughout the day

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
N/A
Vorgeschichte
metastatic breast cancer
Andere Medikamente
letrozole, valium, melatonin, vitamin C, B12 and Zinc
Allergien
compazine
Vorherige Impfungen
-

VAERS 2301542

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
66,0
Geschlecht
F
Eingang
28.05.2022
Impfdatum
07.01.2022
Beginn
08.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cardiac disorder Condition aggravated Disturbance in attention Feeling abnormal Heart rate increased Impaired work ability Migraine

Symptomtext

Got more migraines went from 10-15 days to 28+ days and 2-5 a day. My heart is beating faster, brain fog, loss of work. Loss of consentration

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
Dr, report Mar, 22 Ask to go to brain Dr. Do to more migraines, concentration , brain fog. Dr. May 2022. Has my on a preventative. That is not working but I am giving to two months.
Aktuelle Erkrankungen
Migraines 10-15 a month
Vorgeschichte
Now my Migraines are 28+ days with 2-4 a day. Brain fog, have a heart problem that has been gone for over 6 years. After the shot I have had to get back on the e medical. I miss more work then before, do to the migraines
Andere Medikamente
Norco, Soma, ultram, imatrex, C,A,D,K, multiple vit. Pumpkin seed oil, fish oil, zinc, diasapan
Allergien
Topamax, nicbans,
Vorherige Impfungen
Janssen

VAERS 2284776

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
TN
Alter
43,0
Geschlecht
F
Eingang
19.05.2022
Impfdatum
16.11.2021
Beginn
30.11.2021
Tage bis Beginn
14,0
Dosis
2
Route/Site
SYR / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Back pain Blood test COVID-19 Cough Dysgraphia Dyspnoea Fatigue Feeling abnormal Inflammatory marker increased Memory impairment Rheumatoid arthritis X-ray normal

Symptomtext

Towards end of November a few weeks after my vaccine I did begin to have symptoms occur. I began to have bad pain in hip joint where it feels like my leg wants to disconnect from my hip along with lower back pain. Pain in my elbows as well. Reached out to PCP and they referred me to a rheumatologist after not being able to find anything on X-rays. I have also had major brain fog where I forget things easily, and sometimes I will even have moments where it is hard for me to write out certain things correctly as I copy them. At the rheumatologist, I did get more testing done, and past blood work, inflammatory factors are running high and I was then diagnosed with zero negative rheumatoid arthritis. I am still currently having joint pain and the doctor did put me on medication to help with pain management. Some days they have worsened and other days when it is still around the baseline pain level. I did contract COVID-19 January 13th 2022, overall fatigue, hard to breath, a lot of coughing, I never ran a fever. These symptoms lasted for about 10 days all together and the difficulty breathing had taken about 2-3 weeks.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
X-Rays: That showed no abnormalities Bloodwork: Inflammatory factors elevated
Aktuelle Erkrankungen
N/A
Vorgeschichte
High Blood Pressure Depression Anxiety Obesity Sleep Apnea
Andere Medikamente
Sertraline 150 Mg Lisinopril 20Mg Hydrochlorothiazide 120Mg Buspirone 30Mg Hydrocodone 325Mg PRN Vitamin B Complex D3 1000Mg Birth Control IUD Vitamin C
Allergien
Penicillin Mushrooms Visceral Sutures
Vorherige Impfungen
-

VAERS 2275731

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
DE
Alter
53,0
Geschlecht
F
Eingang
13.05.2022
Impfdatum
24.11.2021
Beginn
10.12.2021
Tage bis Beginn
16,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Alopecia Asthenia Blood test abnormal Bone pain Condition aggravated Dysphonia Fatigue Irritability Memory impairment Stress Swelling Throat tightness Thyroid disorder Thyroid function test abnormal Weight increased

Symptomtext

My thyroid condition worsened up despite taking the levothyroxine. I started to feel worse condition of thyroid that I got after the 1st shot. I started to feel all swollen, gained weight like crazy again. All my bones are achy. I feel chronically tired. Highly irritated. No energy. Memory get worse. Losing hair worse that it was before. Voice became harsh and, when I feel stressed, something inside my throat feels like its choking me.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
Blood Tests in April - my thyroid was worse again. My doctor increased my dose of levothyroxine.
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Levothyroxine 25mcg, Vitamin D
Allergien
none
Vorherige Impfungen
Dose 1 Covid Jannsen - 05/02/2021 - Right after the dose, within 24 hours, I got high fever which lasted a couple of days. I cou

VAERS 2275260

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
PA
Alter
56,0
Geschlecht
M
Eingang
13.05.2022
Impfdatum
-
Beginn
06.01.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Dizziness Feeling abnormal Gastrooesophageal reflux disease Heart rate Heart rate increased Paraesthesia Pruritus Rash SARS-CoV-2 test

Symptomtext

RED BUMPS ON ARMS, LEGS AND CHEST; ITCHY ARMS, LEGS AND CHEST; ACID REFLUX; SKIN TINGLING; CONFIRMED COVID-19 INFECTION; ELEVATED HEART RATE, INTERMITTENT; LIGHT HEADED; FOGGY; This spontaneous report received from a patient concerned a 56 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: alcohol user (1 per week, infrequent), and non smoker, and other pre-existing medical conditions included: The patient did not have known drug allergies. The patient did not have any history of drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191 and expiry: UNKNOWN) dose was not reported, administered on 05-JAN-2022 for prophylactic vaccination. Age at time of vaccination 56 years old. No concomitant medications were reported. On 06-JAN-2022, the patient experienced confirmed covid-19 infection, elevated heart rate, intermittent, light headed, and foggy. Laboratory data included: Heart rate (NR: not provided) Elevated (Elevated heart rate, intermittent). On 08-JAN-2022, the patient experienced skin tingling. On 10-JAN-2022, the patient experienced acid reflux, and itchy arms, legs and chest. On 24-JAN-2022, Laboratory data included: COVID-19 virus test (NR: not provided) positive. On an unspecified date, the patient experienced red bumps on arms, legs and chest. Treatment medications (dates unspecified) included: omeprazole. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from confirmed covid-19 infection, was recovering from foggy, light headed, and elevated heart rate, intermittent, and had not recovered from red bumps on arms, legs and chest, itchy arms, legs and chest, acid reflux, and skin tingling. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
Test Date: 20220106; Test Name: Heart rate; Result Unstructured Data: Elevated; Comments: Elevated heart rate, intermittent; Test Date: 20220124; Test Name: COVID-19 virus test; Result Unstructured Data: positive
Aktuelle Erkrankungen
Alcohol use (1 per week, infrequent); Non-smoker.
Vorgeschichte
Comments: The patient did not have known drug allergies. The patient did not have any history of drug abuse or illicit drug usage.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2260631

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
44,0
Geschlecht
F
Eingang
02.05.2022
Impfdatum
16.12.2021
Beginn
25.03.2022
Tage bis Beginn
99,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: ja
Anticoagulant therapy Arteriogram carotid abnormal Blood test COVID-19 Cardiac stress test abnormal Carditis Chest X-ray Chest discomfort Coronary arterial stent insertion Coronary artery occlusion Discomfort Dyspnoea Echocardiogram normal Electrocardiogram normal Fatigue Headache Pain Pleurisy

Symptomtext

From 1/21/22 onwards I had headaches and tiredness . By 3/22 I felt twinges occasionally in my chest. 3/25/22 I was not I BLT rubbing my chest and had Drs appointment on 3/27/22. It got worse daily. By 3/31/22 around midnight I had a lot of pain and pressure and 4/1/22 shortness of breath and major pain. Went to urgent care and EKG was fine, chest X-ray was fine and troponen levels were elevated. Sent to Medical Center E.R. Was admitted and given blood thinner shots to stomach and a pill for heart inflammation in case it was pleuritus. More EKG and bloodwork done . Normal held for heart ultrasound and stress test. Heart ultrasound normal stress test positive. Did angiogram and was told by cardiologist it was beautiful no blocks, plaque nothing until he got to my LAD?Widow MAKER? are teary it was over 95%blocked with a clot. Stent put in.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
4,0
Labordaten
Several EKGs 3/27/22,4/1/22,4/2/22 Chest X-ray 4/1/22 Heart ultrasound 4/2/22 Stress test chemical 4/3/22 Angiogram 4/3/22
Aktuelle Erkrankungen
Caught Covid 1/21/22
Vorgeschichte
Diabetes Type 2
Andere Medikamente
Met Forman Glipizode B12 B3 Vitamin C
Allergien
Lanasa Prill
Vorherige Impfungen
Migraines after J& J vaccine

VAERS 2241079

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CO
Alter
27,0
Geschlecht
F
Eingang
19.04.2022
Impfdatum
21.12.2021
Beginn
08.03.2022
Tage bis Beginn
77,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Antiphospholipid antibodies Blood culture C-reactive protein COVID-19 pneumonia Full blood count Lipids Liver function test Metabolic function test

Symptomtext

Patient hospitalized for COVID-19 pneumonia after COVID-19 vaccination. Received remdesivir and steroids and discharged to home medically stable.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19 pneumonia
Hospital-Tage
-
Labordaten
Blood counts Comprehensive metabolic panel Liver function tests Lipids Antiphospholipid serology Blood culture & sensitivity C-reactive protien
Aktuelle Erkrankungen
Spontaneous bacterial peritonitis Abdominal pain and distention Nausea and vomiting Pleural effusion Right internal jugular thrombus
Vorgeschichte
Systemic lupus erythematosus Lupus nephritis Chronic kidney disease/Proteinuria Rheumatoid arthritis Cirrhosis
Andere Medikamente
Hydroxychloroquine Methylprednisolone Spironolactone Pantoprazole Carvedilol Folic acid Lactulose
Allergien
No known drug allergies
Vorherige Impfungen
-

VAERS 2218317

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
VA
Alter
52,0
Geschlecht
F
Eingang
06.04.2022
Impfdatum
05.03.2022
Beginn
18.03.2022
Tage bis Beginn
13,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Feeling abnormal Mobility decreased Neck pain Pain Skin warm

Symptomtext

For the past two weeks, left side has been hurting (off and on). There's a pain in my neck and shoulder. Recently, it has become difficult to lift my left arm past a certain point (mid-body). Sometimes, left arm feels hot. It feels like someone is sticking something in my back near shoulder area and along neck.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
allergies
Vorgeschichte
None
Andere Medikamente
zyrtec, veripimil, acyclovir
Allergien
None
Vorherige Impfungen
-

VAERS 2199212

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
WA
Alter
41,0
Geschlecht
F
Eingang
25.03.2022
Impfdatum
21.03.2022
Beginn
21.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Burning sensation Dizziness Dyspnoea Feeling abnormal Headache Heart rate increased Injection site vesicles Neck pain Pyrexia

Symptomtext

11 AM - J&J vaccine administered. 12 PM - Patient arrives home with headache, brain fog, fatigue, shortness of breath, O2 sat 92%, fever of 102F, dizziness, heart rate 113 BPM, blisters at injection site, severe neck pain, and severe feelings of burning in lungs. Patient laid down and slept until 3 PM. 3 PM - Patient wakes up with shortness of breath. 10 PM - 100.6F fever 6:30 AM (next day) - neck pain (pain scale 10/10), fever

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
Blood pressure stable as of 3/25/2022
Aktuelle Erkrankungen
None known
Vorgeschichte
History of blood clots
Andere Medikamente
Warfarin
Allergien
Gabapentin - Severe depression Flu vaccine - Peripheral neuropathy (resulting in gabapentin prescription) Kiwi - Mouth becomes numb, throat swelling
Vorherige Impfungen
Flu vaccine (peripheral neuropathy -> gabapentin prescription)

VAERS 2194912

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
DE
Alter
59,0
Geschlecht
M
Eingang
23.03.2022
Impfdatum
20.12.2021
Beginn
02.01.2022
Tage bis Beginn
13,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Blood test Burning sensation Computerised tomogram Electrocardiogram Hypoaesthesia Lip swelling Magnetic resonance imaging Neurological symptom Pain Pain in extremity Paraesthesia Peripheral swelling

Symptomtext

Neurological issues with numbing, tingling, burning, pains to various areas of my body. Primarily to my lower left extremities. Swelling of lips and fingers.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
3,0
Labordaten
January 2, 2022, EKG, MRI, CTSCAN, Blood work performed at general hospital. January 5, 2022, alternate Medical Center
Aktuelle Erkrankungen
Chronic Post Nasal Drip Hypertension
Vorgeschichte
Post Nasal Drip Hypertension TBI PTSD LOWER BACK PAIN MIGRAINE HEADACHES
Andere Medikamente
Ergocalcif 50,000 mg Guaifenesin 600 mg Amlodipine/benazepril 10/20 mg Azelastine HCI 0.1% Gabapentin 800 mg
Allergien
None
Vorherige Impfungen
-

VAERS 2162506

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
IN
Alter
39,0
Geschlecht
F
Eingang
07.03.2022
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Lip swelling Paraesthesia oral Urticaria

Symptomtext

PATIENT HAD TINGLING AND SWELLING IN THE LIPS THE SAME DAY AS RECEIVING THE COVID-19 VACCINE AND TOOK BENADRYL AND SYMPTOMS RESOLVED. THE NEXT DAY, SATURDAY, THE PATIENT BROKE OUT IN HIVES IN THE TORSO AREA AND TOOK BENADRYL AGAIN AND THE SYMPTOMS RESOLVED. THE PATIENT HAS NOT HAD ANY OTHER SYMPTOMS.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia oral
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
HYPERLIPIDEMIA
Andere Medikamente
ATORVASTATIN 20 MG DAILY MIRENA
Allergien
NKA
Vorherige Impfungen
-

VAERS 2162030

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
TX
Alter
39,0
Geschlecht
F
Eingang
06.03.2022
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Arthritis Back pain Erythema Eye irritation Fatigue Headache Ocular hyperaemia Oropharyngeal pain Pain in extremity Paraesthesia Rash Rash macular

Symptomtext

Received vaccine at ~0900am. At ~1000am, developed red, splotchy rash below bottom lip and on chin with tingling sensation, as well as rash to upper chest. Resolved with Benadryl. Starting at ~1400pm, had generalized headache, started with sore throat (L>R), and redness/burning of eyes. Over next 48 hours, had increasingly painful and inflamed joints to hands, knees, feet, and lower back. Headache, sore throat, painful and swollen joints, and extreme fatigue continues at 48 hours post vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
Rheumatoid arthritis
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2158573

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
27,0
Geschlecht
M
Eingang
04.03.2022
Impfdatum
03.03.2022
Beginn
03.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Angiogram Echocardiogram Full blood count Metabolic function test Pyrexia Supraventricular extrasystoles Tachycardia Troponin

Symptomtext

fever, tachycardia, PACs. Tachycardia to 160s. Fever to 39C.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tachycardia
Hospital-Tage
-
Labordaten
CBC. CMP, troponin, CTA chest, echocardiogram
Aktuelle Erkrankungen
no
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2152573

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
NJ
Alter
34,0
Geschlecht
F
Eingang
02.03.2022
Impfdatum
22.02.2022
Beginn
24.02.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Eye irritation Eye pain Hypoaesthesia Injection site bruising Lacrimation increased Mobility decreased Pain in extremity Peripheral coldness Vision blurred

Symptomtext

Blurry vision Burning/painful eyes Watery eyes Pain/Numbness throughout entire arm/hand of arm used Cold painful fingers of hand on arm used Limited range of motion on arm used Bruising at injection site

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Hypothyroidism
Vorgeschichte
Hypothyroidism
Andere Medikamente
Synthroid 200 mcg 1 tablet once daily Phentermine 37.5 mg 1 capsule once daily Vitamin D 50,000 units 1 capsule once every 2 weeks
Allergien
None
Vorherige Impfungen
-

VAERS 2151048

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
31,0
Geschlecht
F
Eingang
01.03.2022
Impfdatum
28.02.2022
Beginn
28.02.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Asthenia Dizziness Erythema Eye pruritus Fatigue Interchange of vaccine products Nausea Ocular hyperaemia Pruritus Somnolence Tachycardia Tremor Vomiting

Symptomtext

Patient presented at 17:30 with itching of her face and eyes after being vaccinated with the J&J COVID-19 vaccine at 17:15. Doctor advised to administer Benadryl and discharge if improved after 30min. Patient had no complaints of dizziness, lightheaded, patient's breath sounds were bilaterally clear. Patient had no stridor, no tightness of the throat or swelling of throat or tongue. Patient was given 25mg of Benadryl at 17:35 and an additional 25mg of Benadryl at 17:50 due to continued itching and redness of the face, eyes, and forehead. Patient improved after administration of Benadryl with reduced itching of the face and eyes. Patient's father is driving her home. Patient was advised that if her symptom worsen, or she feels swelling of the throat or tongue, or difficulty breathing to call 9/11. Patient's breath sounds were clear when discharged at 18:15 with no complaints of difficulty breathing, and no stridor. VS 17:35 BP 151/87, HR 88, SpO2 98% T 97.8 VS 17:50 BP 148/88, HR 81, SpO2 98% VS 18:05 BP 141/91, HR 84, SpO2 100% Patient went home and took a nap when she woke up, felt fatigued and tired w/ nausea/vomiting, vomiting while on call, shaking, tachy, p=110-120, and groggy, very weak Non bloody. Was shaking at home. Possibly was anxious about how she was feeling. Patient went to ED and was examined with no skin rash, no swelling, no sob. Patient was administered Ondansetron (4mg). Lactated Ringers IV Bolus (1,000 ml), and Acetaminophen (1,000 mg) and discharged.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tachycardia
Hospital-Tage
-
Labordaten
VS 17:35 BP 151/87, HR 88, SpO2 98% T 97.8 VS 17:50 BP 148/88, HR 81, SpO2 98% VS 18:05 BP 141/91, HR 84, SpO2 100%
Aktuelle Erkrankungen
None
Vorgeschichte
GERD Intermittent Asthma Human Papilloma Virus Infection Major Depressive Disorder, Recurrent Episode
Andere Medikamente
None
Allergien
Avocado - Itching Cantaloupe - Throat Swelling Coconut - Rash Codeine - Rash COVID-19 Vaccine, mRNA, Bnt162b2, Lnp-s (Pfizer) - Anaphylaxis Latex - Rash
Vorherige Impfungen
Pfizer-BioNTech COVID-19 Vaccination on 2/10/2021, patient 30 years of age at time of event. After administration of her first C

VAERS 2140151

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
-
Alter
79,0
Geschlecht
M
Eingang
25.02.2022
Impfdatum
03.12.2021
Beginn
25.02.2022
Tage bis Beginn
84,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 pneumonia

Symptomtext

covid pna

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19 pneumonia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2137287

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
51,0
Geschlecht
M
Eingang
24.02.2022
Impfdatum
11.01.2022
Beginn
25.01.2022
Tage bis Beginn
14,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Heart rate irregular Palpitations

Symptomtext

Heart palpation at irregular intervals, irregular time

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
HTN
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2129655

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
NY
Alter
48,0
Geschlecht
F
Eingang
21.02.2022
Impfdatum
-
Beginn
01.12.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood pressure increased Blood pressure measurement Dizziness Feeling hot Headache Hot flush Nausea Pain Paraesthesia Peripheral swelling

Symptomtext

BLOOD PRESSURE ELEVATED/FELT BLOOD PRESSURE IN THE LEFT SIDE OF THE HEAD; DIZZINESS; HOT FLASHES; NAUSEA; LOW GRADE HEADACHE; TINGLING SENSATION; SHOOTING WEIRD PAINS IN BODY; SENSATION FELT ACHY; SENSATION FELT HOT; FELT LIKE ARM SWOLLEN; This spontaneous report received from a patient concerned a 48 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: hypertension, drug allergy, hypothyroidism, and venous malformation in left temporal lobe. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: UNKNOWN) dose was not reported, administered on 05-DEC-2021 for prophylactic vaccination. Concomitant medications included lisinopril for hypertension, and levothyroxine for hypothyroidism. On DEC-2021, the patient experienced felt like arm swollen. On 05-DEC-2021, the patient experienced sensation felt hot, shooting weird pains in body, sensation felt achy, and tingling sensation. On 06-DEC-2021, the patient experienced low grade headache. On 14-FEB-2022, Laboratory data included: Blood pressure (NR: not provided) 160/100. On an unspecified date, the patient experienced blood pressure elevated/felt blood pressure in the left side of the head, dizziness, hot flashes, and nausea. Laboratory data (dates unspecified) included: Blood pressure (NR: not provided) 140/90 elevated. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from shooting weird pains in body, and tingling sensation on DEC-2021, had not recovered from low grade headache, and the outcome of sensation felt hot, felt like arm swollen, blood pressure elevated/felt blood pressure in the left side of the head, nausea, dizziness, hot flashes and sensation felt achy was not reported. This report was non-serious.; Sender's Comments: V0 Medical assessment comment not required as per standard procedure as the case was assessed as non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
Test Date: 20220214; Test Name: Blood pressure; Result Unstructured Data: 160/100; Test Name: Blood pressure; Result Unstructured Data: 140/90 elevated
Aktuelle Erkrankungen
Hypertension (takes lisinopril 10 mg OD); Hypothyroidism (takes 75 mcg levothyroxine OD); Malformation venous
Vorgeschichte
Comments: Unknown
Andere Medikamente
LISINOPRIL; LEVOTHYROXINE
Allergien
Drug allergy (allergy to Ampicillin- itchy, 21 years ago, formal allergy testing not done)
Vorherige Impfungen
-

VAERS 2110271

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
AR
Alter
26,0
Geschlecht
F
Eingang
14.02.2022
Impfdatum
31.01.2022
Beginn
01.02.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Chest pain Electrocardiogram normal Interchange of vaccine products Palpitations Troponin normal

Symptomtext

I was barely pregnant at the time, but didn't know it. Due date is October 16, 2022. I had a previous reaction to the Covid moderna vaccine in July 2021 with chest pain and heart palpitations for a week. The day after I received the Janssen vaccine I woke up in the middle of the night with severe heart palpitations that felt life-threatening. They woke me up multiple times that night and another night a couple of nights later. I experienced more severe palpitations on and off during the days for 2 weeks following the vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
February 3rd: troponin--within range EKG--normal
Aktuelle Erkrankungen
none
Vorgeschichte
-
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
Covid moderna in July 2021, 26 years old, chest pain and palpitations

VAERS 2109579

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
56,0
Geschlecht
F
Eingang
13.02.2022
Impfdatum
10.01.2022
Beginn
11.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cardiac monitoring Dizziness Dyspnoea Palpitations

Symptomtext

I have been having heart palpitations, dizziness and shortness of breath. I am currently wearing a ZIO patch to monitor the palpitations.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
COVID-19
Vorgeschichte
None
Andere Medikamente
None
Allergien
Latex and Indomethacin
Vorherige Impfungen
-

VAERS 2091472

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
SD
Alter
31,0
Geschlecht
M
Eingang
05.02.2022
Impfdatum
03.02.2022
Beginn
03.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Back pain Chills Cough Dyspnoea Headache Heart rate increased Hypopnoea Pyrexia

Symptomtext

02/03/2022 at 20:00 - Severe Chills, Severe Headache, Backache, Fever 101.9, High Heart Rate, Mild Difficulty Breathing 02/04/2022 all Day - Shallow breathing, Cough, Headache, Backache, High Heart Rate 02/05/2022 - High Heart Rate, Cough, Mild Difficulty Breathing

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
Heart Rate monitor, temperature taken at home
Aktuelle Erkrankungen
COVID 19 Positive Test Jan 10
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2088135

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
36,0
Geschlecht
F
Eingang
04.02.2022
Impfdatum
28.01.2022
Beginn
28.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Confusional state Dizziness Dyspnoea Fatigue Fear Gastric dilatation Injection site pain Peripheral swelling Vaccination complication

Symptomtext

Within 30 minutes to about 1 hour after receiving the vaccine, I mentioned to my boyfriend that it was so strange that I was having trouble breathing, I wasn't aware that this was a known reaction. When I come in contact with gluten from cross-contamination I take Benadryl, as the breathing was becoming labored, my stomach became distended and my fingers became swollen. As soon as my fingers started swelling up I took 2 servings of Benadryl and within 30 minutes my breathing was improving and my joints had marked improvement from pain within 3 days. I continued taking Benadryl for the next three days. I basically feel like the vaccine put me into a flare, which I had been concerned about as my joints do swell up from time to time. The lack of breathing was scary, it felt like being at 10,000 ft in altitude without adjusting. I was also light headed and confused and tired for those three days but only had expected pain at the injection site. I am still feeling a little confusion which is typical for me in a flare up, so I'm hoping that goes away soon.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
no
Vorgeschichte
Inflammatory Issues, cause not known
Andere Medikamente
n/a
Allergien
Gluten
Vorherige Impfungen
-

VAERS 2088057

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
OH
Alter
45,0
Geschlecht
F
Eingang
04.02.2022
Impfdatum
03.02.2022
Beginn
04.02.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Chest pain

Symptomtext

Husband called stating pt was experiencing "Significant chest pain." Instructed him to seek immediate emergency medical care for her as that could be a sign of a blood clot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none noted on form
Vorgeschichte
none noted on form
Andere Medikamente
none listed on form
Allergien
none noted on form
Vorherige Impfungen
-

VAERS 2071552

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
PA
Alter
-
Geschlecht
F
Eingang
28.01.2022
Impfdatum
-
Beginn
14.01.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Back pain Chest pain Chills Cough Dyspnoea Fatigue Feeling abnormal Nausea Oropharyngeal pain Pain Pain in extremity Productive cough Rhinorrhoea

Symptomtext

HEART/CHEST HURT; BACK HURTS; EVERYTHING HURTS; COUGHING UP PHLEGM; CURL UP AND DIE; ARM HURT LIKE HELL; TIRED; SICK TO STOMACH; WEAK; CHILLS; CANNOT BREATH; COUGH; SORE THROAT; RUNNY NOSE; This spontaneous report received from a patient concerned a 64 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: UNKNOWN) dose was not reported, administered on 13-JAN-2022 for prophylactic vaccination. No concomitant medications were reported. On 14-JAN-2022, the patient experienced cannot breath, cough, sore throat, runny nose, chills, and weak. On an unspecified date, the patient experienced heart/chest hurt, back hurts, everything hurts, coughing up phlegm, curl up and die, arm hurt like hell, tired, and sick to stomach. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from arm hurt like hell, had not recovered from cannot breath, chills, weak, cough, sore throat, runny nose, back hurts, heart/chest hurt, everything hurts, tired, coughing up phlegm, and sick to stomach, and the outcome of curl up and die was not reported. This report was non-serious.; Sender's Comments: V0 Medical assessment comment not required as per standard procedure as the case was assessed as non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2065899

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
66,0
Geschlecht
F
Eingang
26.01.2022
Impfdatum
14.01.2022
Beginn
14.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Headache Hypoaesthesia Nausea Paraesthesia Vomiting

Symptomtext

She got her vaccine, she first started with headaches, nausea and then vomiting. She then had facial numbness on Saturday. She did take Phenergren for the nausea and did help. She went back to bed, and when she woke up Sunday still had numbness in her face, and found that her features were symmetrical and not having a stroke. She called the advice center and they told her if it did not resolve in a couple of days that she needed to be seen. On Monday it started to go away and Tuesday better, but has pretty much resolved. Has occasional numbness and tingling around her eyes and her mouth as well. They consulted the ER doctor when she called the advice center since she didn't have a way to get in, and they told her to come in if it did not get better. She has concerns if she has to get further vaccines if it's going to be worse or some other disease process or condition. She does have an over-active immune system. Did take Dupixent in the past, but quit when COVID came around.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None.
Vorgeschichte
IBS and eczema.
Andere Medikamente
Mobic prn
Allergien
Codeine.
Vorherige Impfungen
-

VAERS 2057827

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
AZ
Alter
31,0
Geschlecht
M
Eingang
23.01.2022
Impfdatum
14.01.2022
Beginn
15.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Arthralgia Muscle spasms Muscle tightness Pain in extremity Paraesthesia Ultrasound scan

Symptomtext

Saturday got minor leg pain in upper calf. Sunday spread to ankle and foot with tingling. Monday the thigh and hamstring got cramps as well with left still hurting. Continued till Friday. Tingling and muscle tightness moved to face including cheeks and jaw. Saturday night. One week later. Moved to arms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
Checked for clots with ultrasound.
Aktuelle Erkrankungen
24 hour Stomach flu 1/1
Vorgeschichte
None
Andere Medikamente
Omeprazole
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2055459

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
33,0
Geschlecht
M
Eingang
21.01.2022
Impfdatum
20.01.2022
Beginn
20.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Anxiety Drooling Eye movement disorder Fall Head injury Headache Swelling Tremor

Symptomtext

Patient was vaccinated at 1606, then sat down to be observed. Staff observed patient fall to floor from his chair and another patient came to help the patient. Staff came over to assess patient and saw that patient?s legs were shaking and he was trying to get up. Staff observed patient?s eyes roll to the back of his head and drool was present. When trying to get patient?s attention while he was trying to get up, he did not respond and seemed unaware of his actions. 911 was called, while calling patient was alert and oriented. Paramedics arrived on scene, vital signs- SpO2:99, HR:74, BG:77, BP 150/90, 12 lead sinus rhythm. Patient explained he felt very nervous and anxious about getting his vaccine because he is afraid od needles. Paramedics think he had an anxiety episode. Paramedics and clinic staff advised patient to get checked out at ER due to potential head injury. Patient described throbbing pain at forehead and paramedics observed swollen spot on his forehead. Staff offered ice pack for head. Advised to discuss what happened with his doctor. Patient left with his wife and decided against medical advice to go to the ER. He appeared stable as he left.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Appendectomy
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2039501

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
35,0
Geschlecht
F
Eingang
17.01.2022
Impfdatum
17.01.2022
Beginn
17.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dizziness Dyspnoea Hyperhidrosis Hypotension

Symptomtext

Patient reported feeling dizzy, sweaty, and short of breath a few minutes after vaccine administration. Patient has history of fainting with injections, but reports has not had a fainting episode since she was young. Pt hypotensive post-administration with BP 66/37.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2036618

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
NC
Alter
62,0
Geschlecht
F
Eingang
14.01.2022
Impfdatum
14.01.2022
Beginn
14.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dyspnoea Feeling hot Pharyngeal swelling Wheezing

Symptomtext

Patient received first dose on Janssen vaccine at 6:00 PM. Approximately 5 to 10 minutes later patient asked for assistance from pharmacy staff due to feeling short of breath, wheezing, throat swelling and feeling hot. Patient received epinephrine 0.3 mg at 6:13 PM and 911 was called. Symptoms immediately began to subsite. It became easier to breathe within minutes of epi. Patient then began to complain of epipen common side effects including a head ache and shaky feelings. Blood pressure and heart rate was monitored. EMS arrived at 6:45 PM and took patient to their vehicle for further evaluation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
6:17 bp 181/126, 6:19 164/ 120, 6:24 154/105, 6:27 heart rate 124. 6:29 bp 161 and heart rate 109, 6:34 bp 139/105 and hr 110, 6:45 bp 148/99 hr 102
Aktuelle Erkrankungen
n/a
Vorgeschichte
Diabetes, rheumatoid arthritis. Had covid previously and received monoclonal antibodies 9/1/2021
Andere Medikamente
-
Allergien
Clorox, benadryl, gas fumes, fresh peaches, eggs, shell membrane, morphine, ketamine, diesel fumes. Per patient, has had anaphylaxis several times before and has been on a vent ~5 times due to anaphylaxis.
Vorherige Impfungen
-

VAERS 2036027

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
VA
Alter
21,0
Geschlecht
M
Eingang
14.01.2022
Impfdatum
13.01.2022
Beginn
13.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Condition aggravated Headache Hyperhidrosis Pyrexia

Symptomtext

Started experiencing chills at 2200 on date of vaccination (01/13). Progressed to severe chills about half an hour later. By 0300 on 01/14, I developed a fever of 105.0 degrees. I was experiencing severe chills, sweating, and an extremely painful headache. By 0600, the fever went down to 103 degrees. By 0800, my temperature was about 99 degrees, but I was still experiencing a severe headache, like an incessant throbbing. By 0930, the head pain had subsided. Throughout the day, minor chills have come and gone, and a minor headache remains.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
I had COVID during the week following Christmas.
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
I never caught the flu until I took my first flu vaccine at age 13 (01/2014). I became extremely sick and experienced severe chi

VAERS 2033042

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
18,0
Geschlecht
F
Eingang
13.01.2022
Impfdatum
10.01.2022
Beginn
10.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Dysstasia Eye pain Fatigue Feeling abnormal Neck pain Pain Pain in extremity Pyrexia Sitting disability Tremor Vision blurred

Symptomtext

I got the shot at 6pm and felt a bit tired afterwards and my arm was a bit sore. Later that night, I had a fever and was shaking severely. My entire body ached and my neck was especially sore. My eyes hurt and I had trouble focusing them and felt a bit dizzy. The next day I could barely spend anytime sitting or standing up and I laid down for nearly the entire day. I was very sore, tired, and felt foggy. I am still having trouble focusing my eyes today (three days after I received my shot) and I still feel very tired and sore.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
I did not seek out medical attention after my shot; I took Tylenol and ibuprofen to reduce the fever and stayed in bed.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Glutathione, CoQ10, immune system supplements with vitamin C
Allergien
-
Vorherige Impfungen
-

VAERS 2031690

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
MN
Alter
55,0
Geschlecht
F
Eingang
13.01.2022
Impfdatum
08.12.2021
Beginn
09.12.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Angina pectoris Balance disorder Chest X-ray normal Chest discomfort Dizziness Electrocardiogram normal Palpitations Sleep disorder Troponin normal

Symptomtext

Within 24 hrs a lot of dizziness and racing heart. By 12/10/21 began to notice "heart jabs" and dizziness to point of feeling like falling over. On 12/17/21 called HCP as jabs were waking me up in the night; recommended I go to ER which I did. HCP incorrectly called me "past history of pericarditis" - this was a misrepresentation of our conversation. Also incorrectly stated that jabs came on with deep breathing. I NEVER said that at any time. HCP recommended ibuprofen (although that was NOT included in the discharge papers), which I began upon return home. Ibuprofen did provide relief, but after 3 consecutive days, despite concomitant use of famotidine, stomach would get very upset, so I would skip a day and heart jabs would return. They are gradually becoming less prominent and less frequent. There is no activity that I can tie to the occurrence of these feelings in my chest. I have had no chest wall injury or any activity that exacerbates the episodes. Moving muscles around the area of pain does nothing to worsen or relieve the episodes. HCP in ER never asked any of these questions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
12/17/21: EKG without evidence of acute ischemia or arrhythmia. Troponin is normal x 2, and patient is a HEART score of 1 (H0E0A1R0T0). Chest x-ray shows no evidence of pneumonia, pneumothorax, CHF, or mediastinal widening. Considered pulmonary embolism however she is low risk by Wells criteria, has no shortness of breath, and symptoms are intermittent and actually absent at present examination.
Aktuelle Erkrankungen
None
Vorgeschichte
Shoulder issues consistent with acute brachial neuropathy following previously reported event following Shingrix vaccine administration that has not completely resolved as of 12/8/2021. Was never officially diagnosed as "acute brachial neuropathy" but timeline and description consistent with medical description.
Andere Medikamente
Vitamin D, Vitamin C, Zinc, Ibuprofen, Pepcid, Aspirin
Allergien
NKA
Vorherige Impfungen
Shingrix AE's already reported to VAERS

VAERS 2027297

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
MN
Alter
46,0
Geschlecht
F
Eingang
11.01.2022
Impfdatum
06.01.2022
Beginn
07.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Breast pain Breast tenderness Chills Headache Hyperhidrosis Impaired work ability Injection site pain Lymph node pain Pain Pain in extremity Palpitations Pyrexia

Symptomtext

Around 3:00am following my vaccine, around 11 hours after the injection, I woke up with my heart racing. It kept doing this for a few hours. I had chills and was sweating. I grabbed my thermometer because I was certain I had a fever. My digital thermometer read between 102-103 for about 12 hours. I used Advil and Tylenol to reduce the fever. It helped a little with aches but not with the fever. From head to toe my body ached. Even as I got up to go use the restroom the pads of my feet hurt to walk. I had a pounding headache for two days. This is day 5 after receiving my vaccine and my breasts are very sore and tender still and have been since the day after my vax. I believe it is lymph nodes, but they feel as though I am engorged from milk when I was nursing my kids. The injection side stopped hurting today. I obviously could not go to my teaching job the day after my vax. Day two was Saturday, and I was better but still in bed for most of the day. The fever had subsided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2017442

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
PA
Alter
-
Geschlecht
M
Eingang
08.01.2022
Impfdatum
24.12.2021
Beginn
24.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Body temperature Chest pain Chills Heart rate Oxygen therapy Pyrexia

Symptomtext

CHEST PAIN; CHILLS; FEVER; This spontaneous report received from a parent concerned an 18 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously received non-company bnt 162 vaccine (dose number in series was 1) (form of admin, route of admin not reported, batch number: FW0161) dose was not reported, administered on 19-APR-2021 for prophylactic vaccination. On an unspecified date, the patient experienced chest pain following vaccination with non-company bnt 162 vaccine (dose number in series was 1). The patient previously received non-company bnt 162 vaccine (dose number in series was 1) (form of admin, route of admin not reported, batch number: ER8736) dose was not reported, administered on 19-MAY-2021 for prophylactic vaccination. On an unspecified date, the patient experienced chest pain following vaccination with non-company bnt 162 vaccine (dose number in series was 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series was 2) (suspension for injection, route of admin not reported, batch number: 1855191 expiry: 11-APR-2022) dose was not reported, 1 total, administered on 24-DEC-2021 to Left Deltoid for prophylactic vaccination. Concomitant medications included naproxen. On 24-DEC-2021, within 6 hours from vaccination, the patient experienced fever, chest pain and chills following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series was 2). Laboratory data (dates unspecified) included: Body temperature (not provided) 100.5 (units unspecified), Oxygen supplementation (not provided) 98 %, and Pulse rate (not provided) 90's. The patient received treatment with Aleve. Patient's chest pain symptom was faded. Patient's health care professional (HCP) suspected that the vaccination causes chest pain. Patient did not go to emergency room (ER) and was discussed with an ER doctor. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 25-DEC-2021, and fever, and was recovering from chest pain. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
Test Name: Body temperature; Result Unstructured Data: 100.5; Test Name: Oxygen supplementation; Result Unstructured Data: 98 %; Test Name: Pulse rate; Result Unstructured Data: 90's
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
NAPROSYN
Allergien
-
Vorherige Impfungen
-

VAERS 2010275

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
ID
Alter
36,0
Geschlecht
M
Eingang
06.01.2022
Impfdatum
05.01.2022
Beginn
05.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal pain Chest discomfort Dizziness Hypoaesthesia Pain in extremity Pallor Paraesthesia

Symptomtext

Pt felt lightheaded and was pale about 10 minutes following vaccine. We laid him down in trendelenberg and he began to complain of numbness and tingling in feet, legs, hands and arms. Carpal spasms began in both hands. We placed him on O2 and enougraged deep breathing, including into a paper bag. He continued to experience symptoms and then complained of abdominal pain, which progressed to chest pressure. EMS was called at that point, an IV was started. On arrival of EMS, patient was feeling slightly better and patient and his family declined transport. Vital signs were stable throughout. WIthin about one hour patient felt "100% better" and was discharged home with family. Walked to car in stable condition.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
denies
Vorgeschichte
denies
Andere Medikamente
denies
Allergien
denies
Vorherige Impfungen
-

VAERS 2003169

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
35,0
Geschlecht
F
Eingang
04.01.2022
Impfdatum
01.01.2022
Beginn
03.01.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Feeling abnormal Headache Hypoaesthesia Nightmare Paraesthesia

Symptomtext

Non stop Tingling all over my body. Brain fog Numbness in my face periodically Headaches Nightmares

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
None yet
Aktuelle Erkrankungen
Cough
Vorgeschichte
-
Andere Medikamente
Tylenol
Allergien
-
Vorherige Impfungen
Flu

VAERS 1999783

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
WA
Alter
37,0
Geschlecht
M
Eingang
03.01.2022
Impfdatum
23.04.2021
Beginn
26.04.2021
Tage bis Beginn
3,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood prolactin decreased Chest discomfort Chest pain Electrocardiogram normal Inflammatory marker test Red blood cell sedimentation rate decreased Vaccination complication

Symptomtext

I started to feel intermittent chest pain within 1 week of my second dose of the Pfizer vaccine. The chest pain occurred across multiple hours of the day and did not last long when it was noticed. It was not debilitating. The pains persisted over the summer and into the fall and now sometimes I feel a dull throbbing discomfort at my xiphoid process, and less pains in my left chest near my heart. I can still exercise to full intensity and typically do not feel the pain then. Because of the persistence of the pain, and the time of onset (within 1 week after 2nd dose and not ever before), I discussed with my doctor at that time. After a few discussions of concern, I convinced him to order and EKG and also a panel of inflammatory markers that are suggested to be assayed for cases of myocarditis/pericarditis. The results came back normal. I also spoke to a cardiologist, and he mentioned what I was feeling was most likely due to the vaccine, but because of the lack of problems when exercising its not of a concern. Because of my continued concern, I have switched medical insurance providers and will get more testing done through another primary care doctor and/or cardiologist.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-EKG - normal (8/2/21) -CPG - less than 1 mg/L (8/20/21) - SED rate - less than 2 mm/h (8/20/21)
Aktuelle Erkrankungen
n/a
Vorgeschichte
anxiety
Andere Medikamente
Sertraline HCl; 25 mg daily
Allergien
Penicillin; gluten
Vorherige Impfungen
-

VAERS 1997413

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
39,0
Geschlecht
M
Eingang
01.01.2022
Impfdatum
30.12.2021
Beginn
01.01.2022
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Angina pectoris Chest pain Dizziness Fatigue Nausea Pain

Symptomtext

Very tired, sore arm for several days, periodic shooting chest/heart pains, light headed, nausea after eating. None of these symptoms were present before vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
Haven?t bothered the doctor because the reason I was told I was forced to get the vaccine e was so that I wouldn?t we a burden on the healthcare system in the event that I actually got Covid. So, if I go to the doctor because of the vaccine then its defeating the point of the vaccine mandate, since I?m not a burden. So I feel guilty about going to the doctor since I don?t actually have Covid.
Aktuelle Erkrankungen
None
Vorgeschichte
Afib
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1996085

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
50,0
Geschlecht
F
Eingang
31.12.2021
Impfdatum
01.12.2021
Beginn
29.12.2021
Tage bis Beginn
28,0
Dosis
2
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Balance disorder Dysphagia Flushing Headache Oropharyngeal discomfort Paraesthesia oral

Symptomtext

Headache, flushing face, tingling lips, balance off, general weakness, pressure in throat, difficulty swallowing

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia oral
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
PEG, Latex, kiwi fruit
Vorherige Impfungen
Same symptoms as this booster... but less severe, improved with Benadryl, resolved in a few days 50y/o, F, Janssen, 04/02/21, C

VAERS 1992960

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
53,0
Geschlecht
F
Eingang
30.12.2021
Impfdatum
15.12.2021
Beginn
15.12.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Dizziness Fatigue Headache Injected limb mobility decreased Injection site bruising Injection site pain Lymphadenopathy Muscular weakness Nausea Pain Palpitations Pyrexia

Symptomtext

"Janssen COVID-19 Vaccine EUA" Mild nausea began within one hour of injection. Within six hours developed severe nausea, headache, and chills, fever, generalized body aches, swollen glands in neck and groin, fatigue, dizziness, debilitating weakness in legs, racing heart, and bruising and pain at injection site. Symptoms were severe for 48 hours, then moderate for another 48 hours. Pain at injection site prevented lifting arm for 6 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Mild COVID-19, with symptoms starting on 11/08/2021
Vorgeschichte
none
Andere Medikamente
none
Allergien
pollen
Vorherige Impfungen
-

VAERS 1985200

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
FL
Alter
64,0
Geschlecht
F
Eingang
28.12.2021
Impfdatum
24.12.2021
Beginn
24.08.1957
Tage bis Beginn
-
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chest pain Cough Headache Influenza like illness Vasodilatation

Symptomtext

HEAD PAIN SHARP, PAIN IN CHEST FOR TWO DAYS, VIENS FELT LIKE THEY WERE GOING TO EXPLODE, FLU LIEK SYMPTOM, DRY COUGH , THROBBING HEAD

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NA
Vorgeschichte
HEART PROBLEMS AND STROKE
Andere Medikamente
MELATONIN, DIPHENHYDRAMINE
Allergien
NONE
Vorherige Impfungen
-

VAERS 1985053

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
LA
Alter
26,0
Geschlecht
M
Eingang
28.12.2021
Impfdatum
16.12.2021
Beginn
24.12.2021
Tage bis Beginn
8,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Chest pain Pain in extremity Palpitations

Symptomtext

Chest pain, subtle pain in left arm, racing heartbeat started 8-10 after injection and has been persistent since.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Amphetamine Salt Combo (20mg 2x/day)
Allergien
-
Vorherige Impfungen
-

VAERS 1978544

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
TX
Alter
44,0
Geschlecht
F
Eingang
24.12.2021
Impfdatum
-
Beginn
18.12.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Headache Injection site pain Injection site paraesthesia Injection site rash Injection site reaction Pain in extremity Somnolence

Symptomtext

FEELING WEAKNESS IN INJECTION ARM; TINGLING IN INJECTION ARM THAT GOES ALL THE WAY DOWN LEFT ARM; FEELS LIKE COULD SLEEP FOR DAYS THAT STARTED TO GET WORSE; BUMP UNDER SKIN ON ARM GOT INJECTION; LEFT ARM PAIN, EVERY DAY IT HAS PROGRESSED AND GOTTEN A LITTLE WORSE, VERY ARM SORE; PAIN AROUND INJECTION SITE; HEADACHE; This spontaneous report received from a patient concerned a 44 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: 11-APR-2022) dose was not reported, administered on 18-DEC-2021 12:12 for prophylactic vaccination. No concomitant medications were reported. On 18-DEC-2021, the patient experienced headache. On 19-DEC-2021, the patient experienced left arm pain, every day it has progressed and gotten a little worse, very arm sore, and pain around injection site. On 20-DEC-2021, the patient experienced feels like could sleep for days that started to get worse, and bump under skin on arm got injection. On 22-DEC-2021, the patient experienced feeling weakness in injection arm, and tingling in injection arm that goes all the way down left arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from left arm pain, every day it has progressed and gotten a little worse, very arm sore, bump under skin on arm got injection, feeling weakness in injection arm, tingling in injection arm that goes all the way down left arm, headache, feels like could sleep for days that started to get worse, and pain around injection site. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1970387

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
FL
Alter
40,0
Geschlecht
F
Eingang
22.12.2021
Impfdatum
-
Beginn
01.12.2021
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Alopecia Chest discomfort Dyspnoea Headache Heavy menstrual bleeding Injection site pain Lethargy Menstruation irregular Paraesthesia

Symptomtext

HEAVY VAGINAL BLEEDING (FEW DAYS AFTER HAVING FINISHED PERIOD); PERIOD 3 WEEKS EARLY; PAIN AT INJECTION SITE; TINGLING IN ARMS AND LEGS; HEADACHE/TENDERNESS ON TOP OF HEAD; INCREASED HAIR LOSS; LETHARGY (SLEPT 15 HOURS A DAY FOR 3 DAYS); DIFFICULTY BREATHING/ SHORTNESS OF BREATH; CHEST TIGHTNESS; This spontaneous report received from a patient concerned a 40 year old female. The patient's weight was 118 pounds and height was not reported. The patient's concurrent conditions included: autistic spectrum (processing disorder), abstained from alcohol, non smoker, ADHD (Attention deficit hyperactivity disorder), severe anxiety disorder, Ehlers Danlos (connective tissue disorder), complex post-traumatic stress disorder, contrast dye allergy, allergy to antidepressant and allergy medication, and vaccine reaction when she was a child, and other pre-existing medical conditions included: The patient had no history of drug abuse or illicit drug use. The patient was planning to have genetic test for allergies and how medications react. The patient previously received covid-19 vaccine ad26.cov2.s (dose number in Series 1) (suspension for injection, route of admin not reported and batch number: 205A21A) dose was not reported, 1 total, administered on 12-APR-2021 for prophylactic vaccination. The patient had bad reaction such as chest tightness, difficulty breathing/ shortness of breath, hair falling out, headache/tenderness on top of head, pain at injection site hurt for about week and a half, period stopped for 4 months, sick for a week and involuntary weight loss following vaccination with first dose of covid-19 vaccine ad26. cov2. s (dose number in Series 1). The patient's period had stopped on 09-DEC-2021. The patient recovered from chest tightness, shortness of breath/difficulty breathing, sick for a week, headache/tenderness on top of head, and pain at injection site hurt for about a week a half, and had not recovered from hair falling out, and involuntary weight loss following vaccination. The outcome of period stopped for 4 months was unknown. The patient received covid-19 vaccine ad26.cov2.s (dose number in Series 2) (suspension for injection, route of admin not reported, batch number: 1855191, expiry: UNKNOWN) dose was not reported, 1 total, administered on right arm on 10-DEC-2021 for prophylactic vaccination. Concomitant medications included Xanax (alprazolam), marihuana (cannabis sativa) and ketamine for complex post-traumatic stress disorder. On 10-DEC-2021, following vaccination with covid-19 vaccine ad26.cov2.s (dose number in Series 2), the patient had pain at injection site. On 12-DEC-2021, patient had period 3 weeks early and heavy vaginal bleeding (few days after having finished period). She stated that she used one super tampon for 2 hours maximum. On an unspecified date in DEC-2021, the patient had same symptoms as with first vaccine. She had increased hair loss, lethargy (slept 15 hours a day for 3 days), difficulty breathing/ shortness of breath, chest tightness, headache/ tenderness on top of head, experienced tingling in arms and legs. As on report time, patient had just tenderness and excessive bleeding (dose number in Series 2). The JNJ booster doubled hair loss and "period 3 weeks early". The patient visited emergency room for the treatment of the events. It was reported that, the patient talked to her old doctor about symptoms who had heard a lot about JNJ and these effects and recommended patient to get a full hormone panel and patient was planning to do as she could not found an appointment with doctor of medicine (MD) before February The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from increased hair loss, lethargy (slept 15 hours a day for 3 days), difficulty breathing/ shortness of breath, chest tightness, and tingling in arms and legs on DEC-2021, and pain at injection site on 15-DEC-2021, had not recovered from headache/tenderness on top of head, and heavy vaginal bleeding (few days after having finished period), and the outcome of period 3 weeks early was not reported. This report was non-serious. This case, involving the same patient is linked to 20211235199.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Abstains from alcohol; ADHD; Allergy to vaccine (vaccine given in 1/4 doses); Anxiety disorder; Autistic disorder; Contrast media allergy; Drug allergy; Ehlers-Danlos syndrome; Non-smoker; Post-traumatic stress disorder
Vorgeschichte
Comments: The patient had no history of drug abuse or illicit drug use. The patient was planning to have genetic test for allergies and how medication react.
Andere Medikamente
XANAX; KETAMINE; MARIHUANA
Allergien
-
Vorherige Impfungen
-

VAERS 1961739

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CO
Alter
27,0
Geschlecht
F
Eingang
18.12.2021
Impfdatum
16.12.2021
Beginn
17.12.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Back pain Chills Headache Ligament sprain Nausea Neck pain Palpitations Pyrexia Spinal pain Vomiting

Symptomtext

severe chills and fever... 103 degrees. racing heart, Nausea, vomiting, severe frontal headache, severe joint pain, especially spinal pain, back and neck pain, severe hip pain, and a right lateral side of ankle that still feels sprained 2 1/2 days later. I have not been in to see a doctor yet because I am finally recovering from the fever.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1952419

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CT
Alter
61,0
Geschlecht
F
Eingang
16.12.2021
Impfdatum
15.12.2021
Beginn
15.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Eye pain Fatigue Head discomfort Hypoaesthesia Headache Peripheral swelling Vision blurred Muscle spasms Paraesthesia Swelling face

Symptomtext

Within 10 minutes: Dizzy, sharp pain in left eye with blurring vision, numbness/tingling on left side of face, pressure base of skull and down spine, numbness/tingling down left arm, intercostal muscles left rib cage spasm, numbness/tingling down left left leg, mild swelling in left hand Next morning: Swelling of right side of face, extreme fatigue, numbness not subsided No fever

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
NOTE: Contacting MS Specialist for advice on 12/16/2021 Pharmacy wanted to notify ED - but refused. Did not feel life-threatening, but similar to reaction related to doses of Copaxone (MS injectable drug) prior to allergic response/sensitization to drug product. In other words - been there done that...still alive
Aktuelle Erkrankungen
None (acute)
Vorgeschichte
Multiple Sclerosis Cancer survivor (3yr. Tripple negative breast)
Andere Medikamente
Vitamin D, Zinc
Allergien
Copaxone (injectible drug)
Vorherige Impfungen
-

VAERS 1952632

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
GA
Alter
74,0
Geschlecht
M
Eingang
15.12.2021
Impfdatum
15.12.2021
Beginn
15.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Feeling abnormal Palpitations

Symptomtext

PATIENT REPORTED FEELING A "RUSH" LIKE HIS HEART WAS POUNDING.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1943686

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
NJ
Alter
44,0
Geschlecht
U
Eingang
13.12.2021
Impfdatum
06.12.2021
Beginn
06.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Back pain Chest discomfort Dyspnoea Headache Hypoaesthesia Muscle tightness Neck pain Pain Pain in extremity Rhinorrhoea Tinnitus

Symptomtext

A few hours after receiving injection right arm was sore and numb down to right hand and muscles in hand and forearm are tight (still having issue currently after 7 days), Headaches (still having issue currently after 7 days), Runny Nose, Sore Body (still having issue currently after 7 days in neck, shoulder, back and legs), Ringing Noise in Ears (Still hear ringing constantly has been 7 days), Tightness in my chest and heavy breathing (lasted 3 days - comes and goes for a few hours every few days).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Multivitamin
Allergien
None
Vorherige Impfungen
-

VAERS 1940282

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
50,0
Geschlecht
F
Eingang
10.12.2021
Impfdatum
10.12.2021
Beginn
10.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Interchange of vaccine products Paraesthesia oral Pharyngeal swelling Throat irritation Throat tightness

Symptomtext

Patient is a 50 year old female who has completed a 30-minute observation period with the following signs and symptoms of an adverse reaction: sensation of throat swelling or throat closure, tingling in the tip of the tongue, itching in the throat. Janssen/J&J COVID-19 vaccine #2 in series administered. Patient received moderna as first dose on 1/7/21 at a satellite clinic per patient. Patient had numbness on left side of face and arm after getting moderna but did not go to emergency. Numbness went away per pateint. Msg was sent to doctor and was advised to take J&J to complete vaccination. Patient here for j and J vaccine Upon examination, no swelling of lips noted, no tongue swelling, throat is clear. Voice is clear, speaking in full sentences. No audible wheezing noted. No rash, no hives. Vital signs as follows Vitals: 12/10/21 1407 12/10/21 1412 12/10/21 1420 12/10/21 1430 BP: (!) 143/90 122/84 124/78 Pulse: 77 72 71 71 Resp: 20 18 20 18 SpO2: 100% 100% 100% 100% Action(s) taken: Another drug administered - Benadryl 25 mg PO x1 Allergy to COVID-19 vaccine documented in Allergies activity: No, advised to see doctor for advise. Patient advised to discuss second dose considerations with a clinician Sent home at 230pm. Feeling better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia oral
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Specialty HYPERLIPIDEMIA Other MODERATE PERSISTENT ASTHMA, CONTROLLED PANIC DISORDER HEAVY MENSTRUAL BLEEDING (MENORRHAGIA) W REGULAR CYCLES UTERINE CERVIX STENOSIS UTERINE FIBROIDS CALCIFIED PULMONARY GRANULOMA HX OF TOTAL HYSTERECTOMY, NO VAGINAL PAP SMEAR REQUIRED ENDOMETRIAL POLYP ABNL UTERINE BLEEDING
Vorgeschichte
Specialty HYPERLIPIDEMIA Other MODERATE PERSISTENT ASTHMA, CONTROLLED PANIC DISORDER HEAVY MENSTRUAL BLEEDING (MENORRHAGIA) W REGULAR CYCLES UTERINE CERVIX STENOSIS UTERINE FIBROIDS CALCIFIED PULMONARY GRANULOMA HX OF TOTAL HYSTERECTOMY, NO VAGINAL PAP SMEAR REQUIRED ENDOMETRIAL POLYP ABNL UTERINE BLEEDING
Andere Medikamente
Prozac, Albuterol, Atarax, Florinef, Nasacort
Allergien
Allergies Covid-19 Vaccine, Mrna-1273, Lnp-s (Moderna) Covid-19 Vaccine, Mrna-1273, Lnp-s (Moderna)--reaction tingling
Vorherige Impfungen
numbness on face/tingling hands, 50, 1/7/21, Moderna Covid Vaccine

VAERS 1938356

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
FL
Alter
68,0
Geschlecht
F
Eingang
10.12.2021
Impfdatum
-
Beginn
02.12.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Complex regional pain syndrome Discomfort Erythema Gait inability Headache Injection site discomfort Injection site erythema Injection site pain Injection site warmth Migraine Movement disorder

Symptomtext

COULDN'T WALK; FLARE OF AUTOIMMUNE REFLEX SYMPATHETIC DYSTROPHY (RSD) SYMPTOMS; SPLITTING MIGRAINE; INJECTION SITE UNCOMFORTABLE; WAS VERY UNCOMFORTABLE; REDNESS GREW DOWN ARM TO ALMOST ELBOW; INJECTION SITE SORE; HEADACHE; HOTNESS AT INJECTION SITE; REDNESS AT INJECTION SITE; DIFFICULTY MOVING ARMS AND LEGS; This spontaneous report received from a pharmacist concerned a 68 year old female. The patient's height, and weight were not reported. The patient's past medical history included: sympathetic nerve cut, and surgery, and concurrent conditions included: multiple autoimmune disorders, reflex sympathetic dystrophy, penicillin allergy, lymphoma, allergy to dye/filler in generic medications, pet allergy, oak and pine trees allergy, and outdoor allergens, and other pre-existing medical conditions included: The patient experiences allergy with things around the house, anything that blooms. The patient experienced stomach problems when treated with gabapentin for reflex sympathetic dystrophy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: 11-APR-2022) dose was not reported, administered on 02-DEC-2021 for prophylactic vaccination (dose number in series 1). No concomitant medications were reported. On 02-DEC-2021, the patient experienced difficulty moving arms and legs. On 02-DEC-2021, the patient experienced hotness at injection site. On 02-DEC-2021, the patient experienced redness at injection site. On 03-DEC-2021, the patient experienced splitting migraine. On 03-DEC-2021, the patient experienced was very uncomfortable. On 03-DEC-2021, the patient experienced redness grew down arm to almost elbow. On 03-DEC-2021, the patient experienced injection site uncomfortable. On 03-DEC-2021, the patient experienced injection site sore. On 03-DEC-2021, the patient experienced headache. On 04-DEC-2021, the patient experienced flare of autoimmune reflex sympathetic dystrophy (rsd) symptoms. On 04-DEC-2021, the patient experienced couldn't walk. Treatment medications (dates unspecified) included: acetylsalicylic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from splitting migraine, and headache on 04-DEC-2021, had not recovered from redness at injection site, difficulty moving arms and legs, couldn't walk, flare of autoimmune reflex sympathetic dystrophy (rsd) symptoms, injection site sore, and hotness at injection site, and the outcome of was very uncomfortable, injection site uncomfortable and redness grew down arm to almost elbow was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Migraine
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Allergy to animals; Autoimmune disorder; Lymphoma; Multiple allergies; Penicillin allergy (closes throat, swell up in big hives (since infancy)); Reaction to drug excipients; Reflex sympathetic dystrophy (RSD had been worse for last 11 years for patient, began 2 weeks after a sympathetic nerve was cut during surgery years ago.); Seasonal allergy
Vorgeschichte
Medical History/Concurrent Conditions: Surgery; Sympathetic nerve injury; Comments: The patient experiences allergy with things around the house, anything that blooms.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1931294

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
FL
Alter
-
Geschlecht
F
Eingang
08.12.2021
Impfdatum
-
Beginn
06.12.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Feeling cold Headache Heart rate Heart rate increased Hyperhidrosis Palpitations

Symptomtext

HEART RACING; HEART RATE OVER 150; POURING SWEAT; SHIVERING; FREEZING COLD; WORST HEADACHE; This spontaneous report received from a patient concerned a 25 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient did not have medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191 and expiry: UNKNOWN) dose was not reported, administered on 06-DEC-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-DEC-2021, the patient experienced heart racing. On 06-DEC-2021, the patient experienced heart rate over 150. On 06-DEC-2021, the patient experienced pouring sweat. On 06-DEC-2021, the patient experienced shivering. On 06-DEC-2021, the patient experienced freezing cold. On 06-DEC-2021, the patient experienced worst headache. Laboratory data included: Heart rate (NR: not provided) over 150. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the worst headache, pouring sweat, shivering, freezing cold, heart racing and heart rate over 150 was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
Test Date: 20211206; Test Name: Heart rate; Result Unstructured Data: over 150
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: Patient did not have medical history.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1929452

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
-
Alter
51,0
Geschlecht
F
Eingang
07.12.2021
Impfdatum
01.11.2021
Beginn
06.12.2021
Tage bis Beginn
35,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Chest discomfort Dyspnoea Fatigue Influenza like illness Myalgia SARS-CoV-2 test positive

Symptomtext

Patient has flu-like symptoms with myalgia, fatigue, chills, chest tightness, SOB x 1 week. Patient is getting better after natural treatments.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
Covid 19 positive 11/29/21
Aktuelle Erkrankungen
Neuropathy
Vorgeschichte
Neuropathy
Andere Medikamente
Many
Allergien
-
Vorherige Impfungen
-

VAERS 1925637

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
38,0
Geschlecht
F
Eingang
06.12.2021
Impfdatum
04.11.2021
Beginn
27.11.2021
Tage bis Beginn
23,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Back pain Bone pain Chills Cough Dysphagia Feeling of body temperature change Mobility decreased Oropharyngeal pain Pain Pyrexia

Symptomtext

My throat hurt, couldn't shallow, hot and cold chills, fever, and coughing. My body was sore. Couldn't even get out of bed. Also my back and bones were hurting as well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
Result- on 12/02/2021 I had an Over the phone consultant- I was prescribed: Inhaler 160 MCG-1 puff 2xday and Benzonatate 100mg 1 -3xday
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Iron pills 35mg 1xday
Allergien
None
Vorherige Impfungen
Flu shot- Got bad flu reaction

VAERS 1890636

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
54,0
Geschlecht
M
Eingang
22.11.2021
Impfdatum
15.11.2021
Beginn
16.11.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Dizziness Fatigue Hallucination, visual Hypoaesthesia Injection site pain Insomnia Migraine Mobility decreased Nausea

Symptomtext

Pt. states that after receiving the 1st dose of Jansen J&J 11/15/2021, started experiencing symptoms 11/16/2021 of severe migraines/headaches, dizziness, extreme numbness in extremities, pain at injection site, difficulty moving arm (right), extreme nausea and fatigue, insomnia, "hallucination-like" visions, slight fever (100.0), and chills. Still continuing to experience symptoms, no noted Primary visit/communications.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Migraine
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 1889562

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
OH
Alter
33,0
Geschlecht
M
Eingang
22.11.2021
Impfdatum
19.11.2021
Beginn
19.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Burning sensation Paraesthesia

Symptomtext

Adverse symptoms experienced were severe burning throughout entire body. Felt as though nerve endings were on fire and intensified with even minimal applied pressures. Symptoms did not cease until well into the following day. Sense of touch was impaired for the remainder of that day. Burning sensation has since ceased and normal touch sensations have since returned to normal.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
None as of yet. Currently seeking a PCP for their advisement.
Aktuelle Erkrankungen
Flulike symptoms were experienced two weeks prior to receiving vaccine. Symptoms experienced were more than well-managed and feeling fine prior to taking vaccine.
Vorgeschichte
N/A
Andere Medikamente
One Daily Multivitamin (MEN'S)
Allergien
No known drug, food or other allergies to vaccines, inoculations, or other applied medications.
Vorherige Impfungen
-

VAERS 1885923

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CO
Alter
24,0
Geschlecht
F
Eingang
19.11.2021
Impfdatum
18.11.2021
Beginn
18.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Hypoaesthesia Hypoaesthesia oral Limb discomfort Lip swelling Paraesthesia Pharyngeal paraesthesia

Symptomtext

While I was working, a lady came to the counseling window to ask a question. She told me she had gotten a Johnson and Johnson COVID shot ten minutes before and stated her arms felt numb, tingly, and heavy. She asked whether this normal. I told her it?s not a normal, common side effect. I asked her if she had a history of reactions to vaccinations. She told me she hadn?t. I asked her for her name and phone number so I can report it to VAERs. She then complained of sudden numbness in her upper lip. I realized it might be an allergic reaction. I grabbed a chair and had her sit down. I then got an epipen and went into the office to tell a manager to call 911. I went back to check on the customer and asked how she was doing. She stated her throat was starting to tingle. I noticed upper lip was starting to swell. I asked her if she could wait for the paramedics to arrive, but she asked me to give her the epipen shot. She mentioned she got an epipen shot when she young. She didn?t know what she?s allegoric to, but this wasn?t the first time she was given an epipen shot. I gave her the shot. She started feeling better, and I gave her some water and some candy because she appeared to be in a state of low-sugar. The paramedics arrived shortly after this. I explained the situation to the paramedics and what I had done for the customer. Leaving the customer in the care of the paramedics, I went back to the pharmacy. She left with the paramedics shortly after this.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
No
Aktuelle Erkrankungen
No information provided
Vorgeschichte
No information
Andere Medikamente
No information provided
Allergien
Yes , but she does not remember
Vorherige Impfungen
-

VAERS 1885322

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CT
Alter
39,0
Geschlecht
M
Eingang
19.11.2021
Impfdatum
14.11.2021
Beginn
14.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Dizziness Feeling abnormal Hypoaesthesia Palpitations Paraesthesia

Symptomtext

Shortly after receiving the Janssen COVID-19 vaccine IM in the right arm, patient reported "not feeling right." He reported feeling dizzy, and then reported having a "racing heart." He then reported his left arm was becoming numb and tingling. Paramedics were called and he was transported via ambulance to the hospital of his choice.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Unknown
Andere Medikamente
Janssen COVID-19 vaccine OTC vitamins
Allergien
None
Vorherige Impfungen
-

VAERS 1884870

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
CA
Alter
55,0
Geschlecht
F
Eingang
19.11.2021
Impfdatum
18.11.2021
Beginn
18.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Condition aggravated Dizziness Hypertension

Symptomtext

Patient started having dizziness at 1459. Took her back to an exam room and did vitals. Patient was hypertensive and admits to taking her BP meds this morning. She denies any shortness of breath, hives, chest pain, or chest tightness. Monitored patient for x2 rounds of vitals and patient remains hypertensive. Nurse STAT called at 1518. She is evaluated by RN and she is transferred to the urgent care for further evaluation. No medications administered. Patient took benadryl 20 min prior to her vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
n/a
Vorgeschichte
hypertension, hyperlipidemia, A fib, Wolfe Parkinson white syndrome
Andere Medikamente
Benadryl, Lisinopril, Amlodipine
Allergien
Bupropion, clindamycin, gabapentin, morphine, pantoprazole, omeprazole, sulfa
Vorherige Impfungen
-

VAERS 1844730

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
NJ
Alter
37,0
Geschlecht
F
Eingang
04.11.2021
Impfdatum
01.11.2021
Beginn
04.11.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dyspnoea Urticaria

Symptomtext

Severe hives all over the face and difficulty breathing.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
No
Allergien
Encephalitis vaccine; stone fruits; nuts; insect bites
Vorherige Impfungen
-

VAERS 1836928

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
-
Alter
60,0
Geschlecht
M
Eingang
02.11.2021
Impfdatum
28.10.2021
Beginn
28.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Chest pain Heart rate increased Nightmare Pyrexia

Symptomtext

Bad dreams, slight fever, chest pain and increased heart rate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1831649

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

moderat
Staat
NY
Alter
58,0
Geschlecht
F
Eingang
30.10.2021
Impfdatum
28.10.2021
Beginn
29.10.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain upper Balance disorder Chills Ear pain Eye pain Headache Muscle spasms Paraesthesia Pyrexia Sinus pain Tinnitus Vision blurred

Symptomtext

Symptoms occurred 24 hrs after vaccination - fever 103+, severe headache, chills, stomach cramping, blurred vision, loss of balance, ear ringing, leg cramps, tingling sensations fingertips & toes, ear pain, eye pain, sinus pain

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None- Long haul Covid since March 2020 before that time no illness
Vorgeschichte
long haul Covid since March 2020 recovered after debilitating symptoms in May 2021 - hx of myocarditis, blood clots, POS, MCAS during long haul Covid
Andere Medikamente
Vitamin D, K2, E, Zinc, C, biotin, B6, Quercitan, Tumeric,
Allergien
PEG allergy all concentrations - levels from 200+
Vorherige Impfungen
seasonal flu vaccine - GB syndrome - 2018

VAERS 2696140

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
-
Alter
85,0
Geschlecht
M
Eingang
14.10.2023
Impfdatum
30.12.2021
Beginn
04.09.2023
Tage bis Beginn
613,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Angiogram abnormal Blood bicarbonate decreased Blood creatinine Blood sodium increased Brain compression Bronchitis COVID-19 Cerebral mass effect Chest X-ray abnormal Computerised tomogram head abnormal Computerised tomogram kidney abnormal Culture urine positive Escherichia test positive Faeces discoloured Fatigue Gastrointestinal haemorrhage Haemoglobin International normalised ratio increased

Symptomtext

Patient is a 87 y.o. male patient of DO with history of Hypertension, CKD, Anemia, Diverticulitis, GI bleed, Prostate cancer, Alzheimer's dementia, presented to Medical Center with with AMS found to have SDH with brain compression. Hospitalization complicated by GI bleed UTI. Covid-19 Virus Infection Onset ~ 9/3, + Test on 9/4/23 Sx Fatigue, fever Imaging: CXR clear lungs PCXR 9/17-Increased lung markings bilaterally, may be related to minimal pulmonary vascular congestion versus bronchitis. Baseline on RA, then required 2L NC but back on room air Medical therapy: Decadron, Remdesivir Consultants following: ID E-consult, not a candidate for Paxlovid, discussed with ID Anticipated special isolation end date: 9/15/2023 No longer symptomatic See Quick note 9/15 Subdural Hematoma Brain Compression, POA CT Head 9/5 with Acute on Subacute 14 mm SDH with mass effect on L cerebral hemisphere and minimal 2mm MLS NSGY assessed and recs L SDH evacuation-family decline Repeat CT Head 9/6 stable Neuro checks q2h neuro checks Family fearful of worsening neurologic status after surgery or physical decline Neurosurgery now signed off Palliative care consulted Nutrition consulted-boost plus 1 x per day PT evaluated patient and difficult to have him progress due to inability to follow commands Discussed PT evaluation with family, continue to want to work toward rehabilitation GIB Chronic anemia Plan hemoglobin 9.9 (11/23/2019) -- > 10.5 on admission CTA dissection negative for active GI hemorrhage INR 1.3 Noted as of active bleed Hemoglobin stable, 9.5, Hgb stable at 9.2, 8.2 9/11, 8 9/12, 8.4 9/13, 8.3 9/15, 8.7 9/16 Monitor for any worsening, given COVID-19/oxygen dependence not ideal for endoscopy at this time Patient is a specific religion per palliative care documentation Dark bowel movement 9/9 per nursing, will monitor for now but if he has another we will consult GI Smear of blood with wiping, likely hemorrhoids Heme consulted-will place blood conservation orders will order SPEP, IFX given patient age, GFR and anemia F/u GI outpt F/u Heme Outpt UTI Leukocytosis WBC elevated 11K 9/13; 16K 9/15, 12K 9/16 Likely secondary to steroids, no fevers, no longer requiring oxygen AAS and U/A, Urine cx- E coli with sensitivities pending. Bladder scan scheduled for SNF Follow per SNF physician pending U/A cx. Start empiric Keflex 250 BID x 7 days starting 9/17 per discussion with nursing at SNF and faxed updated AVS 9/16 AM Edema Rt hand Xray -Nonspecific soft tissue swelling along the dorsal aspect of the hand. This is nonspecific. Cellulitis is in the differential.No acute bone or joint abnormality. Interphalangeal joint osteoarthritis is noted. Keep elevated Heat ordered prn Follow per SNF physician Acute metabolic encephalopathy Dementia, alzheimer's Likely due to SDH, COVID superimposed on underlying dementia At baseline dependent for most ADLs SDH and COVID mgmt as above Palliative following for goals of care At this time goals seem to be life-prolonging, rehabilitative Discussed limitations with family briefly Palliative consulted Nutrition consulted-boost plus 2 x per day Abnormal CT kidney CTA revealed 2 cm heterogenously enhancing lesion in the posterior aspect of the right kidney new from 2019 concerning for renal neoplasm, 1.5 cm possible enhancing lesion posterior aspect left kidney likely unchanged from 2019 Plan arrange outpatient renal protocol MRI per PCP Thyroid nodule CT revealed 3.2 cm right thyroid nodule Arrange outpatient thyroid ultrasound per PCP Essential hypertension Benign, controlled Holding amlodipine Electrolyte abnormalities- Resolved CKD stage III Sodium 146 9/11, 9/12, 144 9/13 bicarb 20 9/11 Creatinine 1.92 (11/23/2019) -- > 1.24 on admission Cr rising to 1.44, 1.2 9/11, 9/12, 1.3 9/15 Started MIVF bolus, bladder scan ordered Avoid NSAIDs, IV Dye

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
12,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2614566

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
MI
Alter
84,0
Geschlecht
F
Eingang
13.04.2023
Impfdatum
18.11.2021
Beginn
08.04.2023
Tage bis Beginn
506,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia COVID-19 Diarrhoea Hypoxia SARS-CoV-2 test positive Sepsis

Symptomtext

Discharge Provider: DO Primary Care Provider at Discharge: DO Admission Date: 4/8/2023 Discharge Date: 04/10/2023 Discharge Disposition: Home PRESENTING PROBLEM: Diarrhea & weakness HOSPITAL COURSE: Patient is a 86-year-old female who was admitted on 04/08/2023 for sepsis and questionable pneumonia, she was given Rocephin and azithromycin on 04/08, but no further doses as film array returned positive for COVID-19 infection. Initially patient was also hypoxic down to 85% on room air and requiring 3 L, she has now been weaned to room air for 24 hours. She was started on Decadron 6 mg daily for 2 doses, will not continue at discharge. Patient was thought to not be taking her Eliquis, as this had not been filled since September of 2022. However patient states that Eliquis was not affordable and Cardiology was able to get her samples, she still has enough for 1.5 months. Patient feels great and wants to go home. Vitals are stable. Medically clear for discharge.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
DDD (degenerative disc disease), lumbar CAD (coronary artery disease), native coronary artery Hyperlipidemia LDL goal < 100 Benign essential hypertension Osteoarthritis of lumbar spine Sepsis due to pneumonia CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min Congestive heart failure, unspecified HF chronicity, unspecified heart failure type Atrial fibrillation, persistent Systolic CHF, acute Unspecified severe protein-calorie malnutrition Anemia Diverticulitis Physical deconditioning Hypokalemia Acute on chronic systolic (congestive) heart failure Severe mitral regurgitation Acute on chronic systolic heart failure Paroxysmal ventricular tachycardia LBBB (left bundle branch block) Non-ischemic cardiomyopathy Colonic diverticular abscess Iron deficiency anemia, unspecified Anemia in stage 4 chronic kidney disease Atrial fibrillation with RVR Bacteremia due to Gram-negative bacteria Hartmann's procedure 2/2 diverticular abscess (1/2021) then takedown of colostomy 3/17/22 Myalgia Heart failure due to valvular disease, unspecified heart failure type COVID-19
Andere Medikamente
amiodarone (PACERONE) 200 mg tablet apixaban (ELIQUIS) 2.5 MG tablet calcitriol (ROCALTROL) 0.25 MCG capsule furosemide (LASIX) 40 MG tablet hydrALAZINE (APRESOLINE) 10 MG tablet HYDROcodone-acetaminophen (NORCO) 10-325 MG per tablet isosor
Allergien
Pravastatin Sulfa DrugsItching
Vorherige Impfungen
-

VAERS 2558745

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
NY
Alter
26,0
Geschlecht
M
Eingang
12.01.2023
Impfdatum
11.01.2022
Beginn
11.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Abdominal pain upper Chills Choking sensation Cough Dry mouth Dry throat Dysphonia Lethargy Nasopharyngitis Neurogenic cough Pyrexia Reflux laryngitis Restlessness Retching SARS-CoV-2 antibody test negative Sinus congestion Thirst Upper-airway cough syndrome

Symptomtext

I had fever, chills, lots of shivering, terrible stomach, pain lasting several hours, clogged sinuses, extremely thirsty, dry mouth, experienced restlessness. Next day felt more like cold symptoms dry mouth, fatigue lethargic, experienced a cough, postnasal drip progressing to dry throat impeding voice, symptoms lasted over a month started dry heaving felt like I was choking on my own saliva all day long. Had to go to an urgent care due to symptoms also had to go to ENT and was the diagnosed laryngopharyngeal reflux. Was given a proton pump and dietary restrictions lessened symptoms somewhat was placed on nerve meds as a diagnosis of neurogenic cough.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain upper
Hospital-Tage
-
Labordaten
Covid antibody test/ no Covid antibodies detected.
Aktuelle Erkrankungen
None
Vorgeschichte
Seasonal allergies
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2555764

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CO
Alter
64,0
Geschlecht
F
Eingang
10.01.2023
Impfdatum
08.01.2022
Beginn
28.11.2022
Tage bis Beginn
324,0
Dosis
3
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Cough Fatigue Headache Pain Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Tested positive for COVID. Fatigue, aches, headache, congestion, cough. These symptoms lasted about a week then fatigue for another week. Received Paxlovid treatment on first day of symptoms and testing positive with home test. Also took Advil for headache.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
Home COVID test.
Aktuelle Erkrankungen
None
Vorgeschichte
High blood pressure Low thyroid Asthma
Andere Medikamente
Caduet, atacand, Levothyroxin, trelegy, Fluticasone, Montelukast
Allergien
Sulfur
Vorherige Impfungen
-

VAERS 2541314

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
FL
Alter
64,0
Geschlecht
F
Eingang
23.12.2022
Impfdatum
13.12.2021
Beginn
09.01.2022
Tage bis Beginn
27,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Biopsy Granuloma annulare Skin test Urticaria

Symptomtext

GRANULOMA ANNULARE ON TORSO BACK OF 1 ARM AND LEGS; BAD HIVES; This spontaneous report received from a patient concerned a 64 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: eczema (mild used topical Flucinonide occasionally when needed), and drug allergy (allergies to Propolis, Iodopropynyl Butylcarbamate), and other pre-existing medical conditions included: The patient had no Chronic or long-standing health conditions. The patient was not pregnant at the time of vaccination. The patient did not have an adverse event following any previous vaccine. The patient previously received dose 1 with covid-19 vaccine ad26.cov2.s (Dose number in series 1), (suspension for injection, route of admin, batch number and expiry date were not reported) dose was not reported, 1 total administered start therapy date were not reported for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination (Dose number in series 1). The patient received booster with covid-19 vaccine ad26.cov2.s (Dose number in series 2), (suspension for injection, route of admin not reported, batch number: 1855191 expiry: UNKNOWN) dose was not reported, 1 total administered on 13-DEC-2021 11:00 to right arm for covid-19 prophylaxis. Age at time of vaccination 64 years old. Concomitant medications included fluocinonide for eczema, calcium, colecalciferol, curcuma longa, cyanocobalamin, fish oil, paracetamol, and tocopherol. On 09-JAN-2022 11:00, the patient experienced rash and was diagnosed with granuloma annulare on torso back of 1 arm and legs (Dose number in series 2). On same day, the patient also experienced bad hives along with symptoms of allergies and swelling of lips and tongue (Dose number in series 2). Laboratory data (dates unspecified) included: Biopsy to determine the Rash was Granduloma Annulare, and Skin test showed allergies to Propolis, Iodopropynyl Butylcarbamate. The patient also visited physician office. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from granuloma annulare on torso back of 1 arm and legs, and bad hives. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
Test Name: SKIN TEST; Result Unstructured Data: showed allergies to Propolis, Iodopropynyl Butylcarbamate; Test Name: BIOPSY; Result Unstructured Data: to determine the Rash was Granduloma Annulare
Aktuelle Erkrankungen
Drug allergy (allergies to Propolis, Iodopropynyl Butylcarbamate); Eczema (mild used topical Flucinonide occasionally when needed)
Vorgeschichte
Comments: The patient had no Chronic or long-standing health conditions. The patient was not pregnant at the time of vaccination. The patient did not had an adverse event following any previous vaccine.
Andere Medikamente
TYLENOL [PARACETAMOL]; VITAMIN D3; CALCIUM; VITAMIN E [TOCOPHEROL]; VITAMIN B12 [CYANOCOBALAMIN]; OMEGA 3 [FISH OIL]; TURMERIC [CURCUMA LONGA]; FLUCINONIDE
Allergien
-
Vorherige Impfungen
-

VAERS 2513098

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
UT
Alter
44,0
Geschlecht
F
Eingang
21.11.2022
Impfdatum
27.04.2022
Beginn
27.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Allergy to vaccine Immunisation reaction Injection site bruising Injection site mass Injection site pain Injection site pruritus Injection site urticaria Injection site warmth

Symptomtext

large, sore, tender lump for 3 weeks at the injection site, Started on 4/27/22 through 5/18/22. Bruised, itchy, warm to the touch, hives. time took its course, along with Benadryl, Ibuprofen and Tylenol for pain and ice. Advised my personal doctor and had local County Health took a look at it on 5/6/22 and they advised me to file a vaers report because this wasn't a normal reaction. That I have an allergy/side effect to it

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
ankylose spondylitis, fibromyalgia, PCOS, DDD thoracic, cervical and lower lumbar, Diabetes type 2, hypothyroid
Andere Medikamente
Ibuprofen, vitamin D
Allergien
sulfa, levaquin, latex, mango and shrimp
Vorherige Impfungen
-

VAERS 2502128

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
41,0
Geschlecht
F
Eingang
08.11.2022
Impfdatum
20.12.2020
Beginn
20.12.2020
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Antinuclear antibody negative Antinuclear antibody positive Arthralgia Blood test normal Cardiolipin antibody positive Complement factor C3 Complement factor C4 Crepitations Differential white blood cell count normal Double stranded DNA antibody Full blood count normal Gait inability Immunisation reaction Impaired driving ability Impaired work ability Joint range of motion decreased Laboratory test normal Loss of personal independence in daily activities

Symptomtext

Severe post-COVID 19 vaccine polyarthritis Within 10 hours of receiving the first mRNA Pfizer vaccine, I experienced joint pain and crepitus in the cervical spine, right shoulder, left hip, bilateral knees, and left foot. The pain lasted 3-4 days. 4-5/10 pain Within 10 hours of receiving the second mRNA Pfizer vaccine, I experienced joint in the same joints, but the pain lasted 3 to 4 months. By July 2020, I experienced recurrence of the symptoms every 2 weeks. The pain was 4-5/10. My rheumatologist said the phenomenon of experiencing a flare up of my symptoms months after the vaccine was called "immunologic echo." Because I experienced these symptoms 10 hours after receiving the mRNA vaccine, he said it was probably a vaccine reaction. He also said it could be but less likely reactive arthritis. He said I could never take another mRNA vaccine again. Because I am a health care worker, mandatory COVID 19 booster shot was needed. So I had a Janssen booster, dsDNA. Within 10 hours, I experienced intense pain in all the joints described above and in addition a new symptom of joint pain, crepitus, and decreased motion of my left hand joints. This pain was intense 8/10, and required pain medications daily for 3 months (alternative motrin, tylenol, and occasional benadryl). I could not walk, drive, type, sleep well, and do usual activities. I had to take medical disability leave and needed physical therapy. My joint pain significantly improved within 6 months and depression symptoms within 10 months. My rheumatologist said he has confidence that I will make full recovery. My autoimmune work up and laboratory blood work were normal, only the ANA and anti-cardiolipin antibodies were positive.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
UA, CBC w/ diff, C4, C3, B2 glycoprotein, anti-La, anti-Ro, anti-Sm, anti-dsDNA, anti TPO, CMP were all normal ANA and anticardiolipin antibodies were positive . ANA 1:640 positive, homogeneous and fine speckled.
Aktuelle Erkrankungen
None
Vorgeschichte
Migraines
Andere Medikamente
None
Allergien
Bactrim, body rash
Vorherige Impfungen
-

VAERS 2400373

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
-
Geschlecht
F
Eingang
24.09.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Anosmia COVID-19 Cough Dizziness Headache Off label use Suspected COVID-19 Pyrexia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

This spontaneous report received from a patient concerned a female of unspecified age, race and ethnicity. Initial information was processed along with the additional information received on 22-SEP-2022. The patient's height, and weight were not reported. The patient's concurrent conditions included: drug allergy (polyethylene glycol). The patient previously received dose 1 with covid-19 vaccine ad26.cov2.s (Dose number in series 1), (suspension for injection, route of admin, batch number and expiry date were not reported) dose was not reported, 1 total administered on 28-APR-2021 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination (Dose number in series 1). The patient previously received dose 2 with covid-19 vaccine ad26.cov2.s (Dose number in series 2), (suspension for injection, route of admin, batch number and expiry date were not reported) dose was not reported, 1 total administered on 25-OCT-2021 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination (Dose number in series 2). The patient received dose 3 with covid-19 vaccine ad26.cov2.s (Dose number in series 3), (suspension for injection, route of admin not reported, batch number: 1855191 expiry: UNKNOWN) dose was not reported, 1 total administered on 02-MAY-2022 for covid-19 prophylaxis which was an off label dosing frequency (Dose number in series 3). The drug was associated with Off label use. No concomitant medications were reported. On 01-JUL-2022, 2 months after dose 3, the patient experienced suspected covid-19 infection (Dose number in series 3), and went to hospital for an infusion of monoclonal antibodies. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the off label dosing frequency and suspected covid-19 infection was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000252542. Sender's Comments: V0-20220943780-covid-19 vaccine ad26.cov2.s-Suspected Covid-19 infection. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Drug allergy (polyethylene glycol)
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2400373

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
-
Geschlecht
F
Eingang
24.09.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Anosmia COVID-19 Cough Dizziness Headache Off label use Suspected COVID-19 Pyrexia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

This spontaneous report received from a patient concerned a female of unspecified age, race and ethnicity. Initial information was processed along with the additional information received on 22-SEP-2022. The patient's height, and weight were not reported. The patient's concurrent conditions included: drug allergy (polyethylene glycol). The patient previously received dose 1 with covid-19 vaccine ad26.cov2.s (Dose number in series 1), (suspension for injection, route of admin, batch number and expiry date were not reported) dose was not reported, 1 total administered on 28-APR-2021 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination (Dose number in series 1). The patient previously received dose 2 with covid-19 vaccine ad26.cov2.s (Dose number in series 2), (suspension for injection, route of admin, batch number and expiry date were not reported) dose was not reported, 1 total administered on 25-OCT-2021 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination (Dose number in series 2). The patient received dose 3 with covid-19 vaccine ad26.cov2.s (Dose number in series 3), (suspension for injection, route of admin not reported, batch number: 1855191 expiry: UNKNOWN) dose was not reported, 1 total administered on 02-MAY-2022 for covid-19 prophylaxis which was an off label dosing frequency (Dose number in series 3). The drug was associated with Off label use. No concomitant medications were reported. On 01-JUL-2022, 2 months after dose 3, the patient experienced suspected covid-19 infection (Dose number in series 3), and went to hospital for an infusion of monoclonal antibodies. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the off label dosing frequency and suspected covid-19 infection was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000252542. Sender's Comments: V0-20220943780-covid-19 vaccine ad26.cov2.s-Suspected Covid-19 infection. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Drug allergy (polyethylene glycol)
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2442908

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
-
Alter
93,0
Geschlecht
F
Eingang
13.09.2022
Impfdatum
23.11.2021
Beginn
06.09.2022
Tage bis Beginn
287,0
Dosis
2
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Abdominal pain Asthenia Diarrhoea Nausea Pyrexia Vomiting

Symptomtext

fever, abdominal pain, diarrhea, nausea, vomiting, weakness

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2440660

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
MI
Alter
40,0
Geschlecht
F
Eingang
12.09.2022
Impfdatum
03.01.2022
Beginn
10.09.2022
Tage bis Beginn
250,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pyrexia Respiratory tract congestion

Symptomtext

FEVER, AND CONGESTION.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2405651

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CT
Alter
59,0
Geschlecht
M
Eingang
09.08.2022
Impfdatum
30.06.2022
Beginn
14.07.2022
Tage bis Beginn
14,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Asthenia Balance disorder Deafness Dizziness Ear discomfort Feeling abnormal Gait disturbance Heart rate increased Hyperacusis Nausea Photophobia Tinnitus Vertigo

Symptomtext

Working at my computer about two weeks after the shot and I suddenly had pressure and tinnitus in my left ear and hearing loss. Also nausea and dizziness in my head. The world started spinning, I lost all of my balance, I could not keep my eyes open to see and was hyper sensitive to noise and light. Wasn't sure if I was having a stroke or if it was something else. Pre shot my standing pulse for decades was always 56 to 60. Post shot it usually 77. It was about 85 at the time of the event. I had no balance and the only way I could make it up the stairs was to grab things nearby and hold the rail and keep my eyes closed. I stumbled to our bed and called my wife to come check on me. After about one hour I determined I had severe Vertigo. The entire world was spinning if I opened my eyes and I had no balance. Hyper sensitive to light and noise. This lasted from 5.45 p.m. until 2 a.m. when I was finally able to open my eyes a bit and stumble to the kitchen to get a drink of water. The next morning my head was still nauseas. As I write this I do not feel right. I still have head related nausea and imbalance though it's not as severe as the day of the event. I'm still alive and thankful for that but I feel awful. I have not felt right or myself since having the shot and my standing pulse has gone from 56 to 77. I have ongoing Vertigo though it's not as severe as the day I was completely debilitated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
Stage 4 Cancer survivor of 5 years (cancer free) having undergone 37 radiations and 7 chemos.
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2370040

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
OH
Alter
37,0
Geschlecht
M
Eingang
15.07.2022
Impfdatum
25.06.2022
Beginn
28.06.2022
Tage bis Beginn
3,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pyrexia Rash

Symptomtext

RASH ON NECK; FEVER; This spontaneous report received from a parent concerned a 37 year old male of an unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: autism, diabetes type 2, and inherited high cholesterol. The patient was previously received covid-19 vaccine ad26.cov2.s (Unspecified manufacturer) (Dose number in series: 1) (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, 1 in total administered on an unspecified date for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with initial dose of covid-19 vaccine ad26.cov2.s (Unspecified manufacturer) (Dose number in series: 1). The patient received booster dose of covid-19 vaccine ad26.cov2.s (Dose number in series: 2) (suspension for injection, route of admin not reported, batch number: 1855191 and expiry: Unknown) dose was not reported, 1 in total administered in right arm on 25-JUN-2022 for prophylactic vaccination. Age at time of vaccination 37 years old. Concomitant medications included atorvastatin calcium, fluoxetine hydrochloride, and metformin. On 28-JUN-2022 post vaccination with covid-19 vaccine ad26.cov2.s, the patient experienced fever (Dose number in series: 2) and was resolved approximately 3 days later (JUL-2022). On 02-JUL-2022 (Week after the vaccination), the patient experienced rash on neck (Dose number in series: 2). It was reported that rash was resolved and repapered on 08-JUL-2022 (3 days ago). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on JUL-2022, and had not recovered from rash on neck. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Autism; Hypercholesterolaemia; Type II diabetes mellitus
Vorgeschichte
-
Andere Medikamente
METFORMIN; LIPITOR; PROZAC
Allergien
-
Vorherige Impfungen
-

VAERS 2327025

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
TX
Alter
37,0
Geschlecht
M
Eingang
22.06.2022
Impfdatum
21.12.2021
Beginn
01.03.2022
Tage bis Beginn
70,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Ageusia Anosmia Chills Cough Diarrhoea Eye pruritus Fatigue Headache Influenza virus test negative Lacrimation increased Nasal congestion Pain Productive cough Rhinorrhoea SARS-CoV-2 test negative Sinus pain Streptococcus test negative

Symptomtext

Extreme fatigue, body aches, chills, nasal congestion, headache, itchy watery eyes, cough- dry and wet, loss of taste and smell, sinus pain, nasal discharge, diarrhea. In a 2 month span I went back and forth to the doctor because it was lingering on and on. Dr. prescribed cough medication, antibiotics and pain medication.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
I tested negative for COVID. All the tests kept coming back negative Flu and strep - both negative
Aktuelle Erkrankungen
no I don't believe so
Vorgeschichte
sinusitis
Andere Medikamente
I wasn't taking anything
Allergien
I don't so
Vorherige Impfungen
-

VAERS 2323040

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
37,0
Geschlecht
F
Eingang
17.06.2022
Impfdatum
16.06.2022
Beginn
16.06.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Malaise Vertigo

Symptomtext

Employee sent an email on 06/16/2022 @ 1126 complaining of "feeling very dizzy, room spinning, like I had a of alcohol kind of spinning, It is making me feel like I'm going to be sick" Employee was called right away. She was able to speak in full sentences without any difficulty. She did not complain of shortness of breath or any other adverse effects. She wanted to know who long the dizziness will last. I explained that one of the adverse effect of Janssen was dizziness, no information was given about the duration of the dizziness. I offered to call an ambulance if she is not well, but she declined.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2301541

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
FL
Alter
89,0
Geschlecht
F
Eingang
28.05.2022
Impfdatum
05.01.2022
Beginn
08.01.2022
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dementia Alzheimer's type Vomiting

Symptomtext

Three days after receiving the Janssen booster dose, she vomited twice at 4:25 AM while in be supine in bed with the head elevated a few inches. Amount was one large and one medium emesis, brown and watery. Temp. was 98.1. At 5:00 AM she vomited again, a small amount of the same description. Then at 6:00 AM she vomited again, a small amount of mainly saliva. After cleaning her up, she was back asleep by 7:30 AM and no further problems. Temp. 98.0. This is a major concern because my mother is not able to manage any emesis or call /signal for assistance, due to her Alzheimer's. She could have choked/aspirated. I just happened to be watching her on camera from the next room, and noticed that something looked amiss.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vomiting
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
Alzheimer's disease; hypothyroidism
Andere Medikamente
Levothyroxine 0.05 mg
Allergien
none
Vorherige Impfungen
-

VAERS 2268105

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
57,0
Geschlecht
F
Eingang
09.05.2022
Impfdatum
12.01.2022
Beginn
16.04.2022
Tage bis Beginn
94,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Full blood count Rash Rash macular

Symptomtext

On April 16, I noticed tiny red spots on both lower legs. Covering the fronts and lower sides of both legs. Since then, I have noticed the spots fading away, then coming back. No treatment yet. I sent an email to my PCP today for advice, because they are still there.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
CBC May 7, 2022.
Aktuelle Erkrankungen
None.
Vorgeschichte
High Cholesterol and Depression.
Andere Medikamente
Celexa 20 mg daily. Lipitor 40 mg daily.
Allergien
None.
Vorherige Impfungen
-

VAERS 2262334

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
NJ
Alter
46,0
Geschlecht
F
Eingang
03.05.2022
Impfdatum
20.12.2021
Beginn
20.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain in extremity

Symptomtext

Patient states that arm has been sore ever since she had vaccine .

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
unknown
Allergien
np
Vorherige Impfungen
-

VAERS 2218123

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
VA
Alter
29,0
Geschlecht
M
Eingang
06.04.2022
Impfdatum
20.12.2021
Beginn
22.01.2022
Tage bis Beginn
33,0
Dosis
3
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia COVID-19 Fatigue Inspiratory capacity decreased Interchange of vaccine products SARS-CoV-2 test positive

Symptomtext

I underwent a PCR test on 1/19/2022. On 1/22/2022, I received a text message alert that informed me I had tested positive. I self-isolated at home for about a week afterwards. I normally do Wim Hof exercises to help with my breathing, as I have asthma. I noticed during this time, though, that my exercise performance declined a little. More specifically, I was able to breathe less deeply for less time. I'm normally able to hold my breath for 2 minutes, but during my illness, I was only about to hold it for 45 seconds or less. Overall, I felt weaker and more fatigued. I normally exercise, but I didn't that week. I took all of my usual supplements, but I refrained from taking the Valacyclovir I usually take, since it is an immunosuppressant.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Herpes simplex virus 2; Bronchial asthma
Andere Medikamente
Valacyclovir; Lysine; Glucosamine chondroitin; Quercetin; Omega-3 Fish Oil; Ligaplex 1.
Allergien
None
Vorherige Impfungen
I developed shingles after getting my second dose of Pfizer COVID-19 vaccine.

VAERS 2212978

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
NY
Alter
-
Geschlecht
F
Eingang
02.04.2022
Impfdatum
-
Beginn
30.11.2021
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Insomnia Pain Pain in extremity Rash macular SARS-CoV-2 antibody test SARS-CoV-2 test

Symptomtext

COVID-19; RASH ON BOTH LEGS AND ARMS/RED BLOTCHES RASH; COULD NOT SLEEP; BODY ACHES; PAINS IN ARMS AND LEGS; This spontaneous report received from a patient concerned a 68-year-old female. Initial information was processed along with the additional information received on 30-MAR-2022. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received with covid-19 vaccine ad26. cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 205A21A and expiry: unknown) dose was not reported, 1 total administered on 10-APR-2021 to left arm for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (dose number in series 1). The patient received booster dose of covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191 and expiry: unknown) dose was not reported, 1 total, administered on 30-NOV-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 30-NOV-2021 (night the patient received the booster), patient had pain in arms and legs the and she could not sleep and had body aches (dose number in series 2). The patient developed red blotches rash within 2 days (02-DEC-2021) of her booster vaccination (dose number in series 2). As the days went by, within 7 days, it was bad enough that patient went to see a doctor on 07-DEC-2021. Patient saw the doctor and the doctor said that this was not a reaction to the shot and she gave her hydrocortisone cream and loratadine (Claritin) once a day. On 14-DEC-2021, patient again saw another doctor and the doctor said that she did not think it was related to the booster shot and recommended for her to see the dermatologist. In less than a week time, 20-DEC- 2021, patient saw the dermatologist and told the dermatologist that she felt that she got it because of the vaccine but the dermatologist mentioned hearing about loss of hair but not that rash. Patient reported that, exactly a month later she got Covid-19 on 30-DEC-2021 but it did not kill her as per caller (dose number in series 2). Patient tested positive with rapid test and also with polymerase chain reaction (PCR) on 30-DEC-2021. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from rash on both legs and arms/red blotches rash, and the outcome of could not sleep, body aches, pains in arms and legs and covid-19 was not reported. This report was non-serious. This report was associated with product quality complaint: 90000223840. The suspected product quality complaint has been confirmed to be voided. A product quality complaint was reported for the booster only so PQMS 90000223840 was updated to document the investigation for booster dose 30-NOV-2021 (lot number 1855191). Product quality complaint 90000223841 would be voided as a duplicate based on the PQC evaluation/investigation performed. This case, from the same reporter is linked to 20220362290, 20220363110, 20220362527 and 20220362219.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure since case was assessed as non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
Test Date: 20211230; Test Name: SARS-CoV-2 PCR test; Result Unstructured Data: Positive; Comments: Positive; Test Date: 20211230; Test Name: SARS-CoV-2 rapid antibody test; Result Unstructured Data: Positive; Comments: Positive
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2211248

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
GA
Alter
57,0
Geschlecht
F
Eingang
01.04.2022
Impfdatum
03.12.2021
Beginn
17.12.2021
Tage bis Beginn
14,0
Dosis
2
Route/Site
SYR / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Eye irritation Eye pain Eye pruritus Periorbital swelling Scleritis Swelling face

Symptomtext

Starting 2 weeks after receiving the vaccine, I woke up with an itching sensation and slight burning in my left eye. 2 days later, it continued to get red and puffy. So, I went to the optometrist and they gave me an antibiotic eye drop. 2 days later, it got worse and my face started swelling and my eye was very painful. I went back to the optometrist and they sent me to an eye specialist. Doctor's associate saw me and started me on another antibiotic eye drop. She had me see the other doctor a few days to a week later. Then I started seeing him every 2 weeks until recently. He ended up putting me on oral prednisone and prednisolone eye drops. He diagnosed it as scleritis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Eye pain
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
High blood pressure and Rheumatoid Arthritis
Andere Medikamente
Diovan, Propranolol, Atorvastatin, Fish Oil (occasionally) and Humira injection every 2 weeks
Allergien
None
Vorherige Impfungen
pneumococcal vaccine 15yrs ago caused arm swelling and redness

VAERS 2189146

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
20,0
Geschlecht
F
Eingang
19.03.2022
Impfdatum
19.03.2022
Beginn
19.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Headache Vomiting

Symptomtext

pt felt dizzy minutes after the vaccine, started vomiting, and had a headache. but all symptoms went away after a few minutes. Pharmacy called 911 and paramedic came in and measured her vitals, all were normal, and they left. no treatment was given and she was not taken to the hospital.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
-
Allergien
nka
Vorherige Impfungen
-

VAERS 2177376

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
PA
Alter
40,0
Geschlecht
F
Eingang
13.03.2022
Impfdatum
08.03.2022
Beginn
10.03.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site induration Injection site pruritus Injection site swelling Injection site warmth

Symptomtext

Patient stated she has a warm, red, itchy bump/hard spot on her arm where injection given.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2170902

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
NC
Alter
54,0
Geschlecht
M
Eingang
10.03.2022
Impfdatum
13.12.2021
Beginn
13.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Impaired work ability Loss of personal independence in daily activities Vertigo

Symptomtext

dizziness / vertigo .... mild symptoms for about 3 weeks ... not incapacitating but enough to disrupt day and interfere with work .... symptoms resolved but have since returned in the form of more significant vertigo for the past 4 weeks

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
i have not sought formal medical care to date, symptoms are improving gradually
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
possibly codeine
Vorherige Impfungen
-

VAERS 2170875

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
VA
Alter
48,0
Geschlecht
M
Eingang
10.03.2022
Impfdatum
13.01.2022
Beginn
13.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Pain in extremity

Symptomtext

The injection site, (left arm) is still sore and has occasional pain in it. was told that it would be a few days, is now a few months. no treatment yet... hopefully this pain in the arm will go away, will mention it to my doctor next time I have an appointment. Worried about why there is still arm pain?

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
acyclovir 200 mg
Allergien
none
Vorherige Impfungen
-

VAERS 2140488

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
78,0
Geschlecht
M
Eingang
25.02.2022
Impfdatum
27.01.2022
Beginn
06.02.2022
Tage bis Beginn
10,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Arthralgia Atrophy Bursitis Extra dose administered Joint range of motion decreased Magnetic resonance imaging normal Muscle contractions involuntary Muscular weakness Vaccination complication

Symptomtext

3 days of mild left should pain following the vaccine which he said felt typical that pain resolved. On the 10th day following vaccination with the J&J he developed severe left shoulder pain and thought that maybe he had a rotator cuff injury. He was seen for that with an MRI which was negative but then developed muscle weakness, fasciculations, atrophy, decreased range of motion. The pain has gone down a bit but has been there ever since and his neurologist believes that it is Subacromial-subdeltoid bursitis related to the vaccine possibly Parsonage-Turner Syndrome (PTS).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
MRI unknown date
Aktuelle Erkrankungen
none
Vorgeschichte
Neutropenia
Andere Medikamente
-
Allergien
none
Vorherige Impfungen
-

VAERS 2136990

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
NC
Alter
61,0
Geschlecht
M
Eingang
24.02.2022
Impfdatum
16.02.2022
Beginn
16.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Atrial fibrillation Diarrhoea Electrocardiogram Heart rate irregular

Symptomtext

Irregular heartbeat beginning around 7:45 PM 02/16/2022 First sign of Atrial Fibrillation at 9:40 PM 02/16/2022 Continued irregular heart beat and either inconclusive ECG and intermittent Atrial Fibrillation continued until 8:00 am 02/18/2022 Irregular heartbeat returned with inconclusive ECG at 10:00 PM 02/18/2022 and continued until 8:45 PM 02/19/2022 Diarrhea began at 07:15 am 08/17/2022 and continued until 8:30 am 02/19/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
Samsung Smart Watch 4 used for all ECGs
Aktuelle Erkrankungen
Second positive Covid-19 Feb-02-2022
Vorgeschichte
None
Andere Medikamente
-
Allergien
Penicillian
Vorherige Impfungen
-

VAERS 2134262

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
PA
Alter
35,0
Geschlecht
F
Eingang
23.02.2022
Impfdatum
07.02.2022
Beginn
07.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fatigue Headache Nausea Pain in extremity

Symptomtext

Extreme lower leg pain 14 hours after the injection. Headache, extreme fatigue, nausea.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2129344

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
65,0
Geschlecht
M
Eingang
21.02.2022
Impfdatum
18.02.2022
Beginn
19.02.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pain in extremity

Symptomtext

101.2 F Temperture, left arm pain, lasted approximately 14 hours.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
aspirin 81 mg, lisinopril 5 mg, atorvastatin 40 mg
Allergien
None
Vorherige Impfungen
-

VAERS 2128317

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
NY
Alter
28,0
Geschlecht
F
Eingang
19.02.2022
Impfdatum
17.02.2022
Beginn
18.02.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy Injection site erythema Injection site pain Injection site pruritus Injection site swelling Injection site warmth Skin lesion

Symptomtext

Swelling, redness, warmth, itching and pain surrounding injection site. Lesion is about 2.5 inches in diameter. 18 weeks pregnant at time of vaccination. Pregnancy has been uncomplicated prior to vaccination. No known complications at this time post-vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
Janssen covid vaccine; received 9/11/21; fever and malaise.

VAERS 2119708

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
24,0
Geschlecht
F
Eingang
17.02.2022
Impfdatum
17.02.2022
Beginn
17.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Vomiting

Symptomtext

At 1206 while in observation client asked EMT for the restroom and stated she needed to ?throw up?. Client was given an emesis bag. Client stepped outside and sat in gravity chair without assistance. Vitals were taken. Client informed RN that this is a ?normal thing, and it happens all the time? Client gets anxious with vaccines and ?anything medical.? Client informed RN that?s happened with other vaccines. Client denied itchiness, or shortness of breath. At 1213 client stated she felt much better after vomiting and denied having a headache or stomach pain. Client had breakfast before vaccine. Client had one vomiting episode and stated she had chills before vomiting but denied dizziness. Vitals at 1233 BP 99/57 HR 57 02 98% RR 16. Client stated she was feeling ?good? and denied any other symptoms. RN educated client on emergency precautions, and to follow up with her primary care provider. Client verbalized understanding. Client was able to stand from zero gravity chair without assistance and denied any dizziness. Client left vaccination site at 1236 in a steady gait.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none reported
Vorgeschichte
none reported
Andere Medikamente
none
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2115631

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
FL
Alter
-
Geschlecht
F
Eingang
16.02.2022
Impfdatum
-
Beginn
04.02.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Bone pain Cough Fatigue Joint noise Myalgia Pain Physical examination Pyrexia SARS-CoV-2 test

Symptomtext

HEARING A NOISE FROM THE BONES WHEN MOVING HER LEGS WHILE GETTING UP FROM A LYING DOWN OR SEATED POSITION FOR A PERIOD OF TIME; COUGH; PAIN IN THE BONES; PAIN ALL OVER THE BODY; FEVER; PAIN IN THE MUSCLES; FEELING REALLY TIRED; NO ENERGY TO DO ANYTHING; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included: covid-19. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: UNKNOWN) dose was not reported, administered on 04-FEB-2022 10:00 for prophylactic vaccination. No concomitant medications were reported. On JUL-2020, Laboratory data included: COVID-19 virus test (NR: not provided) positive. On 14-JAN-2022, Laboratory data included: Physical examination (NR: not provided) doing very well. On 04-FEB-2022, the patient experienced pain in the bones, pain all over the body, fever, pain in the muscles, feeling really tired, and no energy to do anything. On 10-FEB-2022, the patient experienced cough. On an unspecified date, the patient experienced hearing a noise from the bones when moving her legs while getting up from a lying down or seated position for a period of time. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 06-FEB-2022, and had not recovered from cough, hearing a noise from the bones when moving her legs while getting up from a lying down or seated position for a period of time, pain in the muscles, feeling really tired, pain in the bones, pain all over the body, and no energy to do anything. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bone pain
Hospital-Tage
-
Labordaten
Test Date: 202007; Test Name: COVID-19 virus test; Result Unstructured Data: positive; Test Date: 20220114; Test Name: Physical examination; Result Unstructured Data: doing very well
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: COVID-19
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2113155

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
TN
Alter
48,0
Geschlecht
M
Eingang
15.02.2022
Impfdatum
31.01.2022
Beginn
31.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Bone pain Burning sensation Epistaxis

Symptomtext

Patient stated he had bone and joint pain, a burning sensation, and excessive nose bleeding.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
-
Allergien
Latex
Vorherige Impfungen
-

VAERS 2109674

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
AZ
Alter
45,0
Geschlecht
M
Eingang
13.02.2022
Impfdatum
08.02.2022
Beginn
08.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Headache Joint stiffness Musculoskeletal stiffness Pyrexia Stomatitis

Symptomtext

Jaw stiffness for 5 days Development of numerous mouth sores Fever for 1 day Frequent headaches for 5 days Back stiffness for 5 days

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2104980

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
47,0
Geschlecht
F
Eingang
11.02.2022
Impfdatum
15.01.2022
Beginn
21.01.2022
Tage bis Beginn
6,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dermatitis allergic Rash

Symptomtext

Severe allergic rash all over body for 3+ weeks. Have been to urgent care twice, 2 rounds of steroid injections, prednisone pills (taper packs), zyrtec, tylenol, pepcid AC, and aquaphor daily. Very little improvement. Had and recovered from long-term COVID-19 disease in December, 2020 - January 2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
None
Vorgeschichte
High Blood Pressure, Obesity, Generalized Anxiety, History of gallbladder removal
Andere Medikamente
Cymbalta (60mg/day), Lisinopril (40mg/day)
Allergien
Sulpha drugs, cats, dust, mold
Vorherige Impfungen
Swollen arm at injection site for several weeks and no period for 3 months.

VAERS 2099704

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
54,0
Geschlecht
F
Eingang
09.02.2022
Impfdatum
28.01.2022
Beginn
31.01.2022
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Arthralgia Feeling abnormal Gait inability Loss of personal independence in daily activities

Symptomtext

PATIENT CALLED THE PHARMACY ON 02/09/2022, SHE WAS ASKING WHAT MEDICATION SHOULD SHE TAKE FOR THE CLOT. I ASKED WHY IS SHE SUSPECTING OF A CLOT. SHE SAID THAT SHE GOT HER BOOSTER ON 01/28/2022 AT OUR PHARMACY AND AFTER 2 DAYS SHE CANNOT WALK AND HAVE SEVERE HIP PAIN. SHE ALSO COMPLAINED ABOUT HAVING BRAIN FOG AND DOING UNUSUAL THINGS AND CANNOT PERFORM USUAL TASK. I ADVISED HER TO GO SEE A DOCTOR SO HER SYMPTOMS COULD BE ASSESSED BETTER OR A LAB WORK COULD BE DONE. AND IF HER SYMPTOMS WORSEN, GO TO URGENT CARE.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
UNKNOWN
Allergien
NKA
Vorherige Impfungen
-

VAERS 2098190

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
NH
Alter
-
Geschlecht
M
Eingang
09.02.2022
Impfdatum
-
Beginn
11.04.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pain in extremity

Symptomtext

SORE ARM; This spontaneous report received from a patient concerned a 57 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: hypertension, alcohol use, and non-smoker, and other pre-existing medical conditions included: Patient has no known drug allergies, patient has no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, the patient experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm on 12-APR-2021. This report was non-serious. This case, involving the same patient is linked to 20220210630.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Alcohol use (occasionally); Hypertension; Non-smoker
Vorgeschichte
Comments: Patient has no known drug allergies, patient has no drug abuse or illicit drug usage
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2092453

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
NY
Alter
39,0
Geschlecht
F
Eingang
07.02.2022
Impfdatum
13.12.2021
Beginn
14.12.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Headache

Symptomtext

I received my Covid vaccine on 12/13/2021 at pharmacy. I felt very tired after and went home and slept. The next day when I woke up around noon, I had a severe headache. This headache continues nonstop since then. Before this, I have never had one headache. This vaccine has ruined my life.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
None because I cannot even function I notified my doctor he said to report it to VAERS
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2091528

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
IL
Alter
30,0
Geschlecht
M
Eingang
05.02.2022
Impfdatum
05.02.2022
Beginn
05.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Depressed level of consciousness Dizziness Hyperhidrosis

Symptomtext

After receiving vaccine, patient started getting dizzy and sweaty. Patient was given water and graham crackers, but patient continued to be warm. Staff had patient lay down and was given ice packs on the back of the neck. Feet were up on a chair while patient was laying. Patient became more alert and felt better and was speaking. The fire department came and took him in the ambulance. He was able to stand and sit in the chair.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
B/p initial right arm 124/82, second set ten minutes later 110/86
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2086188

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
WA
Alter
47,0
Geschlecht
M
Eingang
03.02.2022
Impfdatum
02.02.2022
Beginn
02.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Immediate post-injection reaction Pharyngeal swelling Pruritus Throat irritation

Symptomtext

Patient started having an itchy arm immediately after the injection. In 15-20 minutes he had an itchy throat and some swelling. 911 was called. Medics responded and assessed patient. Patient went to the ER and was treated with Benadry and prednisone and sent home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
unknown
Aktuelle Erkrankungen
hypothyroid
Vorgeschichte
hypothyroid
Andere Medikamente
NP thyroid
Allergien
Tdap
Vorherige Impfungen
Tdap

VAERS 2085250

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
PA
Alter
19,0
Geschlecht
M
Eingang
03.02.2022
Impfdatum
03.01.2022
Beginn
03.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Goitre Headache Lymphadenopathy Magnetic resonance imaging Myalgia Pyrexia

Symptomtext

1st dose given 6/29/21 resulted in headache, swollen glands in neck and extreme muscle aches in neck and shoulder up to top of head. Gave Tylenol for 2 to 3 days. 2nd dose given 1/3/22 resulted in same symptoms as above but also with much worse headache, swollen thyroid and fever for 3 days. Gave Tylenol for 3 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
Doctor noticed enlarged thyroid before 2nd shot and ordered MRI. MRI was done after 2nd shot on1/6/22. Thyromegaly. Thyroid enlargement.
Aktuelle Erkrankungen
-
Vorgeschichte
none
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
3 month delay in speech/response,12mo.,yr2003,1st MMR shot,Merck

VAERS 2079488

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
50,0
Geschlecht
M
Eingang
01.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Disorientation Dizziness Fall Hyperhidrosis

Symptomtext

Patient approached RN in observation and stated he felt light headed. I directed patient to wheelchair but he fell to his knees immediately. RN helped patient to ground without injury. Patient diaphoretic and disoriented. Patient placed on stretcher and assessed. A&O x4. Denies pain. Vitals at 11:20 BP 89/50 Pulse 51 02 98% Vitals at 11:25 BP 96/58 Pulse 40 (epi pen ready to use and EMS ready to be called but pulse increased to high 40s) 02 98% Vitals 11:30 BP 116/75 Pulse 65 02 99% Vitals 11:40 BP 134/87 Pulse 69 02 97% Patient denies pain during reaction and is now fully alert and oriented x4. Patient no longer diaphoretic. Patient states he feels 100% back to normal. Son is with patient and states he will drive them home. Patient states he has had reactions like this in the past. I advised him to tell staff of his past reactions any time he is to be treated with a vaccine in the future. Patient advised to immediately seek medical attention if any further symptoms develop. Patient discharged from nursing care at 11:44

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
HTN uncontrolled, obesity
Andere Medikamente
none
Allergien
NKA
Vorherige Impfungen
patient states he had a similar but less severe reaction with his first dose

VAERS 2075916

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
OH
Alter
90,0
Geschlecht
M
Eingang
31.01.2022
Impfdatum
07.12.2021
Beginn
09.01.2022
Tage bis Beginn
33,0
Dosis
2
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Back pain Eye pain Headache Herpes zoster Neck pain Pain Rash Sacral pain

Symptomtext

Started having severe pain in eye, headache, pain in forehead, top and side of head, neck, shoulder, back, Went to eye doctor, 1/11/22 and diagnosed with shingles. Prescribed Valacyclovir 1 gm tablets. On 1/13 saw CNP and she prescribed Prednisone 20 mg for rash. Symptoms improved some and then worsened again by 1/27 with really severe pain. Called CNP and she prescribed Tramadol 50 mg. As of today, still having all symptoms as described above. (His daughter got same vaccine same day and was diagnosed with shingles on same day as he was, that is why we are reporting adverse reaction).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Back pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
High blood pressure, COPD, diabetes
Andere Medikamente
Entresto 49-51 mg; Breo Ellipta 100-25 MCG Oral INH(30); Tamsulosin 0.4 MG; Metoprolol ER Succinate 25 mg; Metformin 500MG; Multi-vitamin for men 50+; Bayer low dose 81 mg; Furosemide 20 mg; Potassium Chloride 20 meg ER; Pregabalin 75 mg; P
Allergien
none known
Vorherige Impfungen
-

VAERS 2075779

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
53,0
Geschlecht
F
Eingang
31.01.2022
Impfdatum
27.01.2022
Beginn
28.01.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Pain Pyrexia Vaccine positive rechallenge

Symptomtext

Chills, fever, body aches started at 2:30 AM (woke me up). I shivered for maybe 30 minutes before taking a hot bath. This helped with chills, but body aches got worse for the next 12 hours or so. My fever reached 100.7 F. All adverse effects ended within 24 hours of onset.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
Soy
Vorherige Impfungen
Same adverse events as reported above after initial J&J vaccine in April 2021 (age 52).

VAERS 2074743

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
PA
Alter
33,0
Geschlecht
F
Eingang
29.01.2022
Impfdatum
15.01.2022
Beginn
17.01.2022
Tage bis Beginn
2,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Limb injury Pain in extremity

Symptomtext

Hand on left arm now freezes in place after gripping (holding a fork to cut food) and can't release /relax hand. 1st event lasted about 2 minutes, 2nd event lasted about an hour. Arm feel weak after and is painful during the experience.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
I have an EMG scheduled in February.
Aktuelle Erkrankungen
None
Vorgeschichte
Hemochromatosis, obesity, asthma
Andere Medikamente
None
Allergien
Latex, egg, peanut, cephalaxin
Vorherige Impfungen
Gardicle, 20 unknown

VAERS 2070096

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
-
Alter
23,0
Geschlecht
F
Eingang
27.01.2022
Impfdatum
19.01.2022
Beginn
19.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Pruritus Rash Throat irritation Urticaria

Symptomtext

Client presented to the vaccination site on 1/19/2022. The client reported that she received a 1st and 2nd dose of Pfizer COVID vaccine. Client reported hives, rash, and itching all over her body accompanied by a scratchy throat immediately after both Pfizer doses that lasted until she took Benadryl. Lead RN submitted a medical consult via text message requesting to proceed with the COVID vaccine Janssen. Per MD, approval to proceed with COVID vaccine Janssen was obtained from medical consult team via text message. Client received COVID vaccine Janssen Lot# 1855191 on 1/19/2022. The client did not report any symptoms during the 30-minute observation period. Lead RN educated client on possible adverse reactions, when to seek medical care and to register. The client left the vaccination site at 15:15 with a steady gate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2062570

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
MI
Alter
77,0
Geschlecht
F
Eingang
25.01.2022
Impfdatum
06.12.2021
Beginn
20.01.2022
Tage bis Beginn
45,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Cough Dizziness Fatigue Headache Influenza A virus test Influenza B virus test Muscular weakness SARS-CoV-2 test

Symptomtext

muscle weakness, fatigue, some cough, dizziness, headache

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
SARS-CoV-2 (COVID-19) and Influenza AB by Nucleic Acid Amplification, POC
Aktuelle Erkrankungen
-
Vorgeschichte
? Arthritis ? CVA (cerebral vascular accident) (CMS/HCC) RT LEG WEAKNESS ? Diabetes mellitus ? Hypertension ? Obesity
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2058676

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
NC
Alter
49,0
Geschlecht
F
Eingang
24.01.2022
Impfdatum
12.01.2022
Beginn
17.01.2022
Tage bis Beginn
5,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Cough Headache Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

Positive Covid 19 diagnosed on 1/19/2022 Symptoms started 01/17/2022 with a chronic cough then head and some chest congestion, runny nose, headache. Head congestion became increasingly worse over following two days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
01/19/2022
Aktuelle Erkrankungen
-
Vorgeschichte
Chronic Sinusitis
Andere Medikamente
-
Allergien
Avelox
Vorherige Impfungen
-

VAERS 2058513

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CT
Alter
32,0
Geschlecht
F
Eingang
24.01.2022
Impfdatum
14.12.2021
Beginn
18.12.2021
Tage bis Beginn
4,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pruritus Rash Skin discolouration Urticaria

Symptomtext

Rash/Hives all over my whole entire body. Extreme itchiness. Legs look more like my skin was burned - large patches of red and purple. It has now been over a month and it is still persisting.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Blisovi, Vitamin D, Probiotics
Allergien
Cephalosporins, Nitrofurons, Flu Shot, Aspirin, Crustacean Shellfish
Vorherige Impfungen
Flu shot

VAERS 2058360

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
FL
Alter
60,0
Geschlecht
M
Eingang
24.01.2022
Impfdatum
14.12.2021
Beginn
12.01.2022
Tage bis Beginn
29,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein
Arthralgia Computerised tomogram Endoscopy Hypophagia Inflammation Decreased appetite Muscle atrophy Pain Weight decreased

Symptomtext

Same as last shot. Extreme inflamation in abdomin. Unable to consume enough caloris to maintain body weight. Patient lost over 50% muscle mass. Muscles seem to be disolving and due to pain in joints patient cannot exorcise enough to build back muscle mass lost. Patient has gone from 220lbs to 160 with no attenpt to lose weight. At this time patient has painfull swollen inflamed insides and is unable to consume more that 800- 1200 calories

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
Endoscopy, CAT scan
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
-
Allergien
none
Vorherige Impfungen
05/21/2021 Janssen Both Covid shots caused illness

VAERS 2057841

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
MI
Alter
28,0
Geschlecht
F
Eingang
23.01.2022
Impfdatum
14.12.2021
Beginn
14.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal pain Back pain Chills Headache Hyperhidrosis Malaise Pain Pain in extremity Pyrexia

Symptomtext

Full body pain starting in my lower back. Vaccine given at approx 1100AM, back pain started about 1800. Pain radiated to abdomen, upper back, legs, and head by 2000. Nonstop shivering and chills from 2000 throughout the night. Fever of 102.6?. Fever broke at about 0200 on 12/15/2021 and I began sweating profusely. Worst headache of my life started at this time; 10/10 pain. 1500mg Tylenol and 600mg Advil taken between midnight and 0300 to no avail. Generalized malaise remained throughout 12/15/2021. Symptoms subsided by following day, 12/16/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
MMR at age 15; arm swelled up significantly (red and painful to touch)

VAERS 2055441

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
MA
Alter
32,0
Geschlecht
M
Eingang
21.01.2022
Impfdatum
21.01.2022
Beginn
21.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Malaise Pallor

Symptomtext

Patient felt unwell and looked pale within 2 minutes of immunization. I elevated his legs and applied cold pack to neck. Patient's symptoms resolved within 10 minutes

Weitere VAERSDATA-Felder
Praegender Schweregrund
Malaise
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
-

VAERS 2050604

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
GA
Alter
32,0
Geschlecht
F
Eingang
20.01.2022
Impfdatum
18.01.2022
Beginn
18.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal discomfort Chills Headache Nausea Pyrexia Sleep disorder Vomiting

Symptomtext

Severe fever and chills began 4 hours after vaccine administration and lasted for 24 hours. Nausea, vomiting, and abdominal distress began 12 hours after administration. Vomiting ceased after 8 hours while nausea and abdominal distress are still present 48 hours after administration. Severe headache has been present since the fever and chills began and is resistant to any medication. Sleep is greatly disturbed and headache is still as bad as it was initially.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Citalopram
Allergien
None
Vorherige Impfungen
-

VAERS 2050093

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
54,0
Geschlecht
F
Eingang
20.01.2022
Impfdatum
-
Beginn
05.11.2021
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Chills Fatigue Injection site pain Myalgia Pyrexia

Symptomtext

PRETTY SEVERE JOINT PAIN; CHILLS; PRETTY SEVERE/EXTREME MUSCLE PAIN; FEVER; OVERALL FATIGUE; VERY MINOR INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 54 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received covid-19 vaccine ad26.cov2.s (dose number in series 1, unspecified manufacturer) (suspension for injection, route of admin not reported, batch number and expiry not reported) dose was not reported, 1 total, administered on an unspecified date for prophylactic vaccination. No adverse events reported post primary vaccination (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191, and expiry: 11-APR-2022) dose was not reported, 1 total, administered on 05-NOV-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. On 05-NOV-2021, for about 24-48 hours the patient experienced pretty severe muscle pain and joint pain, chills, fever and overall fatigue. She reported extreme muscle pain was still continuing currently and the other side effects went away. She was not sure about the injection arm and assumed left arm since she was right handed, no pain at injection site or might be very minor injection site pain (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pretty severe joint pain, chills, fever, overall fatigue, and very minor injection site pain on 07-NOV-2021, and had not recovered from pretty severe/extreme muscle pain. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2038475

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
IL
Alter
29,0
Geschlecht
F
Eingang
16.01.2022
Impfdatum
06.01.2022
Beginn
12.01.2022
Tage bis Beginn
6,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Rash

Symptomtext

PATIENT DEVELOPED A RASH APPROXIMATELY 6 DAYS LATER

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2038079

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
21,0
Geschlecht
F
Eingang
15.01.2022
Impfdatum
15.01.2022
Beginn
15.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Nausea

Symptomtext

After receiving the Janssen COVID-19 vaccine, the client became dizzy and nauseous while in observation. Our clinical staff helped the client to the ground and placed her in supine position with legs elevated. Patient recovered quickly and was helped to a wheelchair where she was given water and Gatorade. Client was monitored for an additional 30 minutes before she was able to leave with her family under her own power. Patient stated that needles made her anxious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
No Known Allergies
Vorherige Impfungen
-

VAERS 2034098

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
52,0
Geschlecht
F
Eingang
14.01.2022
Impfdatum
-
Beginn
30.12.2021
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Cough Feeling abnormal Oropharyngeal pain Pain Pain in extremity Secretion discharge Throat irritation

Symptomtext

SCRATCHY THROAT; SORE THROAT; COUGHING; WANT TO SPIT OUT MUCUS; BODY ACHING; FELT LIKE WORSE; LEGS AND KNEES HURT; FELT WEAK; SORE ARM; This spontaneous report received from a patient concerned a 52 year old white, not Hispanic or Latino female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously received covid-19 vaccine ad26.cov2.s (manufacturer not specified) (dose number in series 1) (suspension for injection, route of admin not reported, batch number: unknown, and expiry: unknown) dose was not reported, 1 total administered on unspecified date for prophylactic vaccination. The patient experienced unspecified adverse reaction when treated with covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient additionally received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191, and expiry: 11-APR-2022) dose was not reported, 1 total administered to left deltoid on 30-DEC-2021 for prophylactic vaccination. No concomitant medications were reported. On 30-DEC-2021, the patient experienced sore arm. On an unspecified date, the patient experienced scratchy throat, sore throat, coughing, want to spit out mucus, body aching, legs and knees hurt, and felt weak. The patient stated, she felt like worse after receiving booster (dose number in series 2) than before. Treatment medications (dates unspecified) included: Tylenol (paracetamol). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm, and had not recovered from scratchy throat, legs and knees hurt, felt weak, sore throat, coughing, want to spit out mucus, body aching, and felt like worse (dose number in series 2). This report was non-serious. This case, involving the same patient is linked to 20220116291.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Oropharyngeal pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2030953

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
VA
Alter
12,0
Geschlecht
F
Eingang
13.01.2022
Impfdatum
29.12.2021
Beginn
29.12.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Discomfort Headache Injection site pain Myalgia Product administered to patient of inappropriate age Visual impairment

Symptomtext

Patient was given 0.3mls of janssen but was intended to get pfizer

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2027092

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
OH
Alter
18,0
Geschlecht
M
Eingang
12.01.2022
Impfdatum
-
Beginn
06.01.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Back pain Testicular pain

Symptomtext

TESTICULAR PAIN; BACK PAIN/BACK FELT LIKE IT HAD NEEDLES IN IT; JOINT PAIN; This spontaneous report received from a patient concerned an 18 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: unknown) dose was not reported, administered on 06-JAN-2022 for prophylactic vaccination. No concomitant medications were reported. On 06-JAN-2022, the patient experienced joint pain, back pain/back felt like it had needles in it and testicular pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from joint pain, back pain/back felt like it had needles in it and testicular pain. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2554203

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
-
Alter
42,0
Geschlecht
F
Eingang
11.01.2022
Impfdatum
05.01.2022
Beginn
05.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Headache Myalgia

Symptomtext

Headache & Myalgia Narrative:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2025482

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
32,0
Geschlecht
F
Eingang
11.01.2022
Impfdatum
10.01.2022
Beginn
10.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal pain Dizziness Feeling hot

Symptomtext

1600: Noted patient fanning herself with paper. I approached and asked how she was feeling. Pt stated she felt dizzy and hot. Pt was given water, pt initially declined to lay on gurney in procedure room, but then changed her mind. Pt was able to ambulate to procedure room without assistance. Steady gait noted. Pt was given juice and crackers as well. Pt reported she was feeling slightly better as soon as she laid down. Pt also reported she would be starting her menses in the next few days and she had not eaten well today. Has been having intermittent dizziness since this morning. Pt stated she was nervous aobutNo rash, angioedema, difficulty breathing or throat closing sensation reported or noted. Will continue to monitor. 1615: Pt reports dizziness has resolved, continues to to feel hot though that has also improved. Pt states she just started having abdominal cramping 7/10 on scale, constant. BP 145/85 HR 67 SpO2 99% RA. 1624: I have contacted Dr. and given report on patients complaints and vital. Per Dr, pt will be kept in observation another 15-20 minutes and if she is feeling better she may be discharged home, if her condition does not change she will sent to urgent care. Read back completed. 1630: Pt reports she is feeling better. Cramping is now intermittent. No other symptoms reported at this time. 1640: Pt reports cramping continues to improve is almost resolved. 1643: Vitals rechecked. BP 111/76 HR 74. Pt denies any symptoms at this time. 1647: Pt discharged home. Pt was instructed to keep paperwork (EUA and What to Expect After Your Covid 19 Vaccination) in a safe place and to refer to it if she developed any sxs of severe allergic reaction such as swelling of the tongue, throat, face, difficulty breathing, SOB, generalized rash, abdominal pain, vomiting, dizziness and / or palpitations. In which case she should seek immediate medical attention. Pt verbalized understanding and left in stable condition without any complaints of any symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2011619

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
UT
Alter
43,0
Geschlecht
M
Eingang
06.01.2022
Impfdatum
21.12.2021
Beginn
30.12.2021
Tage bis Beginn
9,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Chills Decreased appetite Feeling abnormal Headache Impaired work ability Myalgia Pain Pyrexia

Symptomtext

Started 12/30/21 with chill and a headache that is currently on day seven. . Three days ago I added muscle and joint pain to my growing list of adverse reactions. It hurts everywhere in my body. I feel strange and have barely eaten anything over the past 3 days. I also have had a low grade fever of the past three days. I have had to call in sick for work for the past three days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2010867

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
MA
Alter
18,0
Geschlecht
M
Eingang
06.01.2022
Impfdatum
06.01.2022
Beginn
06.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dysstasia Hyperhidrosis Malaise

Symptomtext

within a few minutes of injection , patient was not feeling well, was sweating and could not stand . We sat him down, gave water, called EMS . Patient came around within a few minutes , emergency crew checked him but he refused additional medical care . Patient left after about 25 minutes and they said they felt fine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Malaise
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
no
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
no
Vorherige Impfungen
-

VAERS 2010650

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
AR
Alter
55,0
Geschlecht
M
Eingang
06.01.2022
Impfdatum
27.12.2021
Beginn
29.12.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site rash Rash

Symptomtext

Rash at site of injection two days after injection. Client took OTC benedryl that resolved local rash, but came back a couple of days later. He has reached out to his primary care for help with symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site rash
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Unknown
Vorgeschichte
PTSD Depression Insomnia
Andere Medikamente
Diclofenac Atorvastin Sertraline Folic acid Triamcinalone Trazadone
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2006292

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
-
Alter
30,0
Geschlecht
F
Eingang
05.01.2022
Impfdatum
06.12.2021
Beginn
10.12.2021
Tage bis Beginn
4,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pruritus Rash Urticaria

Symptomtext

DX: Urticaria- extremities, trunk Symptoms of severe itching, body rash began 4 days post vaccination, persistent hives for approximately 2 weeks, break through hives still present currently on upper extremities Treated with oral antihistamines, topical steroids

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Daily womens vitamin only
Allergien
Penicillin, sulfa drugs
Vorherige Impfungen
-

VAERS 2001013

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
VA
Alter
50,0
Geschlecht
F
Eingang
04.01.2022
Impfdatum
31.12.2021
Beginn
01.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Pruritus Rash Swelling of eyelid

Symptomtext

11:30 AM WOKE WITH BOTH EYES SWOLLEN NEARLY SHUT, RASH ON CHEST SHOWED UP ON 1/2/2022, SPREAD THROUGHOUT ENTIRE BODY OVER THE NEXT TWO DAYS, AWOKE DURING THE EVENINGS WITH SEVERE ITCHING ON BODY/EARS. IN AUGUST 2021, I CONTRACTED COVID AND WAS GIVEN A DOSE OF REGEN-COV AND WITHIN 2 MINS HAD A SEVERE REACTION (HEART RATE AND BLOOD PRESSURE DROPPED AND CHEST COMPRESSIONS WERE GIVEN). THE DOSAGE WAS STOPPED. IT WAS LISTED AS AN ADVERSE REACTION TO THE ANTIBODY TREATMENT

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
PREDNISONE, ALSO HAD AN ALLERGIC REACTION TO REGEN-COV IN AUG
Vorherige Impfungen
-

VAERS 2000294

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
-
Alter
21,0
Geschlecht
F
Eingang
03.01.2022
Impfdatum
02.01.2022
Beginn
02.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Dizziness Tinnitus

Symptomtext

Vaccinated: 11:17 am. Reaction: 11:27 am. Patient reported dizziness and ringing in ears. Vitals: 142/86, 84 and 18. Patient stabilized and released from vaccination site.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKA
Vorherige Impfungen
-

VAERS 2000253

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CT
Alter
53,0
Geschlecht
M
Eingang
03.01.2022
Impfdatum
03.01.2022
Beginn
03.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Nausea

Symptomtext

Patient felt dizzy, lightheaded and nauseous about 5 minutes after vaccination. Provided him with a bottle of water and sat with him for about 15 minutes more (20 minutes wait time total) until he felt well enough to leave.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1999123

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
IN
Alter
43,0
Geschlecht
F
Eingang
03.01.2022
Impfdatum
26.11.2021
Beginn
06.12.2021
Tage bis Beginn
10,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Axillary mass Breast swelling Erythema Inappropriate schedule of product administration Induration Interchange of vaccine products Lymphadenopathy Mammogram normal Pain Swelling Ultrasound scan normal

Symptomtext

I received Moderna on 02/16/21. Ten days later, a lump under my left arm of shot appeared. Over the next 2-3 weeks, the swelling in my lymph nodes spread into my breast and then to the right side. I rotated between ice and epsom salt baths. It was very swollen, red, and painful. I could not sleep well at night. Because the swelling was so bad, I did not get the second shot. I was given lab work, a mammogram, and an ultrasound. All came back normal. Called the Dr of the health board and they said not to give steroids as my "body was fighting it off." After some reading, I decided to take the J & J vaccine on 11/26/21, as it has different ingredients. I was worried as the numbers are so high. Similar to before, 10 days after the vaccine, my lymph nodes swelled up. A bit different was that instead of a slow spread, I awoke to both armpits with lymph nodes swollen. and lymph nodes in my breast swollen. There are hard lumps. I have rotated epsom salt baths and ice. They are still swollen. I have not seen anyone because I honestly don't know if they can do anything. It's very frustrating as a proper contact would be helpful.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
First swelling and vaccine I had a mammogram and ultra sound on 3/15/21. Results were normal.
Aktuelle Erkrankungen
n/a
Vorgeschichte
hypothryoidism
Andere Medikamente
Synthroid, Mulitvitamin, Antihistimine
Allergien
Penacillin
Vorherige Impfungen
-

VAERS 1996014

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
OH
Alter
29,0
Geschlecht
M
Eingang
31.12.2021
Impfdatum
30.12.2021
Beginn
30.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Dizziness Feeling abnormal Headache Hyperhidrosis Nausea Pain Pyrexia Vertigo

Symptomtext

Dizziness and vertigo one hour and twenty minutes after injection. Headache, body ache, fever, chills/sweats, nausea, and foggy thinking beginning twelve hours after injection.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 1994584

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
FL
Alter
-
Geschlecht
F
Eingang
31.12.2021
Impfdatum
-
Beginn
23.12.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Feeling abnormal Haemoptysis Headache Pain in extremity Paranasal sinus hypersecretion

Symptomtext

SINUS DRAINAGE; COUGH FROM SINUS DRAINAGE WITH BLOOD; FELT DRUGGED/FUZZY; SORE ARM; LOW ENERGY; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included: covid, and concurrent conditions included: penicillin allergy, drug allergy, ex-smoker, and non alcohol user, and other pre-existing medical conditions included: The patient had no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: 11-APR-2022) dose was not reported, administered on 22-DEC-2021 for prophylactic vaccination. No concomitant medications were reported. On 23-DEC-2021, the patient experienced sore arm, low energy, and headache. On 24-DEC-2021, the patient experienced felt drugged/fuzzy. On 28-DEC-2021, the patient experienced sinus drainage, and cough from sinus drainage with blood. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on 25-DEC-2021, was recovering from felt drugged/fuzzy, low energy, and sore arm, and had not recovered from sinus drainage, and cough from sinus drainage with blood. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Abstains from alcohol; Drug allergy (Cipro allergy); Ex-smoker (quit smoking 6 months ago); Penicillin allergy
Vorgeschichte
Medical History/Concurrent Conditions: COVID-19 (had covid earlier at the beginning of the year); Comments: The patient had no drug abuse or illicit drug usage.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1991626

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
PA
Alter
63,0
Geschlecht
F
Eingang
30.12.2021
Impfdatum
-
Beginn
19.12.2021
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Feeling cold Pain in extremity

Symptomtext

SORE ARM; EXTREMELY COLD AND COULDN'T GET WARM FOR ABOUT TWO AND HALF HOURS; This spontaneous report received from a patient concerned a 63 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: severe latex allergy and drug allergy (lidocaine). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 202A21A, and expiry: 21-SEP-2021) dose was not reported, on left arm (dose number in series was 1) administered on 09-APR-2021 around 15:00 for prophylactic vaccination. On 10-APR-2021, About 12 hours later, around 2:00, following vaccination with covid-19 vaccine ad26.cov2.s, the patient experienced freezing for a good hour/extremely cold feeling/couldn't get warm for about two and half hours. She was awake for that hour, then it went away and she went back to sleep. On 12-APR-2021 (on day 4 from primary shot), the patient experienced sore arm (dose number in series was 1). The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient received additional covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 1855191, and expiry: 11-APR-2022) dose was not reported, on right arm (dose number in series was 2), 01 total, administered on 18-DEC-2021 for prophylactic vaccination. No concomitant medications were reported. On 19-DEC-2021, about 36 hours after the booster shot, the patient experienced extremely cold and could not get warm for about two and half hours. On 21-DEC-2021, her arm got sore on day 4 from the booster (dose number in series was 2). She had extremely mild side effects, exactly same symptoms that happened after the first shot (dose number in series was 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from extremely cold and couldn't get warm for about two and half hours on DEC-2021, and had not recovered from sore arm (dose number in series was 2), This report was non-serious. This case, involving the same patient is linked to 20211235748 (dose number in series was 1).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Drug allergy (lidocaine); Latex allergy (SEVERE LATEX ALLERGY)
Vorgeschichte
Comments: Unknown
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1989440

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
32,0
Geschlecht
F
Eingang
29.12.2021
Impfdatum
29.12.2021
Beginn
29.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cold sweat Dizziness Feeling abnormal Feeling cold Hyperhidrosis Pallor Tunnel vision Vaccine positive rechallenge

Symptomtext

On Wednesday, 12/29/21, Patient came to Covid-19 Vaccination Site for her Janssen Covid-19 booster vaccine. Client received her Janssen Covid-19 booster dose (LOT #: 1855191) at 1:12 PM in her left deltoid. During assessment questions, client stated her medical history included migraines and takes ajovy and imitrex for them and no known allergies. Client was to be a 15 minute observation. At 1:16 PM, while waiting in Observation Area, client stated to EMT right after sitting down she felt "dizzy, cold and sweaty with tunnel vision." Client was brought over to sit in anti gravity chair by EMT. At 1:16 PM vitals started, BP: 112/79, HR: 112, O2 sat: 98%, RR: 16, skin: pale, clammy and cool. Client stated she did eat a grilled cheese and soda before vaccination. At 1:25 PM, BP: 110/79, HR: 96, O2 sat: 99%, RR: 16, skin: warm, pink and dry. Client stated she feels "fine" now and experiencing no dizziness. Client did state she experienced a similar sensation after her first Janssen vaccine. Client was offered water which she drank and reclined in anti gravity chair. At 1:33 PM, BP: 112/74, HR: 110, O2 sat: 97%, RR: 16, skin: pink, warm and dry. Client states she feels "back to normal" and experiencing no other symptoms. No further interventions needed. Client was educated by EMT on signs and symptoms of adverse reactions and when to go to the ED/call MD. Client was also encouraged to sign-up for after vaccination health checker. At 1:40 PM, client left vaccination site with a steady gait.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none
Vorgeschichte
migraines
Andere Medikamente
Ajovy, Imitrex
Allergien
nka
Vorherige Impfungen
-

VAERS 1988210

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
FL
Alter
-
Geschlecht
M
Eingang
29.12.2021
Impfdatum
-
Beginn
18.12.2021
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain Injection site pain Injection site rash

Symptomtext

SEVERE ABDOMINAL PAIN AT NIGHT AND IS LESS SEVERE DURING THE DAY TO JUST A SLIGHT PAIN; RED DOT AROUND THE INJECTION SITE AFTER BOOSTER 1/2 THE DIAMETER OF A DIME; SORENESS AT THE VACCINATION SITE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously treated with covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029 and expiry: UNKNOWN), 1 in total, dose was not reported, administered on 14-MAR-2021 on left shoulder for prophylactic vaccination (Dose series in number 1). It was unknown whether patient had any adverse event following covid-19 vaccine ad26.cov2.s (Dose series in number 1). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, and expiry: UNKNOWN) dose was not reported, 1 total administered on 18-DEC-2021 on left deltoid for prophylactic vaccination (Dose series in number 2). No concomitant medications were reported. On 18-DEC-2021, following vaccination with covid-19 vaccine ad26.cov2.s, the patient experienced red dot around the injection site after booster which was half the diameter of a dime, and soreness at the vaccination site. On evening of 19-DEC-2021, the patient experienced abdominal pain which was severe in night and is less severe during the day just a slight pain (Dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from severe abdominal pain at night and is less severe during the day to just a slight pain, red dot around the injection site after booster 1/2 the diameter of a dime, and soreness at the vaccination site. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1988208

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
NY
Alter
60,0
Geschlecht
M
Eingang
29.12.2021
Impfdatum
28.11.2021
Beginn
28.11.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Bone pain Loss of personal independence in daily activities

Symptomtext

BONES HURT FOR 5 DAYS AFTER RECEIVING THE BOOSTER DOSE; HARD TO GET UP AND DO THINGS; This spontaneous report received from a patient concerned a 60 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: neuropathy (he was disabled with neuropathy in his feet and cannot feel his feet, since 1997) he had gradually taught himself to walk with crutches and cane and with wheel chair, diabetes, smoker (Cigarettes (half a pack) but he does not let most of the smoke in) and abstains from alcohol, and other pre-existing medical conditions included: Patient had no drug abuse or illicit drug use. Patient had lyrica allergy (slept for 24 hours and his toes were feet) for drug used for unknown indication. The patient previously received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin and batch number were not reported) dose was not reported, 1 total, administered on 01-APR-2021 for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2. s. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191 and expiry: 11-APR-2022) dose was not reported, 1 total, administered on 28-NOV-2021 on right arm for prophylactic vaccination. Concomitant drug included fentanyl. On 28-NOV-2021, following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 2), the patient's bones hurt for 5 days after receiving the booster dose and he did not know whether that was the vaccine that did it and it was hard to get up and do things but it would go away when he started doing things but would come back when he sat down (dose number in series 2). They all resolved after 5 days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bones hurt for 5 days after receiving the booster dose, and hard to get up and do things on 03-DEC-2021. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bone pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Abstains from alcohol; Cane user; Diabetes; Neuropathy (Patient was disabled suffering from neuropathy that he has no feeling in his feet.); Smoker (Cigarettes (half a pack) but he does not let most of the smoke in.)
Vorgeschichte
Medical History/Concurrent Conditions: Drug allergy; Comments: Patient had no drug abuse or illicit drug use.
Andere Medikamente
FENTANYL PATCH
Allergien
-
Vorherige Impfungen
-

VAERS 1984993

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
53,0
Geschlecht
F
Eingang
28.12.2021
Impfdatum
06.12.2021
Beginn
07.12.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Headache Tinnitus

Symptomtext

WITHIN A FEW HOURS I STARTED GETTING EXTREME HEADACHE, CHILLS WITHIN 10 HOURS AND RINGING IN EAR.. THE HEADACHE AND CHILLS WENT AWAY WITHIN A FEW DAYS; HOWEVER THE RINGING IN THE EARS HAS STAYED CONSTANT AND EVERY DAY I NOTICE A LOUD PITCH. I NEVER HAD RINGING IN MY EARS BEFORE.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
NONE YET
Aktuelle Erkrankungen
NONE AT TIME OF VACCINATION; BRONCHITIS PRIOR MONTH NOV 3
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
PENICILLIN
Vorherige Impfungen
-

VAERS 1984762

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
NY
Alter
33,0
Geschlecht
M
Eingang
28.12.2021
Impfdatum
28.12.2021
Beginn
28.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Fall

Symptomtext

administered first dose of janssen covid19 vaccine to patient in left arm at 11:25am on 12/28/21. advised patient to sit for 15 minutes. when he stood up and walked a couple steps and looked down at his phone at approx 11:40 am he fell to the ground. went to check on patient. he reported he got dizzy and lightheaded. he did not feel short of breath and there were no injuries. he did not want us to call 911. gave patient water and advised patient to sit and wait until he felt better. after about 10-15 minutes pt said he felt better after sitting and was ok to leave.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
unknown
Vorgeschichte
asthma
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
-

VAERS 1973970

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
MO
Alter
59,0
Geschlecht
F
Eingang
23.12.2021
Impfdatum
14.12.2021
Beginn
14.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Bedridden Diarrhoea Fatigue Headache Nausea Pain Renal pain Vomiting

Symptomtext

DIARRHEA; WEAKNESS; THREW UP EVERY TIME (VOMITING); NAUSEOUS; RIGHT KIDNEY IS HURTING; COULD NOT GET OUT OUT OF BED; SUPER ACHY; HEADACHES; FATIGUE; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: history of chronic urinary tract infection, penicillin allergy (rash and hives), macrodantin allergy (rash, hives, captured as drug allergy), bactrim (rash and hives, captured as drug allergy) non-smoker, and non-alcoholic The patient had no drug abuse or illicit drug usage. The patient previously received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number 206A21A, expiry: Unknown) dose was not reported,1 total, administered on 03-SEP-2021 for prophylactic vaccination on her right arm. No adverse events were reported (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: 11-APR-2022) dose was not reported, 1 total, administered on 14-DEC-2021 at noon (12:00) for prophylactic vaccination as a booster dose on her left arm (dose number in series 2). No concomitant medications were reported. On 14-DEC-2021, the patient experienced headaches, and fatigue in evening (dose number in series 2). Patient reported that super achy and headache worsened throughout that evening (dose number in series 2). On 15-DEC-2021, the patient could not get out out of bed (dose number in series 2). Patient was nauseous and threw up every time (vomiting) (dose number in series 2). Patient could drink water, but would gag and throw it back up and claimed that her right kidney was hurting (dose number in series 2). On 16-DEC-2021, the patient experienced diarrhea, and weakness.(dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from threw up every time (vomiting), and nauseous on 15-DEC-2021, and headaches on DEC-2021, and had not recovered from fatigue, could not get out out of bed, right kidney is hurting, weakness, diarrhea, and super achy. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Abstains from alcohol; Drug allergy (reaction - rash, hives); Non-smoker; Penicillin allergy (experiences rash and hives); Urinary tract infection
Vorgeschichte
Comments: Patient had no drug abuse or illicit drug usage.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1968196

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
-
Alter
50,0
Geschlecht
F
Eingang
21.12.2021
Impfdatum
20.12.2021
Beginn
20.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Blood pressure decreased Dizziness Somnolence Vision blurred

Symptomtext

Patient came to pharmacy to get Janssen booster and Flucelvax vaccine. After receiving both vaccine, a provider recommended patient to sit down for 15 min. Patient looked normal and she had no sign of reaction. Patient started feeling dizziness in about 1 min, she sat down and her eyes had blurry vision. BP was 64/44 and we tried to keep her stay awake while calling 911. She could answer questions while provider asked her. She felt better when paramedic arrived.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1968186

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
ME
Alter
23,0
Geschlecht
F
Eingang
21.12.2021
Impfdatum
20.12.2021
Beginn
20.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Feeling cold Pallor Tinnitus

Symptomtext

Patient experienced tinnitus, cold feeling, paleness, and lightheadedness (described by her like she felt like she was going to faint but she never progressed to an actual syncopal episode). All experienced within 5 minutes of receiving vaccine. Tinnitus resolved within 10 minutes. Lightheadedness and cold feeling continued to improve and resolved within 20 minutes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Unknown
Allergien
None
Vorherige Impfungen
-

VAERS 1967677

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
MA
Alter
19,0
Geschlecht
M
Eingang
21.12.2021
Impfdatum
15.12.2021
Beginn
16.12.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Vomiting

Symptomtext

Vomiting constantly on the day following his vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vomiting
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
ProAir PRN
Allergien
-
Vorherige Impfungen
-

VAERS 1966637

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
OH
Alter
-
Geschlecht
U
Eingang
21.12.2021
Impfdatum
-
Beginn
10.12.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Burning sensation Chills Contusion Fatigue Headache Injection site pain Pain

Symptomtext

BRUISING/BLOOD SPOTS ON SKIN AND HAD BUMPS ON IT; CHILLS; BAD HEADACHE; REAL TIRED/FATIGUE; BURNING SENSATION AT INJECTION SITE; BODY ACHES; ARM BURNED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included: antibiotic allergy, no alcohol use, and non smoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: UNKNOWN) dose was not reported, administered on 10-DEC-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-DEC-2021, the patient experienced body aches, arm burned, and burning sensation at injection site. On 11-DEC-2021, the patient experienced chills, bad headache, and real tired/fatigue. On 18-DEC-2021, the patient experienced bruising/blood spots on skin and had bumps on it. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, burning sensation at injection site, bad headache, and real tired/fatigue on 12-DEC-2021, and arm burned, and had not recovered from bruising/blood spots on skin and had bumps on it. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Abstains from alcohol; Allergy to antibiotic (Certain antibiotics); Non-smoker
Vorgeschichte
Comments: Unknown
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1966621

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
NY
Alter
51,0
Geschlecht
F
Eingang
21.12.2021
Impfdatum
-
Beginn
14.12.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site bruising Injection site erythema Injection site pain

Symptomtext

BLACK AND BLUE INJECTION SITE; INJECTION SITE PAIN; INJECTION REDNESS; INJECTION SITE TENDERNESS; This spontaneous report received from a patient concerned a 51 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: 11-APR-2022) dose was not reported, administered on 13-DEC-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-DEC-2021, the patient experienced black and blue injection site. On 14-DEC-2021, the patient experienced injection site pain. On 14-DEC-2021, the patient experienced injection redness. On 14-DEC-2021, the patient experienced injection site tenderness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from injection site pain, injection redness, injection site tenderness, and black and blue injection site. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1963725

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
47,0
Geschlecht
M
Eingang
20.12.2021
Impfdatum
17.11.2021
Beginn
24.11.2021
Tage bis Beginn
7,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Malaise SARS-CoV-2 test positive

Symptomtext

Hospital Course and Significant Findings: The patient is 47 M with history of remote stroke admitted for COVID in vaccinated state. Treated with Dex for 4 days and RDV for 5 days. Discharged off oxygen. Symptom onset 11/24, tested 11/28, isolation end based on 20 day protocol by CDC expected to end 12/14.21. He was advised to boost with either Pfizer or Moderna after recovery.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Malaise
Hospital-Tage
10,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1962431

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
GA
Alter
48,0
Geschlecht
F
Eingang
19.12.2021
Impfdatum
19.12.2021
Beginn
19.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Pain in extremity Peripheral coldness

Symptomtext

Patient stated that she was having shooting pain in right arm (from wrist to shoulder) about 10 minutes after she received her vaccination. She said it was difficult to twist her arm. The daughter reported patients right hand was even cold to the touch. These are the only symptoms being experiences. Patients daughter drover her to the emergency room for observation to rule out any other possible events. I called and spoke with daughter at about 6:30p and there had been no change.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
No
Vorgeschichte
None (patient was asked)
Andere Medikamente
None (patient was asked)
Allergien
No known drug allergies
Vorherige Impfungen
-

VAERS 1962408

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
66,0
Geschlecht
M
Eingang
19.12.2021
Impfdatum
17.12.2021
Beginn
17.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood urine present Chills Pollakiuria

Symptomtext

mild chills over night and then frequent urination and blood in the urine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
none as yet
Aktuelle Erkrankungen
none
Vorgeschichte
pre diabetic, some hypertension
Andere Medikamente
metaformin, asprin low dose, atenolol, , finasteride, glipizide, lisinopril, atorvasttin, januvia, hydrochlorthizide
Allergien
penecillin
Vorherige Impfungen
-

VAERS 1959536

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
OH
Alter
33,0
Geschlecht
F
Eingang
17.12.2021
Impfdatum
15.12.2021
Beginn
15.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Asthenia Bone pain Chills Decreased appetite Dizziness Headache Myalgia Nausea Vertigo

Symptomtext

headache, severe bone pain all over body, joint pain, muscle aches, weakness, vertigo, dizziness, chills, nausea, no appetite for 2 days

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
sertraline
Allergien
-
Vorherige Impfungen
influenza

VAERS 1958769

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
PA
Alter
27,0
Geschlecht
M
Eingang
17.12.2021
Impfdatum
16.12.2021
Beginn
16.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Asthenia Chills Feeling abnormal Headache Insomnia

Symptomtext

Chills, Head Fog, Insomnia, Weakness, Headache

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1958237

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
FL
Alter
58,0
Geschlecht
F
Eingang
17.12.2021
Impfdatum
-
Beginn
06.12.2021
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Body temperature Chest discomfort Delirium Dizziness Headache Illness Influenza Pain Pyrexia Stomatitis

Symptomtext

This spontaneous report received from a patient concerned a 58-year-old Not Hispanic/Latino and white female. The patient's height, and weight were not reported. The patient's concurrent conditions included: enterocytes cystitis (captured: cystitis), bad bladder (captured: bladder disorder), bees sting allergy, wasp sting allergy, and sulfa allergy. The patient previously received covid-19 vaccine vaccination (unspecified manufacturer) (suspension for injection, route of admin not reported, batch number: unknown expiry: unknown) dose was not reported, 1 total, administered on unspecified date for prophylactic vaccination (Dose number in series 1). It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine. On 05-DEC-2021, the patient received covid-19 vaccine (suspension for injection, route of admin not reported, lot number: 1855191, expiry: Unknown) dose was not reported,1 total administered to left arm for prophylactic vaccination (Dose number in series 2). No concomitant medications were reported. On 06-DEC-2021 (reported as Monday), the patient woke up on morning really sick and complained of delirium (serious event), dizziness, chest feeling heavy, felt like the worst flu, feeling weak, fever, body aches, headache, "so sick this time", and Fever 102 (dose number in series 2). Laboratory data included: Fever (captured as body temperature) 102 F. On 09-DEC-2021, the patient experienced sores in mouth (dose number in series 2). Laboratory data included: Fever (captured as body temperature) 99.5- 99.8 F (reported as "normally 97.9F). The patient also stated no fever for 3 days as of now and asked for advice on what to do regarding AE (adverse event). The action taken with covid-19 vaccine was not applicable. The outcome of fever 102 was recovered (also reported as not recovered but stated to be recovered by the patient). The outcomes of the following events were not reported/unknown: headache, delirium, weakness, dizziness, body aches, feels like the worst flu, so sick this time, and chest feeling heavy. The outcome of sores in mouth was not recovered. The patient had not recovered from delirium, dizziness, sores in mouth, and feels like the worst flu, and the outcome of sick and chest feeling heavy was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20211222712-COVID-19 VACCINE Delirium. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
Test Date: 20211206; Test Name: Body temperature; Result Unstructured Data: 102 F; Test Date: 20211209; Test Name: Body temperature; Result Unstructured Data: 99.5-99.8 F.
Aktuelle Erkrankungen
Allergic reaction to antibiotics; Allergic reaction to bee sting; Allergic reaction to wasp sting; Bladder disorder; Cystitis
Vorgeschichte
Comments: The patient had history of bad bladder
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1957765

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
FL
Alter
44,0
Geschlecht
M
Eingang
17.12.2021
Impfdatum
-
Beginn
01.12.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Injection site discomfort Injection site pain Pain in extremity Peripheral swelling SARS-CoV-2 test

Symptomtext

DISCOMFORT RIGHT AWAY AT THE INJECTION SITE; INJECTION SITE PAIN; HIS ARM STARTED SWOLLEN; HIS ARM STARTED TO HURT AGAIN AND TENDER ARM PAIN THAT CAME BACK/HURT TO THE TOUCH, HURTS TO SLEEP ON IT; This spontaneous report received from a patient concerned a 44 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, and expiry: 11-APR-2022) dose was not reported, administered on 02-DEC-2021 for prophylactic vaccination. No concomitant medications were reported. On DEC-2021, the patient experienced his arm started swollen. On DEC-2021, the patient experienced his arm started to hurt again and tender arm pain that came back/hurt to the touch, hurts to sleep on it. Laboratory data included: COVID-19 virus test (NR: not provided) NOT REPORTED. On 02-DEC-2021, the patient experienced discomfort right away at the injection site. On 02-DEC-2021, the patient experienced injection site pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from injection site pain, discomfort right away at the injection site, his arm started to hurt again and tender arm pain that came back/hurt to the touch, hurts to sleep on it, and his arm started swollen. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site discomfort
Hospital-Tage
-
Labordaten
Test Date: 202112; Test Name: COVID-19 virus test; Result Unstructured Data: NOT REPORTED
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1952854

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
FL
Alter
56,0
Geschlecht
M
Eingang
15.12.2021
Impfdatum
13.12.2021
Beginn
13.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal pain upper Arthralgia Back pain Diarrhoea Headache Injection site pain Neck pain

Symptomtext

Neck and back aches, stomach cramps, joint pain, injection site soreness, severe headache, diarrhea.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain upper
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
-
Andere Medikamente
10 mg Lisinopril
Allergien
None
Vorherige Impfungen
-

VAERS 1951941

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
FL
Alter
45,0
Geschlecht
M
Eingang
15.12.2021
Impfdatum
03.12.2021
Beginn
04.12.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain upper

Symptomtext

Persistent stomach pain after vaccine, top left side of stomach near heart

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain upper
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
Peanut
Vorherige Impfungen
-

VAERS 1947716

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
OH
Alter
56,0
Geschlecht
F
Eingang
14.12.2021
Impfdatum
01.12.2021
Beginn
01.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fatigue Injection site pain Muscle spasms Neck pain Pain in extremity

Symptomtext

Janssen COVID-19 Vaccine EUA Immediate severe pain during injection, within a few minutes it was down my arm into my hand and also up into my neck. General feeling of exhaustion set in a few hours later and lasted a day. Also during the night I had severe cramps in the leg on that right side (the side I had the injection on). The cramps kept coming all night long all through the right foot and leg. Foot, ankle , upper and lower leg and knee cramps. The cramps were severe.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
None.
Vorgeschichte
None.
Andere Medikamente
None.
Allergien
None.
Vorherige Impfungen
-

VAERS 1946755

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
NY
Alter
27,0
Geschlecht
M
Eingang
14.12.2021
Impfdatum
-
Beginn
12.12.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Injection site pain

Symptomtext

ACHINESS IN ALL BODY JOINTS/LEG JOINTS; PAIN THE INJECTION SITE; This spontaneous report received from a patient concerned a 27 year old male. The patient's weight was 180 pounds, and height was 70 inches. The patient's concurrent conditions included: alcohol user, and nonsmoker, and other pre-existing medical conditions included: No known allergies, No drug abuse or illicit drug usage, Patient not aware of any medical condition, not taking any medication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: UNKNOWN) dose was not reported, administered on 11-DEC-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-DEC-2021, the patient experienced achiness in all body joints/leg joints, and pain the injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain the injection site, and achiness in all body joints/leg joints. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Alcohol use (8 glasses a week); Nonsmoker
Vorgeschichte
Comments: The patient had no known allergies, No drug abuse or illicit drug usage. The patient was not aware of any medical condition, and not taking any medication.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1943980

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
VA
Alter
40,0
Geschlecht
F
Eingang
13.12.2021
Impfdatum
05.12.2021
Beginn
06.12.2021
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Gingival pain Hyperaesthesia teeth Laboratory test Pain in jaw

Symptomtext

Gums in her mouth started to hurt. Real bad cold sensitivity on her from teeth also pain to the gums upper and lower jaw. Went to dentist and nothing was found that could have been causing the pain or sensitivity.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Gingival pain
Hospital-Tage
-
Labordaten
yes
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
pristiq 100mg, propranolol 10mg
Allergien
no
Vorherige Impfungen
-

VAERS 1943947

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
FL
Alter
45,0
Geschlecht
F
Eingang
13.12.2021
Impfdatum
13.12.2021
Beginn
13.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Feeling hot

Symptomtext

Patient felt faint, hot, and light headed about 10 minutes after giving the vaccination

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
None known
Aktuelle Erkrankungen
none known
Vorgeschichte
none known
Andere Medikamente
none known
Allergien
reglan
Vorherige Impfungen
-

VAERS 1940277

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
39,0
Geschlecht
F
Eingang
10.12.2021
Impfdatum
09.12.2021
Beginn
09.12.2021
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Chills Headache Hyperhidrosis Illness Myalgia Nausea Tinnitus

Symptomtext

Chills, nausea, sweating, body joint and muscle pain, headache, increased tinnitus, too sick to take my daughter to school

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Hashimotos
Andere Medikamente
Oxcarbazapene, levothyroxine, Tylenol after for symptoms
Allergien
N/A
Vorherige Impfungen
-

VAERS 1933590

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
PA
Alter
50,0
Geschlecht
F
Eingang
08.12.2021
Impfdatum
06.12.2021
Beginn
07.12.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash pruritic

Symptomtext

Extreme itchy feeling and rash

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash pruritic
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None reported
Vorgeschichte
None reported
Andere Medikamente
n/a
Allergien
Flu vaccine
Vorherige Impfungen
Flu but no information given

VAERS 1933589

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
TX
Alter
43,0
Geschlecht
F
Eingang
08.12.2021
Impfdatum
29.11.2021
Beginn
29.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Headache Pain Pyrexia

Symptomtext

Continued fevers, body aches, and headache since the day of vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
None as of yet
Aktuelle Erkrankungen
None
Vorgeschichte
Hypopituitarism
Andere Medikamente
Hydrocortisone Synthroid
Allergien
None
Vorherige Impfungen
-

VAERS 1933109

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
-
Alter
57,0
Geschlecht
M
Eingang
08.12.2021
Impfdatum
26.11.2021
Beginn
26.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Flushing Hyperhidrosis Vomiting

Symptomtext

15mins post vaccination pt c/o vomiting and flushing/sweating. Vitals: 112/67, 60, 12. Pt given water and monitored. VSS Pt stable and released from the vaccination site.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vomiting
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
PMH: HLD, lumbar disc herniation s/p laminectomy
Andere Medikamente
none
Allergien
NKA
Vorherige Impfungen
-

VAERS 1931262

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
NJ
Alter
47,0
Geschlecht
M
Eingang
08.12.2021
Impfdatum
-
Beginn
14.11.2021
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood glucose Blood glucose decreased Body temperature Chills Cough Decreased appetite Headache Hyperhidrosis Myalgia Pain in extremity Product colour issue Pyrexia Sluggishness

Symptomtext

FEELS LIKE HE HAS COUGH COMING ON SOMETIMES; LOW BLOOD SUGAR; DECREASED APPETITE; MUSCLE ACHES UNDER RIBS ON BOTH SIDES; DID NOT EAT OR DRINK VERY MUCH; HEADACHE; SLUGGISH; PRODUCT DISCOLORATION (THE LIQUID WAS PURPLE); SWEATING THROUGH SHIRT; CHILLS/ TEETH CLANKING TOGETHER; SORE ARM; FEVER; This spontaneous report received from a patient concerned a 47-year-old male of other race and unknown ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: diabetic, and the patient had history of migraines. No concomitant medications were reported. The patient was previously treated with covid-19 vaccine ad26. cov2. s (manufacturer not specified )(suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, frequency 1 total administered for prophylactic vaccination (dose series 1). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, and expiry: Unknown) dose was not reported, frequency 1 total administered at right arm on 14-NOV-2021 for prophylactic vaccination (dose series 2). The patient reported that vaccinated liquid was purple (Product discoloration) (dose series 2). On 14-Nov-2021, after vaccination, majority of the day he was fine except sore arm. At 20:30, the patient stated that it was like switch went off and got really sweaty and was soaking through his shirt. The patient also stated that his teeth were clanking together and had chills. The patient experienced Fever 101F, took extra strength Tylenol (2 at 21:30 on 14-Nov-2021 and 2 at 03:00 on 15-Nov-2021). The patient stated that Tylenol brought fever down to 100F, and on 15-Nov-2021, at 03:00 in the morning , the fever was almost 103F. The patient also stated that on both sides of his ribs the muscles felt like he exercised. On 15-Nov-2021, in the morning ,he took 3 steps and felt like he would fall down because his blood sugar was very low. The patient stated that he almost went to hospital because he had never felt like this before. The patient did not eat or drink very much that day and was very sluggish all day. The chills were still there but slowly fading (coming and going but improving). The tightness in the ribs was gone by 17-Nov-2021 and chills were gone by 16-Nov-2021. The patient reported since the vaccination every so often feels like he has a cough coming on, if he gets excited or moves too fast he was able to feel it and will cough to make it go away (dose series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweating through shirt, decreased appetite, sluggishness, chills/ teeth were clanking together, sore arm, and muscle aches under ribs on both sides on 17-NOV-2021, low blood sugar and did not eat or drink all day on 15-NOV-2021, and fever on 16-NOV-2021. The patient had not recovered from feels like he has cough coming on sometimes, and headache, and the outcome of product discoloration (the liquid was purple) was not reported. This report was non-serious. This report was associated with a product quality complaint.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
Test Date: 20211114; Test Name: Body temperature; Result Unstructured Data: 101 F; Test Date: 20211114; Test Name: Body temperature; Result Unstructured Data: 100 F; Test Date: 20211115; Test Name: Blood glucose; Result Unstructured Data: blood sugar was very low; Test Date: 20211115; Test Name: Body temperature; Result Unstructured Data: 103 F
Aktuelle Erkrankungen
Diabetic; Migraine
Vorgeschichte
Comments: Unknown
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1921240

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge 1855191

mild
Staat
OH
Alter
49,0
Geschlecht
F
Eingang
03.12.2021
Impfdatum
02.12.2021
Beginn
02.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Pain Uterine hypertonus

Symptomtext

Extreme Fatigue, Woken in the middle of the night with severe uterine contractions every 5 minutes for 4 +hours, Doubled over in pain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Ear infection and sinus infection
Vorgeschichte
None
Andere Medikamente
Lorazapam Norethidrone
Allergien
No
Vorherige Impfungen
-

VAERS 1917293

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
46,0
Geschlecht
F
Eingang
02.12.2021
Impfdatum
02.12.2021
Beginn
02.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pruritus

Symptomtext

ITCHING ALL OVER BODY

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
IBS, IOSETOARTHRITIS
Andere Medikamente
NONE
Allergien
BENZODIAZEPINE, LATEX, NORCO, AMOXICILIN
Vorherige Impfungen
-

VAERS 1916647

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
TN
Alter
63,0
Geschlecht
F
Eingang
02.12.2021
Impfdatum
30.11.2021
Beginn
01.12.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Conjunctivitis Pain in extremity Pyrexia Rhinorrhoea

Symptomtext

arm soreness, chills, fever, runny nose, pink eye

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none
Vorgeschichte
aural migraine
Andere Medikamente
elderberry gummy, D3 200IU, collagen, bone&joint sup., Occuvite, Hair & Nail B vitamins, estradiol, spirinolactone
Allergien
latex causes blistering
Vorherige Impfungen
Nov. 2020: Shingrix 2nd dose, extreme redness, swelling of arm, fever, nausea for 3 days. No adverse reaction to 1st J&J vaccina

VAERS 1913724

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
NY
Alter
18,0
Geschlecht
M
Eingang
01.12.2021
Impfdatum
30.11.2021
Beginn
01.12.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Headache Vomiting

Symptomtext

Vomiting, headache and fatigue

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Vitamin C, D, multi vitamin
Allergien
None
Vorherige Impfungen
-

VAERS 1912909

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
40,0
Geschlecht
F
Eingang
01.12.2021
Impfdatum
28.11.2021
Beginn
28.11.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Exposure during pregnancy Rash Skin warm

Symptomtext

RECEIVED INJECTION AT 11:30AM, I AM 22 WEEKS PREGNANT, EST DELIVERY DATE 04/02/2022, ABOUT 2:30PM, STARTED GETTING RASH ON CHEEKS , WAS HOT TO THE TOUCH, STARTED GETTING RASH DOWN LEFT SIDE OF NECK, DECIDED TO GO TO ER, GAVE ME BENADRYL, DIDNT GET WORSE SEEM TO GET BETTER, HAD NO ISSUES SINCE.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 1910272

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge 1855191

mild
Staat
CA
Alter
37,0
Geschlecht
M
Eingang
30.11.2021
Impfdatum
30.11.2021
Beginn
30.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Anxiety Dizziness Hyperhidrosis

Symptomtext

PATIENT VERBALIZED DIZZINESS AND WAS SWEATING PROFUSELY AFTER RECEIVING COVID VACCINE, HE VERBALIZED THAT HE HAD A PHOBIA OF NEEDLES AND APPEARED TO BE VERY ANXIOUS. ALERT AND ORIENTED X3, VITAL SIGNS STABLE, BP 128/80 RR 24 PR 88 T 98.1 AFEBRILE. NO S.SX OF ANY ACUTYE DISTRESS, BREATHING IS EVEN AND UNLABORED. DENIES ANY PAIN, NO INDICATORS OF PAIN PRESENT. GATORADE OFFERED, PATIENT STARTEDTO FEEL BETTER A FEW MINUTES AFTER DRINKING GATORADE, ASYPTOMATIC. APPEARED TO BE LESS ANXIOUS. PATIENT RESTATED THAT HE HAS A LONG HISTORY OF NEEDLE PHOBIAS. MONITORED FOR ANOTHER 15 MINUTES, ASYMPTOMATIC. NO SSX OF ANY DISTRESS, MD PRESENT AND CLEARED PATIENT FOR DISCHARGE. NEEDS MET, PROVIDED A CALM,SAFE, AND COMFORTABLE THERAPEUTIC MILIEU.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
VITAL SIGNS @1650 136/78 , PR 82, RR 20, TEMP98.90
Aktuelle Erkrankungen
NONE
Vorgeschichte
PHOBIA OF NEEDLES
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
NEEDLE PHOBIA

VAERS 1906077

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
52,0
Geschlecht
F
Eingang
29.11.2021
Impfdatum
19.11.2021
Beginn
01.11.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Headache Nausea

Symptomtext

Janssen COVID-19 Vaccine EUA - Continuous headache and nausea throughout the day since approximately 48 hours after vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NA
Vorgeschichte
Hiatal Hernia and acid reflux
Andere Medikamente
Naproxen
Allergien
NA
Vorherige Impfungen
-

VAERS 1905329

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
PA
Alter
46,0
Geschlecht
F
Eingang
29.11.2021
Impfdatum
28.11.2021
Beginn
28.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Eye swelling Lip swelling Rash pruritic

Symptomtext

Developed a diffuse itchy rash, swelling around eyes and lips. Took antihistamines which helped. Woke up around 2 am with itch, took some more antihistamines. Woke up at 6 am with puffy eyes and lips. Took more antihistamines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash pruritic
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
Hypothyroidism, B12 deficiency, Vitamin D deficiency
Andere Medikamente
Synthroid, B12
Allergien
none
Vorherige Impfungen
-

VAERS 1876809

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
40,0
Geschlecht
M
Eingang
17.11.2021
Impfdatum
16.11.2021
Beginn
17.11.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Pain

Symptomtext

I have aching at the injection site and throughout my body.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
ankylosing spondylitis
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1875754

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
-
Geschlecht
M
Eingang
17.11.2021
Impfdatum
-
Beginn
11.11.2021
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood urine present Haemorrhage urinary tract Myalgia Pyrexia

Symptomtext

FEVER; MUSCLE ACHES; BLOOD CLOTS IN URINE; BLOODY URINE; This spontaneous report received from a pharmacist concerned a 23 year old male with unspecified ethnic origin. The patient's height, and weight were not reported. The patient's concurrent conditions included: non alcohol user, and non-smoker, and other pre-existing medical conditions included: The patient had no known drug allergy, The patient had no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: 11-APR-2022) dose was not reported, 1 total administered on 11-NOV-2021 17:00 to the left arm for prophylactic vaccination. No concomitant medications were reported. On 11-NOV-2021, between 22.00 to 23.00 the patient experienced blood clots in urine and bloody urine. The patient visited physician for the same. On 12-NOV-2021, the patient experienced fever and muscle aches. Treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from blood clots in urine, and bloody urine on 12-NOV-2021, and had not recovered from fever, and muscle aches. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210414709.; Sender's Comments: V0: 20211130285-COVID-19 VACCINE AD26.COV2.S- blood clots in urine. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myalgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Abstains from alcohol; Non-smoker
Vorgeschichte
Comments: The patient had no known drug allergy, The patient had no history of drug abuse or illicit drug use.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1841543

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
CA
Alter
19,0
Geschlecht
M
Eingang
03.11.2021
Impfdatum
03.11.2021
Beginn
03.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Confusional state Dizziness Fall Injection site pain Pallor

Symptomtext

At 1256 patient received the vaccine and went to the observation area to sit down. At 1257 patient fell to the floor in the observation area. Patient reported feeling dizzy and lightheaded. Patient was alert and oriented to person, place and time. Patient seemed confused about the situation. Patient appeared pale. Patient denied chest pain, head pain, and back pain. Patient reported pain only in the left arm at the injection site. The arm was assessed and it did not appear to be red or swollen. The patient denied any shortness of breath and denied any difficulty breathing. Patient denied any itching. Patient was kept laying down. At 1259 EMS/911 was called. At 1300 patient's BP 90/52 and HR 94 At 1302 patient's BP 88/62 and HR 88. Patient's legs were elevated. At 1305 patient's BP 88/60 and HR 81. At 1309 patient's BP 98/60 and HR 72. At 1310 the fire department arrived at the scene and assumed care of the patient. At 1316 patient's BP 118/77 and HR 78 while sitting. Patient's BP 122/81 and HR 89 while standing. Patient was transferred to a cot and was put in a sitting position. Patient reported some dizziness. At 1321 BP 92/63, HR 72, and O2 Sat 100%. At 1323 Patient refused offer to call family. Patient chose to call his girlfriend on his own. Patient was advised to go to the emergency room with the paramedics to prevent further worsening of his condition. At 1330 patient's BP 96/64, HR 69, and O2 Sat 99%. At 1332 Paramedics arrived on site and assumed care of the patient. Patient was transported to the nearest emergency room by ambulance.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 1837691

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

mild
Staat
WA
Alter
32,0
Geschlecht
F
Eingang
02.11.2021
Impfdatum
02.11.2021
Beginn
02.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Back pain Chills Depression Dizziness Dysstasia Gait disturbance Hypoaesthesia Nausea Pain Vomiting

Symptomtext

Extreme dizziness, nausea, chills, bloody ache. Severe Back pain Difficulty walking or standing Numb limbs Vomiting Depression

Weitere VAERSDATA-Felder
Praegender Schweregrund
Back pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Tri-sprintec
Allergien
-
Vorherige Impfungen
-

VAERS 2710475

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
AL
Alter
-
Geschlecht
F
Eingang
06.11.2023
Impfdatum
05.12.2021
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood glucose increased

Symptomtext

HIGH BLOOD SUGAR; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: non smoker, and non alcohol user, and other pre-existing medical conditions included: The patient had a allergy to pain medication (vomiting). The patients blood sugar level was 5.2 and weight was great before vaccination. The patient was previously treated with covid-19 vaccine ad26. cov2 (dose number in series 1) (suspension for injection, route of admin not reported, batch number: OH3A214 expiry: UNKNOWN), dose was not reported, 1 total administered on 09-APR-2021 for covid-19 prophylaxis (dose number in series 1). No adverse events reported following vaccination (dose number in series 1). The patient additionally received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191 expiry: UNKNOWN) dose was not reported,1 total administered on 05-DEC-2021 to left Arm for covid-19 prophylaxis. Concomitant medications included metformin for drug used for unknown indication. On an unspecified date, the patients blood sugar level increased 6.9 (Dose number in series 2). The patient doctor gave Ozempic for treatment. After stopped taking Ozempic patients blood sugar level again increased. The patient stated that after taking two medications blood sugar level was only 6.2. The patient took Jardiance and had horrible side effects, gave her E.coli (Escherichia). The patient-maintained sugar level by eating 30 carbs per meal. The patient visited gynecologist. The patient was upset because doing everything still side effect are same. Laboratory data (dates unspecified) included: Blood sugar increased 6.9, 6.2. Treatment medications (dates unspecified) included: semaglutide, and empagliflozin. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from high blood sugar. This report was non-serious. This case, from the same reporter is linked to 20231105443.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blood glucose increased
Hospital-Tage
-
Labordaten
Test Name: BLOOD SUGAR TEST; Result Unstructured Data: 6.2; Test Name: BLOOD SUGAR TEST; Result Unstructured Data: 6.9
Aktuelle Erkrankungen
Abstains from alcohol; Non-smoker
Vorgeschichte
Comments: The patient had a allergy to pain medication (vomiting). The patients blood sugar level was 5.2 and weight was great before vaccination.
Andere Medikamente
METFORMIN
Allergien
-
Vorherige Impfungen
-

VAERS 2647872

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
-
Alter
62,0
Geschlecht
M
Eingang
21.06.2023
Impfdatum
26.11.2021
Beginn
17.12.2022
Tage bis Beginn
386,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Transient ischaemic attack

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE TRANSIENT CEREBRAL ISCHEMIA

Weitere VAERSDATA-Felder
Praegender Schweregrund
Transient ischaemic attack
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2626925

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
-
Alter
50,0
Geschlecht
M
Eingang
05.05.2023
Impfdatum
28.11.2021
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Suspected COVID-19

Symptomtext

SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient via another pharmaceutical company (Pfizer Inc.) concerned a 51 year old male. The patient's height, and weight were not reported. The patient's past medical history included: allergy (unspecified). The patient had previously received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1802068 expiry: unknown) dose was not reported, 1 total administered on 23-MAR-2021 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (does number in series 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191 expiry: unknown) dose was not reported, 1 total administered on 28-NOV-2021 for covid-19 prophylaxis. Age at time of vaccination 50 years old. No concomitant medications were reported. On an unspecified date in 2023, the patient experienced covid-19 which was suspected covid-19 infection (dose number in series 2). The patient received non-company suspect drugs included: nirmatrelvir/ritonavir (form of admin and route of admin were not reported, batch number: GG0067 expiry: unknown) dose and frequency were not reported from 08-APR-2023 to 13-APR-2023 for treatment of covid-19. On 17-APR-2023, the patient experienced covid rebound (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with nirmatrelvir/ritonavir was not reported. The patient had not recovered from suspected covid-19 infection. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Suspected COVID-19
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergy (unspecified)
Andere Medikamente
PAXLOVID
Allergien
-
Vorherige Impfungen
-

VAERS 2624460

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
-
Alter
72,0
Geschlecht
M
Eingang
02.05.2023
Impfdatum
17.11.2021
Beginn
10.12.2021
Tage bis Beginn
23,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Chronic respiratory failure Respiratory failure

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE CHRONIC HYPOXEMIC RESPIRATORY FAILURE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chronic respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2593142

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
MI
Alter
82,0
Geschlecht
M
Eingang
08.03.2023
Impfdatum
11.01.2022
Beginn
22.02.2023
Tage bis Beginn
407,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 1 Janssen

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
Covid +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2588640

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
MI
Alter
63,0
Geschlecht
M
Eingang
28.02.2023
Impfdatum
01.01.2022
Beginn
06.06.2022
Tage bis Beginn
156,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 2 vaccines Janssen 3/16/21 Lot# 1802068; Janssen 1/11/22 Lot# 1855191

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
COVID +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2563948

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
54,0
Geschlecht
M
Eingang
19.01.2023
Impfdatum
17.01.2022
Beginn
01.01.2022
Tage bis Beginn
-
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Cognitive disorder Vertigo Visual impairment

Symptomtext

Severy cognitive decline, vertigo, visual impairment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cognitive disorder
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Diabetes
Andere Medikamente
Metformin
Allergien
None
Vorherige Impfungen
-

VAERS 2560038

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
WA
Alter
75,0
Geschlecht
M
Eingang
13.01.2023
Impfdatum
20.12.2021
Beginn
26.12.2021
Tage bis Beginn
6,0
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Ataxia

Symptomtext

Ataxia. Lasted weeks

Weitere VAERSDATA-Felder
Praegender Schweregrund
Ataxia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Pollen allergy
Andere Medikamente
Antihistamine
Allergien
None
Vorherige Impfungen
-

VAERS 2558672

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge 1855191

gering
Staat
CA
Alter
34,0
Geschlecht
F
Eingang
12.01.2023
Impfdatum
11.01.2022
Beginn
01.02.2022
Tage bis Beginn
21,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Heavy menstrual bleeding

Symptomtext

This was the 2nd shot in the series of Janssen COVID-19 vaccination shots. Since that time, my menstrual periods have been significantly heavier, requiring 2-3 times the amount of feminine products to handle the hemorrhage. These symptoms have not changed since that time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Heavy menstrual bleeding
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
Menstrual period hemorrhage and irregularities following first Janssen COVID-19 shot (VAERS report filed).

VAERS 2556608

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
35,0
Geschlecht
M
Eingang
11.01.2023
Impfdatum
08.12.2021
Beginn
27.12.2022
Tage bis Beginn
384,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Suspected COVID-19

Symptomtext

SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a 36 year male of an unspecified race. The patient's height, and weight were not reported. The patient's past medical history included: right hip replacement, and concurrent conditions included: drug allergy (not reported), and other pre-existing medical conditions included: Patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: unknown, expiry: UNKNOWN) dose was not reported, 1 total administered on an unspecified date in left arm for covid-19 prophylaxis. It was unknown whether patient had any adverse event following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 1) . The patient additionally received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191, expiry: UNKNOWN) dose was not reported, 1 total administered on 08-DEC-2021 08:00 in left arm for covid-19 prophylaxis. Age at time of vaccination 35 years old. No concomitant medications were reported. On 27-DEC-2022 14:00, the patient had metallic taste that had lead to nausea and had covid-19 infection (suspected covid-19 infection, dose number in series 2) for which patient received treatment of Paxlovid (form of admin and route of admin were not reported, batch number: GF 4083, expiry: UNKNOWN) dose was not reported, administered on 27-DEC-2022 for treatment of covid-19. Date of last administration was 28-DEC-2022. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of suspected covid-19 infection was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Suspected COVID-19
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Drug allergy (not reported)
Vorgeschichte
Medical History/Concurrent Conditions: Hip replacement; Comments: Patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2556837

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
PA
Alter
71,0
Geschlecht
M
Eingang
10.01.2023
Impfdatum
21.12.2021
Beginn
01.01.2022
Tage bis Beginn
11,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Muscle twitching

Symptomtext

Muscle twitching. Entire body One year continuous

Weitere VAERSDATA-Felder
Praegender Schweregrund
Muscle twitching
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Amlodipine, benazepril, multiple vitamins
Allergien
None
Vorherige Impfungen
-

VAERS 2546316

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
OH
Alter
34,0
Geschlecht
F
Eingang
30.12.2022
Impfdatum
15.12.2021
Beginn
06.10.2022
Tage bis Beginn
295,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 immunisation Cough SARS-CoV-2 test

Symptomtext

PERSISTENT COUGH; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from a patient via other company (Pfizer) concerned a 35 year old female. Initial information was processed along with the additional information received on 23-DEC-2022. The patient's height, and weight were not reported. The patient's past medical history included: covid-19, and other pre-existing medical conditions included: The patient was not pregnant at the time of vaccination. Patient had no other illnesses. The patient had not received any other vaccines within 4 weeks or any other medications within 2 weeks prior to the covid-19 vaccine. Patient had never before prior to the vaccine had an issue getting over a cough. The patient received dose 1 with covid-19 vaccine ad26.cov2.s (Dose number in series 1), (suspension for injection, route of admin not reported, batch number: 1855191 expiry: UNKNOWN) dose was not reported, 1 total administered on 15-DEC-2021 to left arm for covid-19 prophylaxis. Age at time of vaccination 34 years old. No concomitant medications were reported. It was unknown whether patient had any adverse events following vaccination (Dose number in series 1). The patient also received dose 2 with non-company suspect vaccine Pfizer Biontech Covid-19 Vaccine (tozinameran), (Dose number in series 2), (batch number: GJ6665 expiry: UNKNOWN, form of admin, route of admin were not reported) dose was not reported, administered on 06-OCT-2022 to left arm deltoid for covid-19 prophylaxis which was a revaccination with different covid-19 vaccine (Dose number in series 2). On 04-NOV-2022, Since getting booster shot patient had developed a cough (persistent cough), (Dose number in series 2) and had been treated with antibiotics, advent inhaler, albuterol, breathing treatments, and cough medications and her cough was not going away. On 09-DEC-2022, Laboratory data included: COVID-19 virus test Negative. Treatment medications (dates unspecified) included: salbutamol. The action taken with covid-19 vaccine ad26.cov2.s, and tozinameran was not applicable. The patient had not recovered from persistent cough, and the outcome of revaccination with different covid-19 vaccine was not reported. This report was non-serious. This report was associated with product quality complaint: 90000264514.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19 immunisation
Hospital-Tage
-
Labordaten
Test Date: 20221209; Test Name: ABBOTT NASAL SWAB; Test Result: Negative
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: COVID-19; Comments: The patient was not pregnant at the time of vaccination. Patient had no other illnesses. The patient had not received any other vaccines within 4 weeks or any other medications within 2 weeks prior to the covid-19 vaccine. Patient had never before prior to the vaccine had an issue getting over a cough.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544545

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
TX
Alter
49,0
Geschlecht
M
Eingang
28.12.2022
Impfdatum
02.01.2022
Beginn
05.01.2022
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Acoustic stimulation tests normal Disturbance in attention Tinnitus

Symptomtext

Initiation of consistent, bilateral tinnitus, beginning three days following vaccination. Tinnitus has continued, increasing in intensity since 1/5/22. Tinnitus has interfered with ability to concentrate and work, resulting in canceled freelance contracts/client relationships and loss of work. Hearing test was completed by audiologist, with no signs of hearing loss.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acoustic stimulation tests normal
Hospital-Tage
-
Labordaten
Hearing test - Tinnitus questionnaire -
Aktuelle Erkrankungen
none
Vorgeschichte
-
Andere Medikamente
Advil
Allergien
Naprosyn and Flexeryl
Vorherige Impfungen
-

VAERS 2540921

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
TX
Alter
-
Geschlecht
M
Eingang
22.12.2022
Impfdatum
22.12.2021
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Herpes zoster

Symptomtext

Igot Shingles in July 01, 2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Herpes zoster
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2518081

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
AZ
Alter
62,0
Geschlecht
M
Eingang
28.11.2022
Impfdatum
23.11.2021
Beginn
13.12.2021
Tage bis Beginn
20,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Blood test COVID-19 Epidural injection Hypoaesthesia Magnetic resonance imaging Orthosis user SARS-CoV-2 test positive Tendon operation

Symptomtext

About 3 weeks after receiving the second dose of Janssen Covid vaccine, I woke up and my right arm was completely numb. I didn't pay much attention to the numbness, but within 1 week of this happening, I contacted my doctor. I thought that I just slept wrong and pinched a nerve in my neck. I was referred to a thoracic doctor and he performed a MRI. I went back to my original doctor and at about two months later, I received an epidural in my neck which helped. I tried physical therapy, but that didn't really help. I had surgery on my hand where they had to pull a tendon from the front of my hand to the back. I wear a brace on my hand all the time now. I can almost fully open my hand. I also tested positive for COVID-19 about 6 weeks after the vaccine and I tested positive again 11/16/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blood test
Hospital-Tage
-
Labordaten
COVID-19; MRI; blood work; epidural
Aktuelle Erkrankungen
None
Vorgeschichte
I had a stint put in years ago; depression
Andere Medikamente
Albuterol; omeprazole; famotidine; CYMBALTA; levocetirizine; mirtazapine; CELEBREX; FLONASE; coQ10; fish oil; B complex; multivitamin; probiotics; low dose aspirin
Allergien
Morphine; statin's give me an upset stomach
Vorherige Impfungen
-

VAERS 2497103

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
MD
Alter
52,0
Geschlecht
M
Eingang
03.11.2022
Impfdatum
01.12.2021
Beginn
26.10.2022
Tage bis Beginn
329,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 SARS-CoV-2 test Vaccination failure

Symptomtext

CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 52 year old male of an unspecified race. Initial information was processed along with the additional information received from department on 28-OCT-2022. The patient's weight, height and medical history were not reported. The patient previously received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 204A21A and expiry: 18-FEB-2022) dose was not reported, 1 total administered to the left arm on 05-MAY-2021 for covid-19 prophylaxis. It was unknown whether the patient had any adverse events following vaccination with primary dose of covid-19 vaccine ad26.cov2.s (Dose number in series 1). The patient received booster dose of covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191 expiry: 08-SEP-2022) dose was not reported, 1 total administered to the left arm on 01-DEC-2021 for covid-19 prophylaxis. Age at time of vaccination 52 years old. No concomitant medications were reported. The patient stated that on the previous day of report, on 26-OCT-2022, at morning he coughed and was feeling rundown with a headache, chills and was just tired (coded as confirmed covid-19 infection which led to confirmed clinical vaccination failure). It was also reported that on the day of reporting, on 27-OCT-2022 , the patient got covid and was tested positive with a take home test (Binax Now from Abbott) (Dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the confirmed covid-19 infection and confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint: 90000257104.; Sender's Comments: V0: 20221057885- Confirmed clinical vaccination failure- The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event. Specifically: SPECIAL SITUATIONS. Therefore, this event is considered inconsistent with vaccine administration

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
Test Date: 20221027; Test Name: HOME TEST; Test Result: Positive
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2494109

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
MI
Alter
56,0
Geschlecht
F
Eingang
31.10.2022
Impfdatum
31.01.2022
Beginn
28.10.2022
Tage bis Beginn
270,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after two Janssen vaccines Janssen 3/25/21 Lot# 1802082; Janssen 1/31/2022 Lot# 1855191

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
COVID +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2467054

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
59,0
Geschlecht
F
Eingang
03.10.2022
Impfdatum
09.12.2021
Beginn
10.03.2022
Tage bis Beginn
91,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Biopsy lymph gland Breast conserving surgery Chemotherapy HER2 positive breast cancer Invasive ductal breast carcinoma Magnetic resonance imaging Pathology test Positron emission tomogram Radiotherapy Scan with contrast

Symptomtext

First J&J vaccine was on 4/4/2021. Booster was on 12/9/21 Diagnosed with Invasive Ductal Carcinoma, Grade 3, 2.7 x 2.4 x 3.1 cm ER & PgR Negative, HER2 Positive (Score 3+) Right Breast, Stage 2b No history of breast cancer in my family. Very healthy before this diagnosis. Treatment - (6 cycles) Neoadjuvant Chemotherapy: Trastuzumab, Pertuzumab, DOCEtaxel, CARBOplatin 1st on 4/8/22, last was on 7/22/22. Currently on Trastuzumab every 3 weeks for 14 cycles. Lumpectomy Surgery, Right Breast and Right Sentinal Lymph Node Biopsy - 8/25/22 Radiation Treatment - 20 treatments to begin on 10/5/22 for 4 weeks

Weitere VAERSDATA-Felder
Praegender Schweregrund
Biopsy lymph gland
Hospital-Tage
-
Labordaten
Surgical Pathological Report - 3/7/2022 Tumor Biopsy MRI Bilateral Breast w/Contrast - 3/15/2022 PET Scan - 03/25/2022
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Sertraline, Trazodone, Ibuprofen
Allergien
None
Vorherige Impfungen
-

VAERS 2420832

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
MI
Alter
57,0
Geschlecht
F
Eingang
26.08.2022
Impfdatum
15.12.2021
Beginn
23.08.2022
Tage bis Beginn
251,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after two vaccines Janssen4/6/21 Lot# 1802068; Janssen 12/15/21 Lot# 1855191

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
COVID +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2407323

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
WA
Alter
39,0
Geschlecht
M
Eingang
10.08.2022
Impfdatum
29.01.2022
Beginn
05.02.2022
Tage bis Beginn
7,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Tinnitus

Symptomtext

Tinnitus I have experienced ringing of the ears since about a week after my vaccine was administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tinnitus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2400278

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
-
Alter
52,0
Geschlecht
M
Eingang
03.08.2022
Impfdatum
20.03.2022
Beginn
02.08.2022
Tage bis Beginn
135,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Computerised tomogram neck Lipoma Ultrasound Doppler

Symptomtext

Lipoma developed in between carotid artery and jugular vein. 9.6 cm SI x3.3 cm AP x2.3 cm TV.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Computerised tomogram neck
Hospital-Tage
-
Labordaten
Ultrasound of carotid and CT of neck.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2399158

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
MI
Alter
81,0
Geschlecht
M
Eingang
02.08.2022
Impfdatum
18.11.2021
Beginn
28.07.2022
Tage bis Beginn
252,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after two Janssen vaccines Janssen 3/12/21 Lot# 1805020; Janssen 11/18/21 Lot# 1855191

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
COVID +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2394932

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
MI
Alter
86,0
Geschlecht
F
Eingang
28.07.2022
Impfdatum
13.12.2021
Beginn
25.07.2022
Tage bis Beginn
224,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 2 Janssen vaccines Jannsen 3/22/21 Lot# 1805020; Janssen 12/13/21 Lot# 1855191

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
COVID +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2386845

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
PA
Alter
59,0
Geschlecht
F
Eingang
23.07.2022
Impfdatum
04.01.2022
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Suspected COVID-19

Symptomtext

SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a 60 year old female. Initial information was processed along with the additional information on 15-JUL-2022. The patient's height and weight were not reported. The patient was not pregnant at the time of vaccination. The patient had no any drug allergies. The patient was previously received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of administration were not reported, batch number: 202A21A and expiry: Unknown) dose was not reported, 1 total administered on 09-APR-2021 for covid-19 prophylaxis. It was unknown whether the patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26.cov2.s (dose number in series 1). Age at time of vaccination 58 years old. The patient additionally received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191 and expiry: Unknown) dose was not reported, 1 total administered on 04-JAN-2022 for covid-19 prophylaxis. Age at time of vaccination 59 years old. Concomitant medications included Wellbutrin (bupropion hydrochloride), Vitamin D (ergocalciferol), Valtrex (valaciclovir hydrochloride), Z stack vitamin, Probiotic (bifidobacterium lactis) and steroid dose pack. On an unspecified date in 2022, the patient experienced covid-19 captured as suspected covid-19 infection (dose number in series 2). The patient received non-company co-suspect drug Paxlovid (form of administration, route of administration, batch number and expiry were not reported) dose was not reported, administered from 24-JUN-2022 to 29-JUN-2022 for treatment of COVID-19. The patient was received other medications/products within 2 weeks of starting COVID-19 treatment. It was reported that on 04-JUL-2022, the symptoms returned which include fatigue and scratchy throat subsumed under suspected covid-19 infection (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable and with Paxlovid was not reported. The patient was recovering from suspected covid-19 infection. This report was non-serious. This report was associated with a product quality complaint: 90000242437 and 90000242438.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case was assessed as non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Suspected COVID-19
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: The patient was not pregnant at the time of vaccination. The patient had no any drug allergies.
Andere Medikamente
WELLBUTRIN; VITAMIN D [ERGOCALCIFEROL]; VALTREX; PROBIOTIC [BIFIDOBACTERIUM LACTIS]
Allergien
-
Vorherige Impfungen
-

VAERS 2370036

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
MA
Alter
30,0
Geschlecht
M
Eingang
15.07.2022
Impfdatum
20.12.2021
Beginn
01.01.2022
Tage bis Beginn
12,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Bedridden COVID-19 SARS-CoV-2 test

Symptomtext

CONFIRMED COVID-19 INFECTION; BEDRIDDEN FOR DAYS; This spontaneous report received from a patient concerned a 30 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was pretty healthy before vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: UNKNOWN) dose was not reported, administered on 20-DEC-2021 for prophylactic vaccination. Age at time of vaccination 30 years old. No concomitant medications were reported. On 01-JAN-2022, the patient experienced confirmed covid-19 infection, and bedridden for days. Laboratory data included: COVID-19 virus test Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from confirmed covid-19 infection, and bedridden for days on 05-JAN-2022. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bedridden
Hospital-Tage
-
Labordaten
Test Date: 20220101; Test Name: COVID-19 VIRUS TEST; Test Result: Positive
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: The patient was pretty healthy before vaccination.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2370024

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
15.07.2022
Impfdatum
25.01.2022
Beginn
28.06.2022
Tage bis Beginn
154,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Suspected COVID-19 Vaccination failure

Symptomtext

SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient of unspecified age and sex, race, ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: asthma, herpes simplex, htn (hypertension), and penicillin allergy. The patient patient previously received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 201 a21 a expiry: UNKNOWN) dose was not reported, 1 total administered on 10-APR-2021 for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191 expiry: UNKNOWN) dose was not reported, 1 total administered on 25-JAN-2022 for prophylactic vaccination. Concomitant medications included lisinopril. On an unspecified date, the patient experienced covid-19 infection for which patient received Pfizer drug as a treatment. The patient received non-company co-suspect pfizer drug (unspecified) (form of administration, oral route of administration, batch number, and expiry were not reported) dose was not reported, administered from 18-JUN-2022 to 22-JUN-2022 for treatment of COVID-19. The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment. On 28-JUN-2022, the patient experienced recurrence of covid symptoms (captured as suspected covid-19 infection.) which leds to suspected clinical vaccination failure (Dose number in series 2) The action taken with covid-19 vaccine ad26.cov2.s, and covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected covid-19 infection and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint, and reference number requested.; Sender's Comments: V0- 20220716745-covid-19 vaccine ad26.cov2.s-Suspected clinical vaccination failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Suspected COVID-19
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Asthma; Herpes simplex; Hypertension; Penicillin allergy
Vorgeschichte
-
Andere Medikamente
LISINOPRIL
Allergien
-
Vorherige Impfungen
-

VAERS 2344706

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CT
Alter
59,0
Geschlecht
F
Eingang
30.06.2022
Impfdatum
29.06.2022
Beginn
29.06.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Interchange of vaccine products

Symptomtext

Patient came in for 2nd Pfizer Covid19 booster vaccination (4th total in series). Pharmacist mistakenly administered 0.3 mL of Janssen Covid19 vaccine instead of Pfizer Covid19 booster at approximately 12:16 PM on 6/29/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
Unknown
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Cardiac arrhythmia; Hypothyroidism; other conditions unknown.
Andere Medikamente
Sertraline; Flecainide; Metformin er; Metoprolol er; Levothyroxine; Topiramate;
Allergien
Penicillin; Sulfa; Shellfish.
Vorherige Impfungen
-

VAERS 2331953

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
TN
Alter
35,0
Geschlecht
F
Eingang
24.06.2022
Impfdatum
18.05.2022
Beginn
18.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

Pt administered Immunocompromised dose but is not considered Immunocompromised for DM2 Dx. No adverse symptoms or reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
-
Vorgeschichte
DM 2, HTN
Andere Medikamente
amLODIpine butalbital glyBURIDE losartan MedroxyPROGESTERone pioglitazone triamcinolone venlafaxine Wellbutrin
Allergien
Lisinopril IBU Azithromycin
Vorherige Impfungen
-

VAERS 2313450

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
MO
Alter
63,0
Geschlecht
F
Eingang
08.06.2022
Impfdatum
20.05.2022
Beginn
20.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Wrong product administered

Symptomtext

Patient requested the Pfizer COVID vaccine but received 03ml of the Janssen COVID vaccine instead. No side effects were reported when we let the patient know about the error later that day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2313446

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
MO
Alter
63,0
Geschlecht
M
Eingang
08.06.2022
Impfdatum
20.05.2022
Beginn
20.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administration error Wrong product administered

Symptomtext

Pt requested Pfizer COVID vaccine but was administered 0.3 ml of Janssen instead. No side effects were reported after letting the patient know about the error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2313109

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
MI
Alter
89,0
Geschlecht
F
Eingang
08.06.2022
Impfdatum
05.01.2022
Beginn
03.06.2022
Tage bis Beginn
149,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Confirmed Breakthrough case COVID-19 (Janssen) 1 03/25/2021 Janssen 1802068 COVID-19 (Janssen) 2 01/05/2022 Janssen 1855191

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
Positive PCR Covid test - 6/3/2022
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282682

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
18.05.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered Product storage error

Symptomtext

ADMINISTRATION OF VACCINE FOR MORE THAN 6 HOURS AFTER THE FIRST VIAL PUNCTURE (VIALS STORED IN THE FRIDGE AFTER PUNCTURE) (OUT OF SPECIFICATION PRODUCT USE); INCORRECT PRODUCT STORAGE; This spontaneous report received from a health care professional concerned multiple patients. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced administration of vaccine for more than 6 hours after the first vial puncture (vials stored in the fridge after puncture) (out of specification product use), and incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the incorrect product storage and administration of vaccine for more than 6 hours after the first vial puncture (vials stored in the fridge after puncture) (out of specification product use) was not reported. This report was non-serious. This case, from the same reporter is linked to 20220527916, 20220528115, 20220528178 and 20220528223.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2265998

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
MI
Alter
60,0
Geschlecht
M
Eingang
06.05.2022
Impfdatum
05.05.2022
Beginn
05.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Client was vaccinated with a J &J vaccine. This was the clients first J &J vaccine. Upon reviewing inventory, the vaccine was beyond use date after client recieved it.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2254071

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
-
Geschlecht
M
Eingang
27.04.2022
Impfdatum
-
Beginn
24.04.2022
Tage bis Beginn
-
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration Off label use

Symptomtext

OFF LABEL USE; INAPPROPRIATE SCHEDULE OF VACCINE ADMINISTERED; This spontaneous report received from a health care professional concerned a 61 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient was previously treated with covid-19 vaccine ad26. cov2. s (Dose number in series 1) (suspension for injection, route of admin and batch number were not reported, expiry: unknown) dose was not reported, 1 total, administered on 06-APR-2021 for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (Dose number in series 1). The patient was previously treated with booster dose of covid-19 vaccine ad26. cov2. s (Dose number in series 2) (suspension for injection, route of admin and batch number were not reported, expiry: unknown) dose was not reported, 1 total, administered on 10-NOV-2021 for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with booster dose of covid-19 vaccine ad26. cov2.s (Dose number in series 2). The patient additionally received secondary booster of covid-19 vaccine ad26.cov2.s (Dose number in series 3) (suspension for injection, route of admin not reported, batch number: 1855191, expiry: 08-SEP-2022) dose was not reported, 1 total administered on 24-APR-2022 for prophylactic vaccination which was inappropriate schedule of vaccine administered and off label use (Dose number in series 3). No concomitant medications were reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the inappropriate schedule of vaccine administered and off label use was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2246353

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
62,0
Geschlecht
M
Eingang
21.04.2022
Impfdatum
21.04.2022
Beginn
21.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Wrong product administered

Symptomtext

Patient came in for booster shot and requested Janssen vaccine. However, after vaccination realized patient had already received a booster shot of Janssen in November (his primary dose was also Janssen), so this would be his second booster. Since patient getting 2nd booster he should have received either Moderna or Pfizer (since these are the 2 vaccinations approved for the 2nd booster). Made patient aware of this and at this point he was doing well--no adverse effects as of yet.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2233756

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
WI
Alter
66,0
Geschlecht
F
Eingang
14.04.2022
Impfdatum
09.12.2021
Beginn
01.02.2022
Tage bis Beginn
54,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blister Heavy metal test Laboratory test

Symptomtext

I received my Dose 2, J and J, on 12/09/2021, Lot 1855191. Approximately two months later I stated to have water fill blisters on the left side of my body. They appeared below the bicep, up the arm, down to the lower arm top and bottom then the wrist. March 28, 2022 went my primary who prescribed Gastro Chom Cromolyn Sodium 100mg per 5ml 4 anfills a day, new medication and not associated with her pre-existing issue with hives. I still under nurse practitioner who is my primary care. April 4, 2022, I saw my allergist results was shared with the allergist. The results concluded that I was in the normal limits for metal. The Nedian test showed not free floating nedian in the system. I am still under insurance for this new condition of water fill blisters, with primary and issue not been resolved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blister
Hospital-Tage
-
Labordaten
LTT blood test by primary care provider and results was shared with the allergist and the results concluded that I was in the normal limits for metal. The Nedian test showed not free floating nedian in the system. PRC test was taken and never been diagnosed.
Aktuelle Erkrankungen
No
Vorgeschichte
Ehlers-Danlos Syndrome
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
1993 or 1994 Flu vaccination and not longer get Flu shot.

VAERS 2226822

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
-
Alter
17,0
Geschlecht
F
Eingang
11.04.2022
Impfdatum
27.03.2022
Beginn
27.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

To my knowledge, the patient/client did not suffer a physical adverse reaction to this vaccine. The "J&J" vaccine appears to have been given to a 17 year-old. The administration of this particular vaccine to a 17 year-old client being the primary adverse event. The 17 year age and birthdate are those reported by the client.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2217222

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
MI
Alter
61,0
Geschlecht
F
Eingang
06.04.2022
Impfdatum
01.04.2022
Beginn
02.04.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Herpes zoster

Symptomtext

Herpes zoster infection within 24 hours of vaccination

Weitere VAERSDATA-Felder
Praegender Schweregrund
Herpes zoster
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Mone
Vorgeschichte
Long Covid
Andere Medikamente
None
Allergien
Bee stings
Vorherige Impfungen
vomiting and diarrhea

VAERS 2214213

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
NC
Alter
72,0
Geschlecht
F
Eingang
04.04.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

Patient received a second booster (3 total) of Janssen vaccine before it got approved. Patient experienced AEs at the time of administration. Will follow up with patient 1 day after, 1 week after and 1 month after the shot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2214204

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
NC
Alter
71,0
Geschlecht
M
Eingang
04.04.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

Patient received a second booster (3 total) of Janssen vaccine before it got approved. Patient experienced AEs at the time of administration. Will follow up with patient 1 day after, 1 week after and 1 month after the shot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2214186

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
NC
Alter
92,0
Geschlecht
F
Eingang
04.04.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

Patient received a second booster (3 total) of Janssen vaccine before it got approved. Patient experienced no AEs at the time of administration. Will follow up with patient 1 day after, 1 week after, and 1 month after the shot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2192427

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
60,0
Geschlecht
M
Eingang
22.03.2022
Impfdatum
21.03.2022
Beginn
21.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Interchange of vaccine products

Symptomtext

Pt presented to vaccination site and requested Janssen COVID vaccine booster dose. Patient received Sinovac 1st dose on 3/11/21 and Sinovac 2nd dose 4/9/21. RN 1 educated patient on health risks of Janssen COVID vaccine. Patient verbalized understanding and requested Janssen COVID vaccine booster dose. RN 1 submitted a medical consult via Patient presented to vaccination site and requested Janssen COVID-19 vaccine booster dose. Patient received Pfizer 1st dose on 3/26/21 and Pfizer 2nd dose 4/14/21. RN 1 educated patient on health risks of Janssen COVID-19 vaccine. Patient verbalized understanding and requested Janssen COVID-19 vaccine booster dose. RN 1 submitted a medical consult via collaboration app to clinical project coordinators requesting to proceed with Janssen COVID-19 vaccine. Clinical project coordinator RN 2 elevated request to medical consult team. MD 1 from medical consult team approved request for Janssen COVID-19 vaccine booster dose. On 3/21/21, patient received Janssen COVID-19 vaccine (lot 1855191) booster dose at 1359. EMT 1 educated patient on signs and symptoms of adverse reactions, when to seek emergency care, and to register on v-safe. At approximately 1415, patient left facility with unlabored respirations and steady gait. to Clinical Project Coordinators requesting to proceed with Janssen COVID vaccine. Clinical Project Coordinator RN 2 elevated request to medical consult team. MD 1 from medical consult team approved request for Janssen COVID vaccine booster dose. On 3/21/22, patient received Janssen COVID vaccine (LOT# 1855191) booster dose at 1401. EMT 1 educated patient on signs and symptoms of adverse reactions, when to seek emergency care, and to register on V-Safe. At approximately 1415, patient left facility with unlabored respirations and steady gait.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
None reported
Vorherige Impfungen
-

VAERS 2192418

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
60,0
Geschlecht
F
Eingang
22.03.2022
Impfdatum
21.03.2022
Beginn
21.03.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Interchange of vaccine products

Symptomtext

Pt presented to vaccination site and requested Janssen COVID vaccine booster dose. Patient received Pfizer 1st dose on 3/26/21 and Pfizer 2nd dose 4/14/21. RN 1 educated patient on health risks of Janssen COVID vaccine. Patient verbalized understanding and requested Janssen COVID vaccine booster dose. RN 1 submitted a medical consult via Patient presented to vaccination site and requested Janssen COVID-19 vaccine booster dose. Patient received Pfizer 1st dose on 3/26/21 and Pfizer 2nd dose 4/14/21. RN 1 educated patient on health risks of Janssen COVID-19 vaccine. Patient verbalized understanding and requested Janssen COVID-19 vaccine booster dose. RN 1 submitted a medical consult via collaboration app to clinical project coordinators requesting to proceed with Janssen COVID-19 vaccine. Clinical project coordinator RN 2 elevated request to medical consult team. MD 1 from medical consult team approved request for Janssen COVID-19 vaccine booster dose. On 3/21/21, patient received Janssen COVID-19 vaccine (lot 1855191) booster dose at 1359. EMT 1 educated patient on signs and symptoms of adverse reactions, when to seek emergency care, and to register on v-safe. At approximately 1415, patient left facility with unlabored respirations and steady gait. to Clinical Project Coordinators requesting to proceed with Janssen COVID vaccine. Clinical Project Coordinator RN 2 elevated request to medical consult team. MD 1 from medical consult team approved request for Janssen COVID vaccine booster dose. On 3/21/21, patient received Janssen COVID vaccine (LOT# 1855191) booster dose at 1359. EMT 1 educated patient on signs and symptoms of adverse reactions, when to seek emergency care, and to register on V-Safe. At approximately 1415, patient left facility with unlabored respirations and steady gait.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None reported
Vorgeschichte
None reported
Andere Medikamente
None reported
Allergien
None reported
Vorherige Impfungen
-

VAERS 2192265

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
38,0
Geschlecht
M
Eingang
22.03.2022
Impfdatum
21.03.2022
Beginn
21.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

Client presented to Clinic on 03/21/2022 requesting Janssen booster. Client received Janssen booster Lot # 1855191 at 3:41pm. Client did not report any symptoms during the 15-minute observation period. Client left the vaccination site at 3:56pm with steady gait. At 4:35pm, vaccinator informed lead RN that Janssen vial had passed its beyond use time of 3:05pm. Lead RN submitted a medical consult to COVID vaccine coordinators in regards to how to proceed with incident. Janssen medical representatives were contacted and were explained the incident. Per the Janssen representative, Janssen has not conducted studies to evaluate the efficacy and safety following administration of expired vaccine or vaccines stored outside of the recommended storage conditions. Janssen representative stated that recommended procedures following incident would have to come from own clinical judgment since no further guidance is available. Vaccine coordinator submitted medical consult to two doctors on staff. Both doctors stated that revaccination would not be required; however, client has the option to be revaccinated at any time frame with any COVID vaccine. Client was contacted by lead RN. RN explained that we spoke to Janssen manufacturer and two doctors on staff about how to proceed. We offered revaccination at any time frame with any COVID vaccine. Client stated he is not interested in getting revaccinated. COVID vaccination staff were counseled on proper storage and handling of Janssen vaccine. Staff agreed to set an alarm to remind staff 6 hours has passed for when Janssen vial is unusable.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2184336

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
20,0
Geschlecht
M
Eingang
17.03.2022
Impfdatum
14.12.2021
Beginn
14.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Client received the COVID vaccine Janssen first dose (Lot# 1855191 exp. 04/11/2022) at 4:53 PM administered . While reviewing the participant forms, RN noted the vaccine was administered 53 minutes after beyond use date (time) of 4:00 PM. RN verified with the vaccine preparer the beyond use date (time) was 4:00PM and the vial was punctured at 10:00AM. RN elevated the information to Clinical Project Coordinators. The Clinical Project Coordinators elevated the information to the manufacturer Janssen and consulted with our medical team. The medical consult team's recommendation was to not proceed with a repeat dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2184320

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
36,0
Geschlecht
M
Eingang
17.03.2022
Impfdatum
14.12.2021
Beginn
14.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Client received the COVID vaccine Janssen booster (Lot# 1855191 exp. 04/11/2022) on 12/14/21 at 4:33 PM administered. While reviewing the participant forms, RN noted the vaccine was administered 33 minutes after beyond use date (time) of 4:00 PM. RN verified with the vaccine preparer that the vial was punctured at 10:00AM and the beyond use date (time) was 4:00PM. RN elevated the information to Vaccine Operations Leads. Vaccine Operations Leads elevated the information to the manufacturer Janssen and consulted with our medical team. The medical consult team's recommendation was not to proceed with a repeat dose. RN educated client on possible adverse reactions, signs and symptoms of Guillain-Barre syndrome, signs and symptoms of thrombosis with thrombocytopenia syndrome, and when to seek medical care. The client voiced understanding of this education.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown.
Vorgeschichte
Unknown.
Andere Medikamente
Unknown.
Allergien
Unknown.
Vorherige Impfungen
-

VAERS 2171023

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
28,0
Geschlecht
M
Eingang
10.03.2022
Impfdatum
10.03.2022
Beginn
10.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Device connection issue Syringe issue Underdose

Symptomtext

UPON VACCINATION THE HUB OF THE NEEDLE BECAME LOOSE AND AN UNKNOWN AMOUNT OF VACCINE LEAKED OUT ONTO PATIENTS ARM. PATIENT WAS ADVISED AND OFFERED A REPEAT DOSE. PATIENT REFUSED TO REPEAT THE DOSE.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Device connection issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
UNKNOWN
Vorgeschichte
UNKNOWN
Andere Medikamente
UNKNOWN
Allergien
UNKNOWN
Vorherige Impfungen
-

VAERS 2155983

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
54,0
Geschlecht
F
Eingang
04.03.2022
Impfdatum
28.11.2021
Beginn
08.12.2021
Tage bis Beginn
10,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Tinnitus

Symptomtext

Experiencing chronic ringing in the ears, mainly left ear. Range from low pitch to high pitch. It is now March, and the ringing has become more chronic.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tinnitus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2194007

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
-
Alter
73,0
Geschlecht
M
Eingang
02.03.2022
Impfdatum
18.01.2022
Beginn
21.01.2022
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Unevaluable event

Symptomtext

Narrative:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2148529

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
48,0
Geschlecht
F
Eingang
28.02.2022
Impfdatum
28.02.2022
Beginn
28.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Interchange of vaccine products No adverse event

Symptomtext

Client presented to ECC vaccination site to receive Janssen Booster. Client informed RN that when she received Pfizer series dose 1 on 12/30/20 and Pfizer dose 2 1/18/21, Client states she developed hives all over the body and fever the same night of both doses 5-6 hrs. after the vaccine. Client denies having shortness of breath, and no itching. Client took Tylenol for symptoms. Client states she didn?t seek emergency care. Client?s primary care provider Dr informed her it was a normal reaction and was ok for her to receive Pfizer booster. Client has no known allergies and no medical conditions. It?s never happened with other vaccines. She?s here to get Janssen, although Dr didn?t recommend Janssen, but recommended Pfizer. Client is afraid of getting Pfizer again. RN submitted a medical consult. MD approved for client to receive Janssen booster. Client was vaccinated with Janssen booster lot#1855191 by RN. Client was educated on Emergency precautions and signs and symptoms of blood clots. Client waited in observation area for 30 minutes, no symptoms were reported. Client left vaccination site in a steady gait.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
unknown
Aktuelle Erkrankungen
unknown
Vorgeschichte
no medical conditions reported
Andere Medikamente
none reported
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2131774

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
FL
Alter
61,0
Geschlecht
M
Eingang
22.02.2022
Impfdatum
04.01.2022
Beginn
19.01.2022
Tage bis Beginn
15,0
Dosis
2
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Unevaluable event

Symptomtext

Hospitalization

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
6,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2131284

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
KY
Alter
47,0
Geschlecht
F
Eingang
22.02.2022
Impfdatum
03.02.2022
Beginn
03.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cardiac flutter Contusion Dysgeusia

Symptomtext

As of today, patient reported that she still has a bruise and fluttering heart beat. She reported a metallic taste on the day the vaccine was given.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac flutter
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None listed
Vorgeschichte
Nerve problems, Asthma
Andere Medikamente
None listed
Allergien
Mega Red, Tumeric, Allegra, Claritin, eggs, latex
Vorherige Impfungen
-

VAERS 2128477

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
NJ
Alter
17,0
Geschlecht
M
Eingang
20.02.2022
Impfdatum
28.12.2021
Beginn
28.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

Janssen COVID-19 vaccine administered to patient who is 17 years old. Spoke to the patient and states he feels fine, no reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2128338

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
29,0
Geschlecht
M
Eingang
19.02.2022
Impfdatum
19.02.2022
Beginn
19.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hyperhidrosis Unresponsive to stimuli

Symptomtext

Vaccinator, RN, was speaking with the client immediately after vaccination when she realized his eyes were closed, chin was down, and his flexed legs became extended. RN, called for assistance. Lead RN, came over to assess. Client was unresponsive, his eyes were closed, and he was leaning forward. Lead RN, attempted a sternal rub without any response from the client. The client was unresponsive from stimulus. Called for Co-lead RN, to call 911. At 1227, RN, called 911. At 1226, the client became responsive. He was shocked when he opened his eyes and did not immediately know where he was. Within 30 seconds, the client became oriented. Client is AOx4. Client sweaty in appearance. At 1228 EMT, checked vital signs. BP: 121/55, HR: 57, SPO2: 100%, RR: 16. At 1229, client asked to lay down. EMT, and RN, assisted client into the anti-gravity chair. Client reports no medical history. No history of allergies. Client self reported that he has become unresponsive before when giving blood approximately 2 years ago. He reports he did not eat breakfast. At 1234, vital signs re-checked. BP: 125/68, HR: 68, SPO2: 100%, RR: 16. Client provided with water, juice, and a snack. He consumed all of the juice and majority of the snack when EMS arrived. EMS arrived at 1236. Per the paramedics, all of the client's vital signs were within normal range. Paramedics checked the client's blood sugar. Blood sugar was 84. Client refused to go with the ambulance and signed AMA. Client remained in the anti-gravity chair. Vital signs checked again at 1248. BP: 124/55, HR: 59, SPO2: 100%, RR: 16. Client asked if he could walk around outside in the sun. Client stood up without assistance. Lead RN, observed the client walking with a steady gait. RN, monitored the client while he walked around outside. Client reports he "feels good". Client sat down in chair. Another set of vitals taken. BP: 134/75, HR: 64, SPO2: 100%, RR: 16.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hyperhidrosis
Hospital-Tage
-
Labordaten
Unknown
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2127952

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge 1855191

gering
Staat
GA
Alter
19,0
Geschlecht
M
Eingang
19.02.2022
Impfdatum
03.09.2020
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event

Symptomtext

None stated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2092745

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
FL
Alter
41,0
Geschlecht
M
Eingang
07.02.2022
Impfdatum
28.10.2021
Beginn
24.01.2022
Tage bis Beginn
88,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration

Symptomtext

None

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Biktarvy
Allergien
None
Vorherige Impfungen
-

VAERS 2087109

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
04.02.2022
Impfdatum
-
Beginn
28.01.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered Product storage error

Symptomtext

INCORRECT PRODUCT STORAGE; VACCINE WAS GIVEN TO 4 PATIENTS AFTER IT WAS REFROZEN AND RETHAWED; This spontaneous report received from a health care professional concerned multiple patients. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191 expiry: 11-APR-2022) dose was not reported, administered on 28-JAN-2022, and dose was not reported, administered on 31-JAN-2022 for prophylactic vaccination. No concomitant medications were reported. On 28-JAN-2022, the patient experienced vaccine was given to 4 patients after it was refrozen and rethawed. On an unspecified date, the patient experienced incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine was given to 4 patients after it was refrozen and rethawed and incorrect product storage was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2084740

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
03.02.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Oxygen saturation Suspected COVID-19 Vaccination failure

Symptomtext

SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient via social media from a company representative concerned a patient of unspecified age, sex, race and ethnicity. Initial information was processed along with additional information received on 21-JAN-2022. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1855191 expiry: UNKNOWN) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced omicron (coded as suspected covid-19 infection and suspected clinical vaccination failure), and and was hospitalized (date unspecified) for 3 days. (Dose number in series 1) Laboratory data (dates unspecified) included: Oxygen (NR: not provided) low. It was reported as "I take your vaccine and booster 4 days after I got my booster I was sick, I was in the hospital with omicron for 3 days" The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected clinical vaccination failure and suspected covid-19 infection was not reported. This report was serious (Hospitalization Caused / Prolonged). This case was associated with product quality complaint number 90000213232. The suspected product quality complaint has been confirmed to be the reported allegation could not be determined. A manufacturing related root cause could not be identified based on the PQC evaluation/investigation performed. This case, involving the same patient is linked to 20220145043 (dose number in series 2). This case, from the same reporter is linked to 20220139924.; Sender's Comments: V0: 20220139342-COVID-19 VACCINE AD26.COV2.S- Suspected clinical vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS 20220139342-COVID-19 VACCINE AD26.COV2.S- Suspected covid-19 infection. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Oxygen saturation
Hospital-Tage
3,0
Labordaten
Test Name: Oxygen saturation; Result Unstructured Data: low
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2079468

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
46,0
Geschlecht
M
Eingang
01.02.2022
Impfdatum
19.11.2021
Beginn
25.11.2021
Tage bis Beginn
6,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Musculoskeletal discomfort Musculoskeletal stiffness

Symptomtext

Left shoulder not functioning like before. Almost stiff.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Musculoskeletal discomfort
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2075001

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
PA
Alter
55,0
Geschlecht
F
Eingang
30.01.2022
Impfdatum
05.12.2021
Beginn
27.12.2021
Tage bis Beginn
22,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Postmenopausal haemorrhage

Symptomtext

POSTMENOPAUSAL 26 MONTHS, BEGAN MENSTRUAL BLEEDING 21 DAYS AFTER J& J COVID VACCINE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Postmenopausal haemorrhage
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
ZOLOFT
Allergien
NKA
Vorherige Impfungen
-

VAERS 2068443

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
FL
Alter
46,0
Geschlecht
M
Eingang
27.01.2022
Impfdatum
10.12.2021
Beginn
20.01.2022
Tage bis Beginn
41,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
SARS-CoV-2 test Suspected COVID-19 Vaccination failure

Symptomtext

SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 46 year old white male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received covid-19 vaccine ad26. cov2. s (Janssen, Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1808609, expiry: UNKNOWN) dose was not reported, 1 total, administered on 25-MAR-2021 into right arm for prophylactic vaccination. It was unknown whether patient had any adverse event following vaccination with covid-19 vaccine ad26.cov2.s (Dose number in series 1) The patient received covid-19 vaccine ad26.cov2.s (Janssen, Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191, expiry: UNKNOWN) dose was not reported, 1 total, administered on 10-DEC-2021 into right arm for prophylactic vaccination. No concomitant medications were reported. On 20-JAN-2022, the patient tested positive for COVID-19 with rapid at home kit test, earlier he tested negative with a home kit test and later in the day around 15:00 he tested again and tested positive. Hence coded suspected clinical vaccination failure, and suspected covid-19 infection. The patient had slight cough and a headache (Subsumed under suspected covid-19 infection) that had been resolved on same day (Dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from suspected covid-19 infection, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint.; Sender's Comments: V0:20220139590-COVID-19 VACCINE AD26.COV2.S-Suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS

Weitere VAERSDATA-Felder
Praegender Schweregrund
SARS-CoV-2 test
Hospital-Tage
-
Labordaten
Test Date: 20220120; Test Name: SARS-CoV-2 rapid diagnostic test; Result Unstructured Data: Positive; Test Date: 20220120; Test Name: SARS-CoV-2 rapid diagnostic test; Result Unstructured Data: Negative
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2065432

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CO
Alter
16,0
Geschlecht
M
Eingang
26.01.2022
Impfdatum
14.12.2021
Beginn
14.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

Patient has a rare autoimmune syndrome called Aicardi-Goutieres, in which the body attacks DNA and potentially RNA in the patients body. Therefore, his primary care neurologist and immunologist have recommended that he get the Janssen vaccine as they feel it will pose less of a risk of side effects in regards to his conditions. The decision to give the patient this vaccine although he is under the age at this time was discussed with MD, MD, MD and the DH safety committee.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Aicardi-Goutieres
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2062662

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
-
Alter
23,0
Geschlecht
F
Eingang
25.01.2022
Impfdatum
08.01.2022
Beginn
08.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

J&J vaccine was dispensed and believed to not be expired. The expiration on the label only had the time of expiration and not the date. The vaccine actually expired the day prior. It was sent to the floor for administration and was subsequently given to the patient. Patient was scheduled for revaccination

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2058732

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
DC
Alter
30,0
Geschlecht
M
Eingang
24.01.2022
Impfdatum
24.01.2022
Beginn
24.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Extra dose administered

Symptomtext

patient received multiple of booster shot dose of vaccine which is against protocol

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2057898

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
30,0
Geschlecht
M
Eingang
23.01.2022
Impfdatum
04.01.2022
Beginn
07.01.2022
Tage bis Beginn
3,0
Dosis
N/A
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Tinnitus

Symptomtext

Constant noticeable tinnitus. Started within 3 days after receiving the Janssen vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tinnitus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2051349

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
WA
Alter
66,0
Geschlecht
M
Eingang
20.01.2022
Impfdatum
18.01.2022
Beginn
19.01.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Tinnitus

Symptomtext

Woke up with severe tinnitus

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tinnitus
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
Amlodipin, multiple vitamin
Allergien
eggs walnuts
Vorherige Impfungen
-

VAERS 2048169

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
NJ
Alter
53,0
Geschlecht
F
Eingang
19.01.2022
Impfdatum
19.01.2022
Beginn
19.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered Interchange of vaccine products No adverse event Wrong product administered

Symptomtext

On 1/19/2022, patient given Janssen vaccine instead of Shingrix vaccine. She completed Pfizer vaccine series in additional of the Pfizer booster Dec 2021. No adverse events noted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
-
Allergien
None
Vorherige Impfungen
-

VAERS 2047933

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
OH
Alter
56,0
Geschlecht
F
Eingang
19.01.2022
Impfdatum
17.12.2021
Beginn
18.12.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Swollen tongue

Symptomtext

second jandj vaccine on 12-17, that evening face and chest were red. On 12-18 in the afternoon tongue started swelling, no problem swallowing or breathing. Says does have difficulty swallowing when mask in place. No chest pain or dysnpna , no nausea or vomiting or diarrhea. No rash but feels her tongue is swollen. Allergy to latex but denies exposure. No history of anaphylaxis or adrenaline use. Patient took 25mg benadryl 1 hour prior to arrival in ED.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2047694

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
AR
Alter
17,0
Geschlecht
M
Eingang
19.01.2022
Impfdatum
08.01.2022
Beginn
08.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

The patient was under 18 yrs old that was overlooked by the vaccinator. The patient is fine and no treatment has been needed. The error was only noticed as the consent form was being filed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
No Treatment has been needed and patient is fine.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2043382

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
54,0
Geschlecht
F
Eingang
18.01.2022
Impfdatum
10.01.2022
Beginn
10.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Tinnitus

Symptomtext

Booster Shot. Very soon after getting the shot I started having tinnitis and to this date of reporting it has not stopped.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tinnitus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Hypertension
Andere Medikamente
Losartan
Allergien
Percocet
Vorherige Impfungen
-

VAERS 2039383

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
57,0
Geschlecht
M
Eingang
17.01.2022
Impfdatum
07.12.2021
Beginn
14.01.2022
Tage bis Beginn
38,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erectile dysfunction

Symptomtext

Janssen COVID-19 Vaccine EUA I have been married with my female spouse for over thirty years and we have two adult children. We still have an active sexual life, but I am now having difficulty having an erection. I exercise every day, I have a very balanced and healthy diet and I can't think of anything else that could have created this adverse effect. I sent the message to my doctor's office today.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erectile dysfunction
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2038316

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
MA
Alter
58,0
Geschlecht
F
Eingang
16.01.2022
Impfdatum
27.11.2021
Beginn
28.11.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Tinnitus Vertigo

Symptomtext

Tinnitus and Vertigo

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tinnitus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
none
Allergien
-
Vorherige Impfungen
-

VAERS 2037725

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 1855191

gering
Staat
MD
Alter
16,0
Geschlecht
F
Eingang
15.01.2022
Impfdatum
14.01.2022
Beginn
14.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

The patient comes in to get Pfizer booster vaccine, and Moderna booster (0.25 ml) was administered by mistake

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2036169

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
63,0
Geschlecht
M
Eingang
14.01.2022
Impfdatum
14.01.2022
Beginn
14.01.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

Client was last vaccinated on 12/17/21 and was given a too early booster on 1/14/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
N/A; patient was monitored for 15 minutes post-vaccination and he denied any side effects or adverse effects.
Aktuelle Erkrankungen
None
Vorgeschichte
Unknown
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2036101

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
-
Alter
57,0
Geschlecht
M
Eingang
14.01.2022
Impfdatum
14.01.2022
Beginn
14.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Interchange of vaccine products

Symptomtext

Client presented to the vaccination site on 01/14/2022. The client notified RN that he received a first dose of Moderna on 04/14/2021 and is here for the first dose of Janssen. Per client, he develop hives all over body approximately 8 hours after administration. No other symptoms were reported, per client he was taken to the nearest hospital by family member and was given oral benadryl and oral prednisone. Client stated he never received second Moderna dose. Per client, he has heart conditions and is taking daily metoprolol and atrovastatin and allergic to Brazilian almonds. RN submitted a medical consult via text message to Vaccine Operations Leads, requesting to proceed with the COVID vaccine Janssen. Approval to administer COVID vaccine Janssen was obtained from medical consult team via text message from MD. Client received COVID vaccine Janssen Lot# 1855191 on 01/14/2022. The client did not report any symptoms during the 30 minute observation period. RN educated client on possible adverse reactions and when to seek medical care. The client left the vaccination site at 2:28pm with a steady gait. VAERS completed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
heart conditions
Andere Medikamente
metropolol and atrovastatin
Allergien
Brazilian almonds
Vorherige Impfungen
-

VAERS 2035038

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
FL
Alter
48,0
Geschlecht
F
Eingang
14.01.2022
Impfdatum
07.01.2022
Beginn
12.01.2022
Tage bis Beginn
5,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Intermenstrual bleeding

Symptomtext

Pink discharge/spotting in between menstrual cycle, began 05Jan2022. Last menstrual cycle ended on 03Jan2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intermenstrual bleeding
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2032886

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
VA
Alter
17,0
Geschlecht
M
Eingang
13.01.2022
Impfdatum
29.12.2021
Beginn
29.12.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Underdose

Symptomtext

Patient was given 0.3mls of janssen but was intended to get pfizer

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2032879

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
VA
Alter
39,0
Geschlecht
M
Eingang
13.01.2022
Impfdatum
29.12.2021
Beginn
29.12.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

Patient was given 0.3mls of janssen but was intended to get pfizer

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2032875

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
VA
Alter
19,0
Geschlecht
F
Eingang
13.01.2022
Impfdatum
29.12.2021
Beginn
29.12.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

Patient was given 0.3mls of janssen but was intended to get pfizer

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2032867

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
VA
Alter
56,0
Geschlecht
F
Eingang
13.01.2022
Impfdatum
29.12.2021
Beginn
29.12.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Underdose

Symptomtext

Patient was given 0.3mls of janssen but was intended to get pfizer

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2027082

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
FL
Alter
-
Geschlecht
M
Eingang
12.01.2022
Impfdatum
29.12.2021
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19

Symptomtext

COVID-19 INFECTION; This spontaneous report received from a patient male. The patient's height and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received bnt 162 (Dose number in series was 1) (form of admin, route of admin, and batch number were not reported) dose was not reported, administered on an unspecified date in APR-2021 for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with bnt 162 (Pfizer). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series was 2) (suspension for injection, route of admin not reported, batch number: 1855191 and expiry: UNKNOWN) dose was not reported, 1 total, administered on 29-DEC-2021 on left deltoid for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced covid-19 infection (Dose number in series was 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid-19 infection was not reported. This report was non-serious. This report was associated with product quality complaint 90000210119. The suspected product quality complaint has been confirmed to be voided (did not meet Regulatory Authority criteria since infection occurred less than 14 days after receiving the booster shot) based on the Regulatory Authority evaluation/investigation performed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2020420

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
10.01.2022
Impfdatum
-
Beginn
06.01.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered

Symptomtext

ADMINISTRATION OF A DOSE OF THE VACCINE 6 HOURS AND 20 MINUTES AFTER FIRST PUNCTURE OF THE VIAL; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191,expiry: UNKNOWN) dose was not reported, administered on 06-JAN-2022 for prophylactic vaccination. No concomitant medications were reported. On 06-JAN-2022, the patient experienced administration of a dose of the vaccine 6 hours and 20 minutes after first puncture of the vial. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of a dose of the vaccine 6 hours and 20 minutes after first puncture of the vial was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2017600

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
WA
Alter
25,0
Geschlecht
M
Eingang
08.01.2022
Impfdatum
-
Beginn
30.12.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered

Symptomtext

OUT OF SPECIFICATION PRODUCT USE (VIAL WAS PUNCTURED APPROXIMATELY 28-DEC-2021 AT 9:00 AND THEN DOSE WAS ADMINISTERED TO THE PATIENT ON 30-DEC-2021 AT 9:00 IN THE MORNING); This spontaneous report received from a health care professional concerned a 25 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: UNKNOWN) dose was not reported, administered on 30-DEC-2021 09:00 for prophylactic vaccination. No concomitant medications were reported. On 30-DEC-2021, the patient experienced out of specification product use (vial was punctured approximately 28-dec-2021 at 9:00 and then dose was administered to the patient on 30-dec-2021 at 9:00 in the morning). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of out of specification product use (vial was punctured approximately 28-dec-2021 at 9:00 and then dose was administered to the patient on 30-dec-2021 at 9:00 in the morning) was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2014560

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge 1855191

gering
Staat
IL
Alter
64,0
Geschlecht
M
Eingang
07.01.2022
Impfdatum
06.01.2022
Beginn
07.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

patient came in to get booster vaccine and received janssen booster dose at 4:18pm. however, the vial was initial puncuntred at 10 am so patient received dose after 6 hour window. BUD for vaccine 10-4pm. We contacted pt and left message to come in and redue vaccine as per cdc guidelines recommendation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
N.a
Aktuelle Erkrankungen
unkown
Vorgeschichte
n/a
Andere Medikamente
unkown
Allergien
unkown
Vorherige Impfungen
-

VAERS 2010231

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
ID
Alter
16,0
Geschlecht
M
Eingang
06.01.2022
Impfdatum
30.12.2021
Beginn
30.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

The Janssen Covid 19 vaccine was given to Clancey, who is 16 years old. This vaccine is only approved for 18 and older.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2010131

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
AZ
Alter
16,0
Geschlecht
M
Eingang
06.01.2022
Impfdatum
05.01.2022
Beginn
05.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

There was no adverse event but the vaccine was given to a patient that was under the recommended age of 18. Our appointment system is flawed and allows patients under 18 to register for the Moderna and Janssen vaccines so this is something we missed when verifying the patient's DOB. Upon calling the patient the patient's father, father said the patient feels fine with no issues at this time. I advised that they reach out to the patient's primary care physician or visit and Emergency Room if the patient's health situation changes. I also, informed them that we made a mistake and that the patient should not have gotten a Janssen vaccine due to him being under 18 years of age.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1999183

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
AZ
Alter
17,0
Geschlecht
F
Eingang
03.01.2022
Impfdatum
31.12.2021
Beginn
31.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient was identified at the time of vaccination to be under the age of 17 after being administered the Janssen vaccine. No signs or symptoms of adverse effects was reported by the family over the course of 3 days. No reported treatment or hospitalization was required from the parent/guardian at this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Unknown
Allergien
Aspirin
Vorherige Impfungen
-

VAERS 1997697

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
AZ
Alter
53,0
Geschlecht
F
Eingang
02.01.2022
Impfdatum
07.12.2021
Beginn
10.12.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Lymphadenitis Lymphadenopathy

Symptomtext

Lymph node swelling (right arm and right leg)--still ongoing Inflammation in lymphs near ears (improved)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Lymphadenitis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 1994569

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
31.12.2021
Impfdatum
-
Beginn
28.12.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered

Symptomtext

VACCINE ADMINISTERED TO A PATIENT 30 MINUTES PAST THE 6 HOUR MARK OF INITIAL PUNCTURE; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: 11-APR-2022) dose was not reported (Dose number in series:1), administered on 28-DEC-2021 for prophylactic vaccination. No concomitant medications were reported. On 28-DEC-2021, the patient experienced vaccine administered to a patient 30 minutes past the 6 hour mark of initial puncture.(Dose number in series:1) The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of vaccine administered to a patient 30 minutes past the 6 hour mark of initial puncture was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1985740

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
52,0
Geschlecht
M
Eingang
28.12.2021
Impfdatum
28.12.2021
Beginn
28.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

No Adverse event. Error in giving vaccine. Vaccine was given after 6 hours of puncture of vial and had expired for over 30 minutes. Spoke with Janssen manufacturer and also CDC guidelines no data available for vaccine stability and will revaccinate patient asap. Patient was contacted and explained situation, appt. was made for patient to return for revaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
-

VAERS 1985084

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
33,0
Geschlecht
F
Eingang
28.12.2021
Impfdatum
14.12.2021
Beginn
14.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Client received the COVID vaccine Janssen booster (Lot# 1855191 exp. 04/11/2022) at 4:41 PM. While reviewing the participant forms, RN noted the Janssen COVID vaccine was administered 41 minutes after beyond use date (time) of 4:00 PM. RN verified with the vaccine preparer the beyond use date (time) was 4:00PM.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 1984906

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
38,0
Geschlecht
F
Eingang
28.12.2021
Impfdatum
27.12.2021
Beginn
27.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Dry throat Feeling hot Throat tightness

Symptomtext

Patient presented to the vaccination site on 12/27/21. Patient stated to vaccinator that she had a severe allergic reaction to her first dose COVID Pfizer vaccine. Vaccinator alerted RN. Patient stated that her PCP prescribed her 25mg oral benadryl TID 12/06/21-1/03/21 and was given an epi-pen to bring with her for COVID second dose vaccine. RN submitted a medical consult via text message to Vaccine Operations Leads, requesting to proceed with the COVID vaccine Pfizer second dose. Per CDC guidance, approval to proceed with COVID vaccine Janssen second dose was obtained from medical consult team, Vaccine Operations Lead, RN via text message. Client received COVID vaccine Janssen Lot# 1855191. Patient was asked to stay in observation for 30 minutes. Patient alerted EMT and stated that her throat felt tight and she felt warm. EMT alerted RN and other RN. EMT took patients vital signs. BP:136/86, HR: 103, O2: 98%. Patient stated that she felt warm and that her throat felt dry and tight. RN called EMS at 1709. EMt retook patients vital signs at 1714. BP: 136/80, HR: 79, O2: 98%. EMS arrived at 1716. EMS assessed patient. Patient signed AMA form at 1722. EMS left vaccination site at 1722. Patient was asked to stay an extra 30 minutes for observation. EMT retook vital signs and reassessed patient at 1735. BP: 138/86, HR: 91, O2: 99%. Patient still felt like her throat was dry but it did not feel as tight. Patient stated that she no longer felt warm. EMT retook vital signs and reassessed patient at 1745. BP: 132/86, HR: 85, O2: 97%. Patient stated that her symptoms are improving. Patient stated that she is no longer hot. Patient completed her extra 30 minute observation. Patient left vaccination site at 1746 with her husband unassisted and with a steady gait.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dry throat
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1984184

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
-
Alter
42,0
Geschlecht
F
Eingang
28.12.2021
Impfdatum
22.12.2021
Beginn
22.12.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Interchange of vaccine products

Symptomtext

Patient reported to RN a first dose reaction to Moderna COVID vaccine (LOT# 042L20A, exp. 07/05/2021) on 01/23/2021. Patient reported she did not receive a second dose of Moderna COVID vaccine. RN assessed patient. Patient reported "subtle" throat swelling approximately one hour after vaccination. Patient reported symptom lasted for 3 days and took benadryl for 3 days. Patient denied itchiness, rashes, and difficulty breathing. Patient reported history of environmental allergies, no chronic conditions, and no current medications. Patient followed up with PCP, and PCP recommended for patient to receive Janssen due to first dose Moderna COVID vaccine reaction. At 1257, RN elevated to Clinical Supervisors. Clinical Supervisors elevated to medical consult team. Medical consult team approved patient to receive Janssen. RN advised patient to wait for 30 minutes in observation and educated patient on signs/symptoms of when to alert observation staff. At 1506, patient received a single dose of Janssen COVID vaccine (LOT# 1855191, exp. 04/11/2022) in the left arm. At approximately 1521, RN assessed patient. Patient denied throat swelling, itchiness, rashes, and difficulty breathing. At approximately 1537, RN reassessed patient. Patient denied throat swelling, itchiness, rashes, and difficulty breathing. RN educated patient on signs/symptoms of when to seek emergency care, to follow up with PCP, and to sign up on V-safe.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none reported
Vorgeschichte
none reported
Andere Medikamente
Zyrtec
Allergien
environmental; augmentin
Vorherige Impfungen
-

VAERS 1981382

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
27.12.2021
Impfdatum
-
Beginn
23.12.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered Product storage error

Symptomtext

VACCINE GIVEN AFTER USE BY TIME. IT HAD BEEN SITTING AT ROOM TEMPERATURE FOR FOUR AND A HALF HOURS; OUT OF SPECIFICATION PRODUCT USE; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, and expiry: 11-APR-2022) dose was not reported, administered on 23-DEC-2021 for prophylactic vaccination. No concomitant medications were reported. On 23-DEC-2021, the patient experienced vaccine given after use by time. it had been sitting at room temperature for four and a half hours, and out of specification product use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine given after use by time. it had been sitting at room temperature for four and a half hours and out of specification product use was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1979408

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
NJ
Alter
32,0
Geschlecht
M
Eingang
24.12.2021
Impfdatum
16.12.2021
Beginn
16.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syringe issue

Symptomtext

Empty syringe was administered, pharmacist realized it and explained to patient. Patient agreed to receive full vaccination after the event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syringe issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1978506

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
PA
Alter
-
Geschlecht
M
Eingang
24.12.2021
Impfdatum
-
Beginn
22.12.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered

Symptomtext

A VACCINE WAS ADMINISTERED AT ROOM TEMPERATURE 5 HOURS AFTER FIRST PUNCTURE; This spontaneous report received from a pharmacist concerned a 47 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191 expiry: UNKNOWN) dose was not reported, administered on 22-DEC-2021 for prophylactic vaccination. No concomitant medications were reported. On 22-DEC-2021, the patient experienced a vaccine was administered at room temperature 5 hours after first puncture. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of a vaccine was administered at room temperature 5 hours after first puncture was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1972480

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
PA
Alter
47,0
Geschlecht
M
Eingang
22.12.2021
Impfdatum
22.12.2021
Beginn
22.12.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administration error

Symptomtext

The Vaccine administered to the patient was administered outside of the 2 hour at room temperature window for the Janssen covid 19 vaccine (was at room temperature for about 5 hours). No issues reported by patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
None
Vorherige Impfungen
-

VAERS 1971514

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
70,0
Geschlecht
M
Eingang
22.12.2021
Impfdatum
21.12.2021
Beginn
21.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

There was a covid vaccine clinic at the weekly showers available to unhoused people. Pt stated he would like to receive a covid vaccine. Pt completed screening form and marked that he had never received a covid vaccine before. We confirmed this verbally. The vaccine was administered. When I entered the vaccine into the database after the clinic, I noticed the pt had received two doses of Moderna (2/23/21 and 3/23/21) and a booster dose of Pfizer on 11/9/21. Pt is homeless and I have no way of contacting him to inform him he received an extra covid vaccine dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
codeine
Vorherige Impfungen
-

VAERS 1968229

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
57,0
Geschlecht
M
Eingang
21.12.2021
Impfdatum
21.12.2021
Beginn
21.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Interchange of vaccine products

Symptomtext

Patient received the Janssen COVID-19 vaccine (batch/lot# 1855191 and expiration date: 04/11/2021), at 10:48 pm in error. He was due for second dose Moderna COVID-19 vaccine. Patient verbalized his request to receive the Janssen dose. The RN/vaccinator gave him the Janssen COVID-19 vaccine. The immunization registry staff brought this to the attention of the lead RN vaccinator after the dose was given. They did not disclose problem until after incident had occurred. Lead RN vaccinator provided education on the importance of verifying doses before administration occurs. Everyone verbalized understanding. Earlier in the day the resource nurse provided a list of clients that needed the COVID-19 vaccine, however this patient was placed on the Janssen COVID-19 vaccine list rather than the Moderna COVID-19 vaccine list. Lead RN vaccinator discussed error with the nurse. During the discussion there was no other evidence of a second dose of Moderna COVID-19 vaccine given prior to today's Janssen COVID-19 vaccine. Resource nurse verbalized understanding of error displayed on the list given. Lead RN made supervisors aware of incident, no further direction needed at this time. Observation period done. No complaints from patient or via staff.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None stated by client.
Vorgeschichte
None stated by client.
Andere Medikamente
None stated by client.
Allergien
None stated by client.
Vorherige Impfungen
-

VAERS 1963950

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
OH
Alter
60,0
Geschlecht
F
Eingang
20.12.2021
Impfdatum
18.11.2021
Beginn
06.12.2021
Tage bis Beginn
18,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Hypoaesthesia Peripheral coldness Raynaud's phenomenon Skin discolouration

Symptomtext

Cold , numb, white fingers comes and goes. Dx Raynaud's

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypoaesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1963315

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
63,0
Geschlecht
F
Eingang
20.12.2021
Impfdatum
14.12.2021
Beginn
15.12.2021
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Vertigo

Symptomtext

The morning after shot, I had vertigo (spinning) when rising. It will stop when I steady my head, but continues to occur any time I lay down, bend over, or move my head quickly.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vertigo
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
hypothyroid
Andere Medikamente
Levothyroid, calcuim and Vit D supplement
Allergien
none
Vorherige Impfungen
-

VAERS 1957781

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
17.12.2021
Impfdatum
-
Beginn
14.12.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered

Symptomtext

3 DOSES ADMINISTERED TO PATIENTS AFTER USE BY TIME; This spontaneous report received from a health care professional concerned multiple patients. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191 expiry: 11-APR-2022) dose was not reported, administered on 14-DEC-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-DEC-2021, the patient experienced 3 doses administered to subjects after use by time. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of 3 doses administered to patients after use by time was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1955599

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
GA
Alter
58,0
Geschlecht
F
Eingang
16.12.2021
Impfdatum
12.11.2021
Beginn
12.12.2021
Tage bis Beginn
30,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Gynaecological examination normal Laboratory test normal Postmenopausal haemorrhage Ultrasound scan vagina normal

Symptomtext

I?ve had post menopausal bleeding since 12/12/21 through now. I haven?t had a period in 3 years

Weitere VAERSDATA-Felder
Praegender Schweregrund
Gynaecological examination normal
Hospital-Tage
-
Labordaten
I went to emergency room and they did lab work and vaginal exam and transvaginal ultrasound all which indicated nothing really abnormal. That was on 12 /13/21
Aktuelle Erkrankungen
Injured left knee
Vorgeschichte
NA
Andere Medikamente
Wellbutrin Vitamins Ozembic
Allergien
Nexium Bactria
Vorherige Impfungen
-

VAERS 1955021

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CO
Alter
23,0
Geschlecht
M
Eingang
16.12.2021
Impfdatum
14.12.2021
Beginn
14.12.2021
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

Patient reported not having been vaccinated against COVID-19 in the past, and was vaccinated. Upon data entry the next day, it was discovered that patient had already received 2 doses of Janssen COVID-19 vaccine - one on 5/6/21 and one on 11/18/21. No adverse events known as of 12/16/21, but a third dose of Janssen is not recommended or approved by CDC.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1945314

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
17,0
Geschlecht
M
Eingang
13.12.2021
Impfdatum
11.12.2021
Beginn
11.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

No actual adverse event. Patient was 17 years old and didn't meet the minimum requirement for being 18 years.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none known
Vorgeschichte
none known
Andere Medikamente
none known
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 1940156

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
WA
Alter
61,0
Geschlecht
M
Eingang
10.12.2021
Impfdatum
09.12.2021
Beginn
09.12.2021
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Interchange of vaccine products

Symptomtext

Patient completed the Moderna Primary Series on 11/11/2021 but received Janssen for booster yesterday.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
denied
Vorgeschichte
denied
Andere Medikamente
denied
Allergien
nka
Vorherige Impfungen
-

VAERS 1931752

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
UT
Alter
21,0
Geschlecht
M
Eingang
08.12.2021
Impfdatum
-
Beginn
03.12.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered

Symptomtext

ADMINISTRATION OF VACCINE FROM PUNCTURED VIAL AFTER 6 HOURS; This spontaneous report received from a health care professional concerned a 21 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: 07-MAR-2022) dose was not reported, administered on 03-DEC-2021 15:30 for prophylactic vaccination. No concomitant medications were reported. On 03-DEC-2021, the patient experienced administration of vaccine from punctured vial to the patient after 6 hours. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of vaccine from punctured vial to the patient after 6 hours was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1925933

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
PA
Alter
33,0
Geschlecht
F
Eingang
06.12.2021
Impfdatum
29.11.2021
Beginn
29.11.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

Patient was given vaccine 20 minutes outside of the 6 hour window for an open vial. Patient was fine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 1924988

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
UT
Alter
21,0
Geschlecht
M
Eingang
06.12.2021
Impfdatum
03.12.2021
Beginn
03.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Once poked, Janssen should be discarded after six hours. The patient was administered a dose after the vial had been poked for six and a half hours. I have reached out to Johnsons and Johnson's medical team.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
NA
Allergien
NA
Vorherige Impfungen
-

VAERS 1921019

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
TX
Alter
57,0
Geschlecht
M
Eingang
03.12.2021
Impfdatum
01.12.2021
Beginn
02.12.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Decreased appetite Lethargy Limb discomfort Loss of personal independence in daily activities

Symptomtext

The day after the shot I was very lethargic and my legs felt like lead. Appetite and desire to go about my daily routine were drastically impacted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Decreased appetite
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1912225

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
01.12.2021
Impfdatum
-
Beginn
01.11.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered Product storage error

Symptomtext

VACCINE WAS ADMINISTERED AFTER 6 HOURS AND 20 MINUTES AFTER VIAL WAS OPENED; INCORRECT PRODUCT STORAGE; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: UNKNOWN) dose was not reported, administered on 29-NOV-2021 for prophylactic vaccination. No concomitant medications were reported. On NOV-2021, the patient experienced incorrect product storage. On 29-NOV-2021, the patient experienced vaccine was administered after 6 hours and 20 minutes after vial was opened. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the incorrect product storage and vaccine was administered after 6 hours and 20 minutes after vial was opened was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1910445

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
-
Alter
38,0
Geschlecht
F
Eingang
30.11.2021
Impfdatum
29.11.2021
Beginn
30.11.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Dermatitis

Symptomtext

Patient broke out in dermatitis on forearm one day later.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dermatitis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1910061

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
-
Alter
42,0
Geschlecht
M
Eingang
30.11.2021
Impfdatum
30.11.2021
Beginn
30.11.2021
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

Client received the 1st COVID vaccine Janssen Lot: 1805020 on 03/09/2021, unknown expiration date and is requesting a Janssen COVIF Booster and Flu vaccine. PHN verified previous dose on databases and only had indicated a initial dose, therefore per CDC guidelines okay to proceed with booster. PHN proceeded with vaccinating client with the Janssen COVID booster when client stated "I think I got my booster before". PHN searched in databases and no booster dose displayed. Upon searching for a third time on database, client was listed under "Check-in" for booster dose on October 26, 2021. participant forms from October 26, 2021 show client listed as receiving Janssen COVID booster. PHN spoke with clinical supervisor who has been made aware of incident. No adverse symptoms noted or reported during observation period. Client was educated on s/sx of when to seek care, follow up with MD, and use of V-Safe.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 1909706

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
66,0
Geschlecht
F
Eingang
30.11.2021
Impfdatum
30.11.2021
Beginn
30.11.2021
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Interchange of vaccine products No adverse event

Symptomtext

Client presented to the vaccination site on 11/30/21. The client received 1st dose AstraZeneca COVID vaccine on 12/30/2021 and 2nd dose AztraZeneca COVID vaccine on 01/27/2021. Client reported no reaction to the vaccine and requested Janssen booster COVID vaccine for travel and work purposes. RN submitted a medical consult via text message to Vaccine Operations Lead requesting to proceed with the COVID vaccine Janssen booster. , RN elevated request to MD who gave approval for client to receive the Janssen booster COVID vaccine. Client received Janssen vaccine (lot# 1855191) on 11/30/2021 at approximately 1115 in the L deltoid. No reaction was observed while client was in observation

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1904659

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
GA
Alter
-
Geschlecht
U
Eingang
29.11.2021
Impfdatum
-
Beginn
26.11.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Off label use Product administered to patient of inappropriate age

Symptomtext

INAPPROPRIATE AGE AT VACCINE ADMINISTRATION (ADMINISTERED TO UNDER THE AGE OF 18); OFF LABEL USE; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191, expiry: 11-APR-2022) dose was not reported, administered on 26-NOV-2021 for prophylactic vaccination. No concomitant medications were reported. On 26-NOV-2021, the patient experienced inappropriate age at vaccine administration (administered to under the age of 18). On 26-NOV-2021, the patient experienced off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the inappropriate age at vaccine administration (administered to under the age of 18) and off label use was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Off label use
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1904336

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
ME
Alter
35,0
Geschlecht
F
Eingang
28.11.2021
Impfdatum
26.11.2021
Beginn
26.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dysgeusia

Symptomtext

Metallic taste in mouth.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dysgeusia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1902245

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
SC
Alter
14,0
Geschlecht
M
Eingang
26.11.2021
Impfdatum
26.11.2021
Beginn
26.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Patient received wrong vaccination. He is 14 years old and was given Janssen covid vaccine. He should have gotten Pfizer.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1889474

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
MS
Alter
20,0
Geschlecht
M
Eingang
22.11.2021
Impfdatum
21.11.2021
Beginn
21.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Interchange of vaccine products

Symptomtext

Administered vaccine at a "homeless" event. Patient stated that he had received Johnson & Johnson in the past. When entering patient's information in the database the patient had received Pfizer vaccines in the past.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
None Known
Andere Medikamente
None Known
Allergien
None Known
Vorherige Impfungen
-

VAERS 1887657

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
UT
Alter
-
Geschlecht
U
Eingang
20.11.2021
Impfdatum
-
Beginn
16.11.2021
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered Product temperature excursion issue

Symptomtext

45 TOTAL VIALS INVOLVED IN TEMPERATURE EXCURSION; ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191 and expiry: 11/APR/2022) dose was not reported, administered on 16-NOV-2021 for prophylactic vaccination. No concomitant medications were reported. On 16-NOV-2021, the patient experienced administration of expired vaccine. On an unspecified date, the patient experienced 45 total vials involved in temperature excursion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration of expired vaccine and 45 total vials involved in temperature excursion was not reported. This report was non-serious. This case, from the same reporter is linked to 20211143090 and 20211139494.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1880001

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
AZ
Alter
-
Geschlecht
U
Eingang
18.11.2021
Impfdatum
-
Beginn
17.11.2021
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered Product storage error

Symptomtext

VACCINE ADMINISTERED WHICH WAS STORED OUTSIDE OF THE RECOMMENDED STORAGE CONDITIONS; VACCINE STORED AT ROOM TEMPERATURE (BELOW 77 F) FOR ABOUT 24 -25 HOURS (STORED AT 36 C INSTEAD OF 36 F); This spontaneous report received from a physician concerned multiple patients. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855191 expiry: 11-APR-2022) dose was not reported, administered on 17-NOV-2021 for prophylactic vaccination. No concomitant medications were reported. On 17-NOV-2021, the patient experienced vaccine administered which was stored outside of the recommended storage conditions. On 17-NOV-2021, the patient experienced vaccine stored at room temperature (below 77 f) for about 24 -25 hours (stored at 36 c instead of 36 f). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine stored at room temperature (below 77 f) for about 24 -25 hours (stored at 36 c instead of 36 f) and vaccine administered which was stored outside of the recommended storage conditions was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1877120

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 1855191

gering
Staat
CA
Alter
56,0
Geschlecht
F
Eingang
17.11.2021
Impfdatum
17.11.2021
Beginn
17.11.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Movement disorder

Symptomtext

patient reported that she couldn't move her legs. no pain reported just frozen. her bp and pulse were normal at 120/80 and 77. her o2 was 99. blood sugar was normal at 91. reported not eating prior.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Movement disorder
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
-
Andere Medikamente
levothyroxine
Allergien
none
Vorherige Impfungen
janseen